{ "version": "2.2", "instance": { "biox-20251231x6k.htm biox-20251231xex99d1.htm": { "nsprefix": "biox", "nsuri": "http://www.biocerescrops.com/20251231", "dts": { "schema": { "local": [ "biox-20251231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/2023/calculation-1.1.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd", "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions-ea/rol_ifrs_ea-dim_2025-03-27.xsd", "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions/rol_full_ifrs-dim_2025-03-27.xsd", "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd", "https://xbrl.sec.gov/country/2025/country-2025.xsd", "https://xbrl.sec.gov/currency/2025/currency-2025.xsd", "https://xbrl.sec.gov/dei/2025/dei-2025.xsd" ] }, "calculationLink": { "local": [ "biox-20251231_cal.xml" ] }, "definitionLink": { "local": [ "biox-20251231_def.xml" ], "remote": [ "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions-ea/dim_ifrs_ea_2025-03-27_role-995000.xml", "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions/dim_full_ifrs_2025-03-27_role-995000.xml" ] }, "labelLink": { "local": [ "biox-20251231_lab.xml" ] }, "presentationLink": { "local": [ "biox-20251231_pre.xml" ] }, "inline": { "local": [ "biox-20251231x6k.htm", "biox-20251231xex99d1.htm" ] } }, "keyStandard": 255, "keyCustom": 140, "axisStandard": 27, "axisCustom": 2, "memberStandard": 49, "memberCustom": 55, "hidden": { "total": 7, "http://xbrl.sec.gov/dei/2025": 6, "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full": 1 }, "contextCount": 439, "entityCount": 1, "segmentCount": 112, "elementCount": 659, "unitCount": 8, "baseTaxonomies": { "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full": 1398, "http://xbrl.sec.gov/dei/2025": 8 }, "report": { "R1": { "role": "http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation", "longName": "00090 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231x6k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231x6k.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition", "longName": "00100 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION", "shortName": "UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "ifrs-full:CurrentTaxAssets", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "unique": true } }, "R3": { "role": "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome", "longName": "00200 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "shortName": "UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_8SVg2OEWOUO-CsCh75qkNw", "name": "ifrs-full:RevenueFromContractsWithCustomers", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_8SVg2OEWOUO-CsCh75qkNw", "name": "biox:ChangeInNetRealizableValueOfAgricultural", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "unique": true } }, "R4": { "role": "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity", "longName": "00300 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY", "shortName": "UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "As_Of_6_30_2024_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_gX_I4hWZHEKyr8fLJhNwCA", "name": "ifrs-full:Equity", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2024_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_gX_I4hWZHEKyr8fLJhNwCA", "name": "ifrs-full:Equity", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R5": { "role": "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows", "longName": "00400 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "shortName": "UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_8SVg2OEWOUO-CsCh75qkNw", "name": "ifrs-full:ProfitLoss", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:AdjustmentsForIncomeTaxExpense", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "unique": true } }, "R6": { "role": "http://www.biocerescrops.com/role/DisclosureGeneralInformation", "longName": "10101 - Disclosure - GENERAL INFORMATION", "shortName": "GENERAL INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "6", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R7": { "role": "http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPreparation", "longName": "10201 - Disclosure - ACCOUNTING STANDARDS AND BASIS OF PREPARATION", "shortName": "ACCOUNTING STANDARDS AND BASIS OF PREPARATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "biox:DisclosureOfAccountingStandardsAndBasisOfPresentationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "biox:DisclosureOfAccountingStandardsAndBasisOfPresentationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.biocerescrops.com/role/DisclosureNewStandardsAmendmentsAndInterpretationsIssuedByIasb", "longName": "10301 - Disclosure - NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB", "shortName": "NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperations", "longName": "10401 - Disclosure - ASSETS SUBJECT TO FORECLOSURE AND DISCONTINUED OPERATIONS", "shortName": "ASSETS SUBJECT TO FORECLOSURE AND DISCONTINUED OPERATIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPosition", "longName": "10501 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "biox:DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "biox:DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncome", "longName": "10601 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "biox:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "biox:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.biocerescrops.com/role/DisclosureTaxation", "longName": "10701 - Disclosure - TAXATION", "shortName": "TAXATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.biocerescrops.com/role/DisclosureEarningPerShare", "longName": "10801 - Disclosure - EARNING PER SHARE", "shortName": "EARNING PER SHARE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.biocerescrops.com/role/DisclosureEquityInformation", "longName": "10901 - Disclosure - EQUITY INFORMATION", "shortName": "EQUITY INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.biocerescrops.com/role/DisclosureCashFlowInformation", "longName": "11001 - Disclosure - CASH FLOW INFORMATION", "shortName": "CASH FLOW INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociates", "longName": "11101 - Disclosure - JOINT VENTURES AND ASSOCIATES", "shortName": "JOINT VENTURES AND ASSOCIATES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "biox:InvestmentsInJointVenturesAndAssociatesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "biox:InvestmentsInJointVenturesAndAssociatesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.biocerescrops.com/role/DisclosureSegmentInformation", "longName": "11201 - Disclosure - SEGMENT INFORMATION", "shortName": "SEGMENT INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagement", "longName": "11301 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT", "shortName": "FINANCIAL INSTRUMENTS - RISK MANAGEMENT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.biocerescrops.com/role/DisclosureLeases", "longName": "11401 - Disclosure - LEASES", "shortName": "LEASES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfLeasesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfLeasesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactions", "longName": "11501 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS", "shortName": "SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensation", "longName": "11601 - Disclosure - KEY MANAGEMENT PERSONNEL COMPENSATION", "shortName": "KEY MANAGEMENT PERSONNEL COMPENSATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.biocerescrops.com/role/DisclosureContingenciesCommitmentsAndRestrictionsOnDistributionOfProfits", "longName": "11701 - Disclosure - CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS", "shortName": "CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfCommitmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfCommitmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.biocerescrops.com/role/DisclosureEventsOccurringAfterReportingPeriod", "longName": "11801 - Disclosure - EVENTS OCCURRING AFTER THE REPORTING PERIOD", "shortName": "EVENTS OCCURRING AFTER THE REPORTING PERIOD", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPreparationPolicies", "longName": "20202 - Disclosure - ACCOUNTING STANDARDS AND BASIS OF PREPARATION (Policies)", "shortName": "ACCOUNTING STANDARDS AND BASIS OF PREPARATION (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "24", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "biox:DescriptionOfAccountingPolicyForBasisOfMeasurementTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "biox:DisclosureOfAccountingStandardsAndBasisOfPresentationTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "biox:DescriptionOfAccountingPolicyForBasisOfMeasurementTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "biox:DisclosureOfAccountingStandardsAndBasisOfPresentationTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsTables", "longName": "30403 - Disclosure - ASSETS SUBJECT TO FORECLOSURE AND DISCONTINUED OPERATIONS (Tables)", "shortName": "ASSETS SUBJECT TO FORECLOSURE AND DISCONTINUED OPERATIONS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables", "longName": "30503 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Tables)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "biox:DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "biox:DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables", "longName": "30603 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Tables)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "biox:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "biox:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.biocerescrops.com/role/DisclosureTaxationTables", "longName": "30703 - Disclosure - TAXATION (Tables)", "shortName": "TAXATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "biox:IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "biox:IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.biocerescrops.com/role/DisclosureEarningPerShareTables", "longName": "30803 - Disclosure - EARNING PER SHARE (Tables)", "shortName": "EARNING PER SHARE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:EarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:EarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.biocerescrops.com/role/DisclosureCashFlowInformationTables", "longName": "31003 - Disclosure - CASH FLOW INFORMATION (Tables)", "shortName": "CASH FLOW INFORMATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "biox:ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "biox:ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesTables", "longName": "31103 - Disclosure - JOINT VENTURES AND ASSOCIATES (Tables)", "shortName": "JOINT VENTURES AND ASSOCIATES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "biox:DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "biox:InvestmentsInJointVenturesAndAssociatesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "biox:DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "biox:InvestmentsInJointVenturesAndAssociatesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.biocerescrops.com/role/DisclosureSegmentInformationTables", "longName": "31203 - Disclosure - SEGMENT INFORMATION (Tables)", "shortName": "SEGMENT INFORMATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementTables", "longName": "31303 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT (Tables)", "shortName": "FINANCIAL INSTRUMENTS - RISK MANAGEMENT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfFinancialAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfFinancialAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.biocerescrops.com/role/DisclosureLeasesTables", "longName": "31403 - Disclosure - LEASES (Tables)", "shortName": "LEASES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "biox:Disclosureofrightofuseleasedassetsandleaseliabilitytabletextblock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfLeasesExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "biox:Disclosureofrightofuseleasedassetsandleaseliabilitytabletextblock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfLeasesExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTables", "longName": "31503 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS (Tables)", "shortName": "SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationTables", "longName": "31603 - Disclosure - KEY MANAGEMENT PERSONNEL COMPENSATION (Tables)", "shortName": "KEY MANAGEMENT PERSONNEL COMPENSATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "biox:DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "biox:DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.biocerescrops.com/role/DisclosureGeneralInformationDetails", "longName": "40101 - Disclosure - GENERAL INFORMATION - (Details)", "shortName": "GENERAL INFORMATION - (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "biox:MinimumNumberOfCountriesWhereEntityMarketedAgriculturalInputs", "unitRef": "Unit_Standard_country_DkOjWzCk4kmc11eyGLeD9A", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "biox:MinimumNumberOfCountriesWhereEntityMarketedAgriculturalInputs", "unitRef": "Unit_Standard_country_DkOjWzCk4kmc11eyGLeD9A", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNarrativeDetails", "longName": "40401 - Disclosure - ASSETS SUBJECT TO FORECLOSURE AND DISCONTINUED OPERATIONS - Narrative (Details)", "shortName": "ASSETS SUBJECT TO FORECLOSURE AND DISCONTINUED OPERATIONS - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_8SVg2OEWOUO-CsCh75qkNw", "name": "ifrs-full:GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_1_20_2026_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_ifrs-full_DiscontinuedOperationsMember_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_ifrs-full_ClassificationOfAssetsAsHeldForSaleMember_hvwn-zvAEkSnV4nnYr7XrQ", "name": "biox:ConsiderationOfferedFromNoteholders", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "p", "ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "unique": true } }, "R39": { "role": "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetLossFromForeclosureDetails", "longName": "40402 - Disclosure - ASSETS SUBJECT TO FORECLOSURE AND DISCONTINUED OPERATIONS - Net loss from foreclosure (Details)", "shortName": "ASSETS SUBJECT TO FORECLOSURE AND DISCONTINUED OPERATIONS - Net loss from foreclosure (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_8SVg2OEWOUO-CsCh75qkNw", "name": "ifrs-full:GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": null }, "R40": { "role": "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "longName": "40403 - Disclosure - ASSETS SUBJECT TO FORECLOSURE AND DISCONTINUED OPERATIONS - Net assets subject to foreclosure (Details)", "shortName": "ASSETS SUBJECT TO FORECLOSURE AND DISCONTINUED OPERATIONS - Net assets subject to foreclosure (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2025_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember_JeDwX27NdUmEsnKuC6ORQA", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "unique": true } }, "R41": { "role": "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetIncomeFromDiscontinuedOperationsDetails", "longName": "40404 - Disclosure - ASSETS SUBJECT TO FORECLOSURE AND DISCONTINUED OPERATIONS - Net income from discontinued operations (Details)", "shortName": "ASSETS SUBJECT TO FORECLOSURE AND DISCONTINUED OPERATIONS - Net income from discontinued operations (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_8SVg2OEWOUO-CsCh75qkNw", "name": "ifrs-full:RevenueFromContractsWithCustomers", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember_A9i4iiQ7r0CQdeXf_7GFhQ", "name": "ifrs-full:RevenueFromContractsWithCustomers", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "unique": true } }, "R42": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionCashAndCashEquivalentsDetails", "longName": "40501 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Cash and cash equivalents (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Cash and cash equivalents (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "ifrs-full:Cash", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "biox:DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "ifrs-full:Cash", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "biox:DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails", "longName": "40502 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other financial assets (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other financial assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "ifrs-full:OtherCurrentFinancialAssets", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2025_ifrs-full_ClassesOfAssetsAxis_biox_MutualFundsMember_soRTYHNiiE2xv0S6u7ipIw", "name": "ifrs-full:OtherCurrentFinancialAssets", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfOtherFinancialAssetsExplanatory", "biox:DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "unique": true } }, "R44": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails", "longName": "40503 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade receivables (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade receivables (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "ifrs-full:CurrentTradeReceivables", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2025_biox_IfrsBalanceSheetLocationAxis_ifrs-full_TradeReceivablesMember_5hypgK3epEOHD89dwinhHQ", "name": "biox:AllowanceForReturnOfGoods", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfTradeReceivablesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "unique": true } }, "R45": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "longName": "40504 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other receivables (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other receivables (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "ifrs-full:OtherCurrentReceivables", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2025_biox_IfrsBalanceSheetLocationAxis_biox_OtherReceivablesMember_NKgmGS2rFkKzZlLbWQ82XQ", "name": "biox:ReceivablesFromTaxCreditsCurrent", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfOtherReceivablesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "unique": true } }, "R46": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails", "longName": "40505 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Inventories (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Inventories (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "ifrs-full:CurrentInventoriesInTransit", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:IfrsScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "ifrs-full:CurrentInventoriesInTransit", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:IfrsScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails", "longName": "40506 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "As_Of_6_30_2025_Y8U9-ZanjkKAcwaBNojQLQ", "name": "ifrs-full:PropertyPlantAndEquipment", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfDepreciationExpenseTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "unique": true } }, "R48": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails", "longName": "40507 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "As_Of_6_30_2025_Y8U9-ZanjkKAcwaBNojQLQ", "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfAccumulatedAmortizationOfIntangibleAssets.TextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "unique": true } }, "R49": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails", "longName": "40508 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Goodwill (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Goodwill (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "ifrs-full:Goodwill", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2025_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_biox_RizobacterArgentinaMember_BU3G5-kuCU682TmaHmjfdg", "name": "ifrs-full:Goodwill", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "unique": true } }, "R50": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayablesDetails", "longName": "40509 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade and other payables (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade and other payables (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "longName": "40510 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "ifrs-full:BondsIssued", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2025_To_1_31_2025_ifrs-full_BorrowingsByNameAxis_biox_BankBorrowingsMember_KQKjw6i3hEa0hoarRgwE0g", "name": "ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "unique": true } }, "R52": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "longName": "40511 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings, carrying amount (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings, carrying amount (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "ifrs-full:ShorttermBorrowings", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2025_ifrs-full_MeasurementAxis_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_9jZdpiCOiEawDGluQ1scyA", "name": "ifrs-full:BondsIssued", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfCarryingValueOfBorrowingsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "unique": true } }, "R53": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails", "longName": "40512 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Secured notes (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Secured notes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "Duration_6_1_2025_To_6_30_2025_goeAIvs_-UGVaVzu2EMwTg", "name": "biox:AccruedPrepaymentPremiumFeeCurrent", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": null }, "R54": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionConsiderationForAcquisitionDetails", "longName": "40513 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Consideration for acquisition (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Consideration for acquisition (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "biox:CurrentContingentConsiderationRecognisedAsOfAcquisitionDate", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfConsiderationForAcquisitionTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "biox:CurrentContingentConsiderationRecognisedAsOfAcquisitionDate", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfConsiderationForAcquisitionTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R55": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionEmployeeBenefitsAndSocialSecurityDetails", "longName": "40514 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Employee benefits and social security (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Employee benefits and social security (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "biox:SalariesAccruedIncentivesVacationsAndSocialSecurityCurrent", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "biox:SalariesAccruedIncentivesVacationsAndSocialSecurityCurrent", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails", "longName": "40515 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Deferred revenue and advances from customers (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Deferred revenue and advances from customers (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "ifrs-full:CurrentAdvances", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfPerformanceObligationsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "ifrs-full:CurrentAdvances", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfPerformanceObligationsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R57": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRevenueFromContractsWithCustomersDetails", "longName": "40601 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Revenue from contracts with customers (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Revenue from contracts with customers (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_8SVg2OEWOUO-CsCh75qkNw", "name": "ifrs-full:RevenueFromRoyalties", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory", "biox:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_ifrs-full_ProductsAndServicesAxis_biox_GoodsAndServicesMember_T-8zATLQNUSVY4Dna4KcYQ", "name": "ifrs-full:RevenueFromContractsWithCustomers", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory", "biox:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "unique": true } }, "R58": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesDetails", "longName": "40602 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Cost of Sales (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Cost of Sales (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "As_Of_9_30_2025___YegFpAgUmIUkymf3UwZQ", "name": "ifrs-full:InventoriesTotal", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfCostOfSalesExplanatory", "biox:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2025___YegFpAgUmIUkymf3UwZQ", "name": "ifrs-full:InventoriesTotal", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfCostOfSalesExplanatory", "biox:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesNarrativeDetails", "longName": "40603 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Cost of Sales - Narrative (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Cost of Sales - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_8SVg2OEWOUO-CsCh75qkNw", "name": "biox:CostOfSalesAfterReclassificationOfDiscontinuedOperations", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "ifrs-full:DisclosureOfCostOfSalesExplanatory", "biox:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_8SVg2OEWOUO-CsCh75qkNw", "name": "biox:CostOfSalesAfterReclassificationOfDiscontinuedOperations", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "ifrs-full:DisclosureOfCostOfSalesExplanatory", "biox:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R60": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails", "longName": "40604 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - R&D classified by nature (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - R&D classified by nature (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfAccumulatedAmortizationOfIntangibleAssets.TextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_8SVg2OEWOUO-CsCh75qkNw", "name": "biox:ResearchAndDevelopmentExpenseCapitalized", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "unique": true } }, "R61": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "longName": "40605 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Expenses classified by nature and functions (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Expenses classified by nature and functions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfAccumulatedAmortizationOfIntangibleAssets.TextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_CostOfSalesMember_yADICCf3VEGrkrq-0r6RpA", "name": "ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfExpensesByNatureExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "unique": true } }, "R62": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails", "longName": "40606 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Other income or expenses, net (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Other income or expenses, net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_8SVg2OEWOUO-CsCh75qkNw", "name": "ifrs-full:RevenueFromSaleOfAgriculturalProduce", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_8SVg2OEWOUO-CsCh75qkNw", "name": "ifrs-full:RevenueFromSaleOfAgriculturalProduce", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R63": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails", "longName": "40607 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Finance results (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Finance results (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_8SVg2OEWOUO-CsCh75qkNw", "name": "ifrs-full:InterestExpenseOnOtherFinancialLiabilities", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_8SVg2OEWOUO-CsCh75qkNw", "name": "ifrs-full:InterestExpenseOnOtherFinancialLiabilities", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R64": { "role": "http://www.biocerescrops.com/role/DisclosureTaxationTaxesOnIncomeDetails", "longName": "40701 - Disclosure - TAXATION - Taxes on income (Details)", "shortName": "TAXATION - Taxes on income (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_8SVg2OEWOUO-CsCh75qkNw", "name": "ifrs-full:CurrentTaxExpenseIncome", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_8SVg2OEWOUO-CsCh75qkNw", "name": "ifrs-full:CurrentTaxExpenseIncome", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R65": { "role": "http://www.biocerescrops.com/role/DisclosureTaxationMovementOnDeferredIncomeTaxDetails", "longName": "40702 - Disclosure - TAXATION - Movement on the deferred income tax (Details)", "shortName": "TAXATION - Movement on the deferred income tax (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "As_Of_6_30_2025_Y8U9-ZanjkKAcwaBNojQLQ", "name": "ifrs-full:DeferredTaxLiabilityAsset", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfDeferredTaxesExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2025_Y8U9-ZanjkKAcwaBNojQLQ", "name": "ifrs-full:DeferredTaxLiabilityAsset", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfDeferredTaxesExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R66": { "role": "http://www.biocerescrops.com/role/DisclosureTaxationNarrativeDetails", "longName": "40703 - Disclosure - TAXATION - narrative (Details)", "shortName": "TAXATION - narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "Duration_7_1_2024_To_12_31_2024_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_ifrs-full_DiscontinuedOperationsMember_s3dlzaQvskOWe_3RVh-cIg", "name": "ifrs-full:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfDeferredTaxesExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2024_To_12_31_2024_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_ifrs-full_DiscontinuedOperationsMember_s3dlzaQvskOWe_3RVh-cIg", "name": "ifrs-full:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfDeferredTaxesExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R67": { "role": "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails", "longName": "40704 - Disclosure - TAXATION - Reconciliation of the statutory tax rate (Details)", "shortName": "TAXATION - Reconciliation of the statutory tax rate (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_8SVg2OEWOUO-CsCh75qkNw", "name": "ifrs-full:AccountingProfit", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_8SVg2OEWOUO-CsCh75qkNw", "name": "ifrs-full:AccountingProfit", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R68": { "role": "http://www.biocerescrops.com/role/DisclosureTaxationIncomeTaxExpenseWasCalculatedByApplyingTaxRateInForceDetails", "longName": "40705 - Disclosure - TAXATION - Income tax expense was calculated by applying the tax rate in force (Details)", "shortName": "TAXATION - Income tax expense was calculated by applying the tax rate in force (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_8SVg2OEWOUO-CsCh75qkNw", "name": "ifrs-full:ProfitLossBeforeTax", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_biox_TaxJurisdictionAxis_biox_LowOrNullTaxationJurisdictionsMember_mrmWN3beP0WR4eGYm3G2kw", "name": "ifrs-full:ProfitLossBeforeTax", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:ScheduleOfIncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "unique": true } }, "R69": { "role": "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails", "longName": "40801 - Disclosure - EARNING PER SHARE (Details)", "shortName": "EARNING PER SHARE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_8SVg2OEWOUO-CsCh75qkNw", "name": "ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:EarningsPerShareExplanatory", "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_8SVg2OEWOUO-CsCh75qkNw", "name": "ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:EarningsPerShareExplanatory", "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R70": { "role": "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails", "longName": "40901 - Disclosure - EQUITY INFORMATION (Details)", "shortName": "EQUITY INFORMATION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "biox:IfrsStockRepurchasedDuringPeriodShares", "unitRef": "Unit_Standard_shares_vnUqf6NkSUqr4ZavKAzRLg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "biox:IfrsStockRepurchasedDuringPeriodShares", "unitRef": "Unit_Standard_shares_vnUqf6NkSUqr4ZavKAzRLg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R71": { "role": "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails", "longName": "41001 - Disclosure - CASH FLOW INFORMATION (Details)", "shortName": "CASH FLOW INFORMATION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "biox:InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities", "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:InterestCostsCapitalised", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities", "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "unique": true } }, "R72": { "role": "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesAssetsAndLiabilitiesDetails", "longName": "41101 - Disclosure - JOINT VENTURES AND ASSOCIATES - Assets and Liabilities (Details)", "shortName": "JOINT VENTURES AND ASSOCIATES - Assets and Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "biox:InvestmentsAccountedForUsingEquityMethodAssets", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2025_ifrs-full_JointVenturesAxis_biox_SynertechIndustriasSaMember_aZcSFTu-5U2PZW6FWPXpfg", "name": "biox:InvestmentsAccountedForUsingEquityMethodAssets", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock", "biox:InvestmentsInJointVenturesAndAssociatesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "unique": true } }, "R73": { "role": "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesChangesInJointVenturesInvestmentsDetails", "longName": "41102 - Disclosure - JOINT VENTURES AND ASSOCIATES - Changes in joint ventures investments (Details)", "shortName": "JOINT VENTURES AND ASSOCIATES - Changes in joint ventures investments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "As_Of_6_30_2025_Y8U9-ZanjkKAcwaBNojQLQ", "name": "ifrs-full:InvestmentAccountedForUsingEquityMethod", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock", "biox:InvestmentsInJointVenturesAndAssociatesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2025_Y8U9-ZanjkKAcwaBNojQLQ", "name": "ifrs-full:InvestmentAccountedForUsingEquityMethod", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock", "biox:InvestmentsInJointVenturesAndAssociatesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R74": { "role": "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesShareOfProfitDetails", "longName": "41103 - Disclosure - JOINT VENTURES AND ASSOCIATES - Share of profit (Details)", "shortName": "JOINT VENTURES AND ASSOCIATES - Share of profit (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_8SVg2OEWOUO-CsCh75qkNw", "name": "ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_ifrs-full_JointVenturesAxis_biox_TrigallGeneticsSaMember_4tSztbs3IU-JQUmCZkgZwg", "name": "ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "unique": true } }, "R75": { "role": "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails", "longName": "41201 - Disclosure - SEGMENT INFORMATION - Group's reporting segments (Details)", "shortName": "SEGMENT INFORMATION - Group's reporting segments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_8SVg2OEWOUO-CsCh75qkNw", "name": "ifrs-full:RevenueFromContractsWithCustomers", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_10_1_2025_To_12_31_2025_8SVg2OEWOUO-CsCh75qkNw", "name": "ifrs-full:Revenue", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "unique": true } }, "R76": { "role": "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails", "longName": "41301 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial assets by category (Details)", "shortName": "FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial assets by category (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "As_Of_12_31_2025_ifrs-full_MeasurementAxis_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_9jZdpiCOiEawDGluQ1scyA", "name": "ifrs-full:FinancialAssets", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "ifrs-full:DisclosureOfFinancialAssetsExplanatory", "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2025_ifrs-full_MeasurementAxis_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_9jZdpiCOiEawDGluQ1scyA", "name": "ifrs-full:FinancialAssets", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "ifrs-full:DisclosureOfFinancialAssetsExplanatory", "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R77": { "role": "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails", "longName": "41302 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial liabilities by category (Details)", "shortName": "FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial liabilities by category (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "As_Of_12_31_2025_ifrs-full_MeasurementAxis_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_9jZdpiCOiEawDGluQ1scyA", "name": "ifrs-full:FinancialLiabilities", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2025_ifrs-full_MeasurementAxis_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_9jZdpiCOiEawDGluQ1scyA", "name": "ifrs-full:FinancialLiabilities", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R78": { "role": "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails", "longName": "41303 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Fair value by hierarchy (Details)", "shortName": "FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Fair value by hierarchy (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "As_Of_12_31_2025_ifrs-full_ClassesOfFinancialLiabilitiesAxis_biox_TradeAndOtherPayablesMember_ifrs-full_LevelsOfFairValueHierarchyAxis_ifrs-full_Level2OfFairValueHierarchyMember_sOqWGLa90km0444qASMY5A", "name": "ifrs-full:FinancialLiabilitiesAtFairValue", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2025_ifrs-full_ClassesOfFinancialLiabilitiesAxis_biox_TradeAndOtherPayablesMember_ifrs-full_LevelsOfFairValueHierarchyAxis_ifrs-full_Level2OfFairValueHierarchyMember_sOqWGLa90km0444qASMY5A", "name": "ifrs-full:FinancialLiabilitiesAtFairValue", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R79": { "role": "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementLiquidityRiskDetails", "longName": "41304 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Liquidity risk (Details)", "shortName": "FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Liquidity risk (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "As_Of_12_31_2025_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanThreeMonthsMember_ifrs-full_TypesOfRisksAxis_ifrs-full_LiquidityRiskMember_X1dVqwWwQkqRTPI0X-qX6w", "name": "ifrs-full:FinancialLiabilities", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:MaturityAnalysisForNonderivativeFinancialLiabilities", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2025_ifrs-full_MaturityAxis_ifrs-full_NotLaterThanThreeMonthsMember_ifrs-full_TypesOfRisksAxis_ifrs-full_LiquidityRiskMember_X1dVqwWwQkqRTPI0X-qX6w", "name": "ifrs-full:FinancialLiabilities", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:MaturityAnalysisForNonderivativeFinancialLiabilities", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R80": { "role": "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails", "longName": "41305 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Currency risk (Details)", "shortName": "FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Currency risk (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "As_Of_12_31_2025_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_tcvBgc_W1E2AuWJqtpTX_w", "name": "ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2025_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_tcvBgc_W1E2AuWJqtpTX_w", "name": "ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R81": { "role": "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails", "longName": "41401 - Disclosure - LEASES - Right-of-use leased asset (Details)", "shortName": "LEASES - Right-of-use leased asset (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "As_Of_6_30_2025_Y8U9-ZanjkKAcwaBNojQLQ", "name": "ifrs-full:RightofuseAssets", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_GOg7oAewAUeeBxf_PL7rrQ", "name": "ifrs-full:AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:Disclosureofrightofuseleasedassetsandleaseliabilitytabletextblock", "ifrs-full:DisclosureOfLeasesExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "unique": true } }, "R82": { "role": "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails", "longName": "41402 - Disclosure - LEASES - Lease liability (Details)", "shortName": "LEASES - Lease liability (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "As_Of_6_30_2025_Y8U9-ZanjkKAcwaBNojQLQ", "name": "ifrs-full:LeaseLiabilities", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "biox:Disclosureofrightofuseleasedassetsandleaseliabilitytabletextblock", "ifrs-full:DisclosureOfLeasesExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "biox:LeasesLiabilitiesAdditions", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:Disclosureofrightofuseleasedassetsandleaseliabilitytabletextblock", "ifrs-full:DisclosureOfLeasesExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "unique": true } }, "R83": { "role": "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails", "longName": "41403 - Disclosure - LEASES - Right-of-use asset by type (Details)", "shortName": "LEASES - Right-of-use asset by type (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "ifrs-full:RightofuseAssets", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2025_srt_CurrencyAxis_currency_USD_iJDoQALeYkO_Dx8Huu_OvA", "name": "ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16", "unitRef": "Unit_Standard_pure_6n8jjQZYqkGquEyMO9cKRA", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "unique": true } }, "R84": { "role": "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails", "longName": "41501 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Transactions (Details)", "shortName": "SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Transactions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "biox:InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities", "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "biox:RelatedPartyTransactions", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "unique": true } }, "R85": { "role": "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails", "longName": "41502 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Receivable (Details)", "shortName": "SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Receivable (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "ifrs-full:OtherCurrentReceivables", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "ifrs-full:AmountsReceivableRelatedPartyTransactions", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "unique": true } }, "R86": { "role": "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails", "longName": "41503 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Payables (Details)", "shortName": "SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Payables (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "86", "firstAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "ifrs-full:AmountsPayableRelatedPartyTransactions", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2025_yHFuYWuX-0aCa-qhrZ8Zlw", "name": "ifrs-full:AmountsPayableRelatedPartyTransactions", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R87": { "role": "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationSummaryOfCompensationOfDirectorsAndOtherMembersDetails", "longName": "41601 - Disclosure - KEY MANAGEMENT PERSONNEL COMPENSATION - Summary of compensation of directors and other members (Details)", "shortName": "KEY MANAGEMENT PERSONNEL COMPENSATION - Summary of compensation of directors and other members (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "87", "firstAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock", "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2025_To_12_31_2025_MdAvvN2ctE-rierlikd--w", "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock", "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true, "unique": true } }, "R88": { "role": "http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPreparationDetails", "longName": "9940201 - Disclosure - ACCOUNTING STANDARDS AND BASIS OF PREPARATION - (Details)", "shortName": "ACCOUNTING STANDARDS AND BASIS OF PREPARATION - (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "88", "firstAnchor": { "contextRef": "Duration_6_1_2025_To_6_30_2025_goeAIvs_-UGVaVzu2EMwTg", "name": "biox:AccruedPrepaymentPremiumFeeCurrent", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": null }, "R89": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails", "longName": "9940506 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Biological assets (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Biological assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "89", "firstAnchor": { "contextRef": "As_Of_6_30_2025_Y8U9-ZanjkKAcwaBNojQLQ", "name": "ifrs-full:BiologicalAssets", "unitRef": "Unit_Standard_USD_VvuXP4tUgUu_4CUWLjEDKA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20251231xex99d1.htm", "first": true }, "uniqueAnchor": null } }, "tag": { "ifrs-full_AccountingProfit": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AccountingProfit", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "Accounting profit", "terseLabel": "Earning before income tax-rate" } }, "en": { "role": { "documentation": "The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r4", "r5", "r208", "r209" ] }, "biox_AccountingStandardsAndBasisOfPreparationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "AccountingStandardsAndBasisOfPreparationAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "ACCOUNTING STANDARDS AND BASIS OF PREPARATION" } } }, "auth_ref": [] }, "biox_AccruedPrepaymentPremiumFeeCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "AccruedPrepaymentPremiumFeeCurrent", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPreparationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails" ], "lang": { "en-us": { "role": { "documentation": "The accrued prepayment premium fee current", "label": "Accrued Prepayment Premium Fee Current", "terseLabel": "Prepayment Premium Fee" } } }, "auth_ref": [] }, "ifrs-full_AccumulatedDepreciationAndAmortisationMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AccumulatedDepreciationAndAmortisationMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated depreciation and amortisation [member]", "verboseLabel": "Depreciation" } } }, "auth_ref": [ "r17", "r387", "r390", "r392", "r394" ] }, "ifrs-full_AccumulatedImpairmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AccumulatedImpairmentMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Allowance for obsolescence", "terseLabel": "Allowance for obsolescence", "verboseLabel": "Accumulated Impairment" } } }, "auth_ref": [ "r135", "r153", "r259", "r364", "r387", "r390", "r392", "r394" ] }, "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferredAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AcquisitiondateFairValueOfTotalConsiderationTransferredAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPreparationDetails" ], "lang": { "en-us": { "role": { "label": "Acquisition-date fair value of total consideration transferred [abstract]", "verboseLabel": "Acquisition-date fair value of total consideration transferred" } } }, "auth_ref": [] }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Additions other than through business combinations, intangible assets other than goodwill", "terseLabel": "Additions" } }, "en": { "role": { "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r50", "r235" ] }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Additions other than through business combinations, property, plant and equipment", "terseLabel": "Additions" } }, "en": { "role": { "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Property, plant and equipment]" } } }, "auth_ref": [ "r10", "r213" ] }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "label": "Additions other than through business combinations, right-of-use assets", "terseLabel": "Additions of the year" } }, "en": { "role": { "documentation": "The amount of additions to right-of-use assets other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Right-of-use assets]" } } }, "auth_ref": [ "r388" ] }, "ifrs-full_AdjustmentsForAmortisationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForAmortisationExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for amortisation expense", "terseLabel": "Amortization of intangible assets" } } }, "auth_ref": [ "r401" ] }, "biox_AdjustmentsForDecreaseIncreaseInDeferredRevenueAndAdvancesFromCustomers": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "AdjustmentsForDecreaseIncreaseInDeferredRevenueAndAdvancesFromCustomers", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Adjustments for decrease (increase) in deferred revenue and advances from customers to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments for Decrease (Increase) in Deferred Revenue and Advances from Customers", "terseLabel": "Deferred revenue and advances from customers" } } }, "auth_ref": [] }, "biox_AdjustmentsForDecreaseIncreaseInEmployeeBenefitsAndSocialSecurity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "AdjustmentsForDecreaseIncreaseInEmployeeBenefitsAndSocialSecurity", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Adjustments for decrease (increase) in employee benefits and social security to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments for Decrease (Increase) in Employee Benefits and Social Security", "terseLabel": "Employee benefits and social security" } } }, "auth_ref": [] }, "biox_AdjustmentsForDecreaseIncreaseInIncomeAndMinimumPresumedIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "AdjustmentsForDecreaseIncreaseInIncomeAndMinimumPresumedIncomeTaxes", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Adjustments for decrease (increase) in income and minimum presumed income taxes to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments for Decrease (Increase) in Income and Minimum Presumed Income Taxes", "terseLabel": "Income and minimum presumed income taxes" } } }, "auth_ref": [] }, "biox_AdjustmentsForDecreaseIncreaseInInflationEffectsOnWorkingCapitalAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "AdjustmentsForDecreaseIncreaseInInflationEffectsOnWorkingCapitalAdjustments", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Adjustments for decrease (increase) in Inflation effects on working capital adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments for Decrease (Increase) in Inflation Effects on Working Capital Adjustments", "terseLabel": "Inflation effects on working capital adjustments" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInInventories", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for decrease (increase) in inventories", "terseLabel": "Inventories and biological assets" } } }, "auth_ref": [ "r398" ] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for decrease (increase) in other operating receivables", "terseLabel": "Other receivables" } } }, "auth_ref": [ "r398" ] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInTradeAccountReceivable", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for decrease (increase) in trade accounts receivable", "terseLabel": "Trade receivables" } } }, "auth_ref": [ "r398" ] }, "ifrs-full_AdjustmentsForDepreciationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForDepreciationExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 21.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for depreciation expense", "terseLabel": "Depreciation of property, plant and equipment" } }, "en": { "role": { "documentation": "Adjustments for depreciation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r401" ] }, "ifrs-full_AdjustmentsForFinanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForFinanceCosts", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 22.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for finance costs", "terseLabel": "Financial results" } } }, "auth_ref": [ "r400" ] }, "ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Impairment loss recognised in profit or loss, trade receivables", "terseLabel": "Allowance for impairment of trade debtors" } } }, "auth_ref": [ "r399" ] }, "ifrs-full_AdjustmentsForIncomeTaxExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForIncomeTaxExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 23.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for income tax expense", "terseLabel": "Income tax" } } }, "auth_ref": [ "r70" ] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for increase (decrease) in trade and other payables", "terseLabel": "Trade and other payables" } }, "en": { "role": { "documentation": "Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]" } } }, "auth_ref": [ "r401" ] }, "ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for losses (gains) on disposal of non-current assets", "terseLabel": "Gain on sale of equipment and intangible assets" } } }, "auth_ref": [ "r395" ] }, "biox_AdjustmentsForObsolescence": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "AdjustmentsForObsolescence", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 13.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 22.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Adjustments for obsolescence to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments for Obsolescence", "terseLabel": "Allowance for obsolescence", "verboseLabel": "Obsolescence" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForProvisions", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for provisions", "terseLabel": "Provisions for contingencies" } } }, "auth_ref": [ "r399" ] }, "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForReconcileProfitLossAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile loss to net cash flows", "verboseLabel": "Adjustments to reconcile profit to net cash flows" } } }, "auth_ref": [] }, "biox_AdjustmentsForRestructuringAndTransactionExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "AdjustmentsForRestructuringAndTransactionExpenses", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Adjustments for restructuring and transaction expenses to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments for Restructuring And Transaction Expenses", "terseLabel": "Restructuring and transactional expenses" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForSharebasedPayments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForSharebasedPayments", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for share-based payments", "terseLabel": "Share-based incentive and stock options" } } }, "auth_ref": [ "r399" ] }, "biox_AdvancesToSuppliersNonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "AdvancesToSuppliersNonCurrent", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": "ifrs-full_OtherNoncurrentReceivables", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of non-current receivables from advances to suppliers.", "label": "Advances to suppliers, Non Current", "terseLabel": "Reimbursements over exports" } } }, "auth_ref": [] }, "biox_AlfalfaTechnologiesS.r.lMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "AlfalfaTechnologiesS.r.lMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Alfalfa Technologies S.R.L.", "label": "Alfalfa Technologies S.R.L", "terseLabel": "Alfalfa Technologies S.R.L." } } }, "auth_ref": [] }, "currency_AllCurrenciesDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/currency/2025", "localname": "AllCurrenciesDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "label": "All Currencies [Domain]" } } }, "auth_ref": [] }, "biox_AllowanceForReturnOfGoods": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "AllowanceForReturnOfGoods", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of allowance for return of goods.", "label": "Allowance for return of goods", "negatedTerseLabel": "Allowance for credit notes to be issued" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AmendmentFlag", "presentation": [ "http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AmortisationIntangibleAssetsOtherThanGoodwill", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Amortisation, intangible assets other than goodwill", "negatedLabel": "Amortization of the period", "terseLabel": "Amortization of intangible assets" } } }, "auth_ref": [ "r52", "r237" ] }, "ifrs-full_AmountsPayableRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AmountsPayableRelatedPartyTransactions", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Amounts payable, related party transactions", "negatedLabel": "Total" } }, "en": { "role": { "documentation": "The amounts payable resulting from related party transactions. [Refer: Total for all related parties [member]]" } } }, "auth_ref": [ "r25", "r32", "r221" ] }, "ifrs-full_AmountsReceivableRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AmountsReceivableRelatedPartyTransactions", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails" ], "lang": { "en-us": { "role": { "label": "Amounts receivable, related party transactions", "terseLabel": "Total" } }, "en": { "role": { "documentation": "The amounts receivable resulting from related party transactions. [Refer: Total for all related parties [member]]" } } }, "auth_ref": [ "r25", "r32", "r221" ] }, "biox_AnalysisAndStorage": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "AnalysisAndStorage", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 2.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of analysis and storage.", "label": "Analysis and Storage", "terseLabel": "Analysis and storage" } } }, "auth_ref": [] }, "ifrs-full_ApplicableTaxRate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ApplicableTaxRate", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationIncomeTaxExpenseWasCalculatedByApplyingTaxRateInForceDetails" ], "lang": { "en-us": { "role": { "label": "Applicable tax rate", "terseLabel": "Weight average applicable tax rate" } }, "en": { "role": { "documentation": "The applicable income tax rate." } } }, "auth_ref": [ "r5", "r209" ] }, "ifrs-full_Assets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Assets", "totalLabel": "Total assets" } }, "en": { "role": { "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r98", "r99", "r100", "r168", "r172", "r268", "r269", "r307" ] }, "ifrs-full_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AssetsAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "ASSETS.", "terseLabel": "ASSETS" } } }, "auth_ref": [] }, "biox_AssetsSubjectToForeclosureGrossCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "AssetsSubjectToForeclosureGrossCarryingAmount", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails": { "parentTag": "ifrs-full_NetAssetsLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNarrativeDetails", "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails" ], "lang": { "en-us": { "role": { "documentation": "The gross carrying amount of assets subject to foreclosure.", "label": "Assets Subject To Foreclosure, Gross Carrying Amount", "totalLabel": "Total assets subject to foreclosure", "verboseLabel": "Assets subject to foreclosure, gross carrying amount" } } }, "auth_ref": [] }, "ifrs-full_AtFairValueMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AtFairValueMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Fair value", "terseLabel": "Fair value" } }, "en": { "role": { "documentation": "This member stands for measurement based on fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date." } } }, "auth_ref": [ "r57", "r63", "r83", "r98", "r245", "r266", "r268" ] }, "ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AttributionOfExpensesByNatureToTheirFunctionAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Attribution of expenses by nature to their function [axis]" } } }, "auth_ref": [ "r411", "r414" ] }, "ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AttributionOfExpensesByNatureToTheirFunctionDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Attribution of expenses by nature to their function [domain]" } } }, "auth_ref": [ "r411", "r414" ] }, "currency_BRL": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/currency/2025", "localname": "BRL", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "label": "BRL" } } }, "auth_ref": [] }, "biox_BankBorrowingsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "BankBorrowingsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for bank borrowings.", "label": "Bank borrowings", "terseLabel": "Bank borrowings" } } }, "auth_ref": [] }, "ifrs-full_BasicEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BasicEarningsLossPerShare", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Basic earnings (loss) per share", "terseLabel": "Basic (loss)/profit attributable to ordinary equity holders of the parent", "verboseLabel": "Basic loss attributable to ordinary equity holders of the parent" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)." } } }, "auth_ref": [ "r37", "r38" ] }, "ifrs-full_BasicEarningsLossPerShareFromContinuingOperations": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BasicEarningsLossPerShareFromContinuingOperations", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Basic earnings (loss) per share from continuing operations", "terseLabel": "Basic (loss)/profit attributable to ordinary equity holders of the parent from continuing operations", "verboseLabel": "Basic loss attributable to ordinary equity holders of the parent" } }, "en": { "role": { "documentation": "Basic earnings (loss) per share from continuing operations. [Refer: Basic earnings (loss) per share; Continuing operations, unless line item indicates otherwise [member]]" } } }, "auth_ref": [ "r37", "r38" ] }, "ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BasicEarningsLossPerShareFromDiscontinuedOperations", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Basic earnings (loss) per share from discontinued operations", "terseLabel": "Basic loss attributable to ordinary equity holders of the parent from discontinued operations", "verboseLabel": "Basic loss attributable to ordinary equity holders of the parent" } }, "en": { "role": { "documentation": "Basic earnings (loss) per share from discontinued operations. [Refer: Basic earnings (loss) per share; Discontinued operations [member]]" } } }, "auth_ref": [ "r38", "r39" ] }, "biox_BioceresCropsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "BioceresCropsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Bioceres Crops.", "label": "Bioceres Crops [Member]", "verboseLabel": "Bioceres Crops S.A." } } }, "auth_ref": [] }, "ifrs-full_BiologicalAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BiologicalAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Biological assets", "periodEndLabel": "End of period", "periodStartLabel": "Beginning of the period", "terseLabel": "Biological assets" } }, "en": { "role": { "documentation": "The amount of living animals or plants recognised as assets." } } }, "auth_ref": [ "r63", "r245", "r296", "r342" ] }, "ifrs-full_BiologicalAssetsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BiologicalAssetsAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Biological assets [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r393" ] }, "ifrs-full_BiologicalAssetsDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BiologicalAssetsDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Biological assets [domain]" } }, "en": { "role": { "documentation": "This member stands for living animals or plants. It also represents the standard value for the 'Biological assets' axis if no other member is used." } } }, "auth_ref": [ "r393" ] }, "ifrs-full_BondsIssued": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BondsIssued", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Bonds issued", "verboseLabel": "Corporate bonds" } }, "en": { "role": { "documentation": "The amount of bonds issued by the entity." } } }, "auth_ref": [ "r414" ] }, "biox_BorrowingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "BorrowingMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementLiquidityRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to borrowings.", "label": "Borrowings [Member]", "terseLabel": "Borrowings" } } }, "auth_ref": [] }, "ifrs-full_BorrowingsAdjustmentToInterestRateBasis": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BorrowingsAdjustmentToInterestRateBasis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Borrowings, adjustment to interest rate basis" } }, "en": { "role": { "documentation": "The adjustment to the basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r409" ] }, "ifrs-full_BorrowingsByNameAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BorrowingsByNameAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Borrowings by name [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r409" ] }, "ifrs-full_BorrowingsByNameDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BorrowingsByNameDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Borrowings by name [domain]" } }, "en": { "role": { "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]" } } }, "auth_ref": [ "r409" ] }, "ifrs-full_BorrowingsInterestRate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BorrowingsInterestRate", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails" ], "lang": { "en-us": { "role": { "label": "Borrowings, interest rate", "terseLabel": "Interest rate", "verboseLabel": "Nominal annual rate" } }, "en": { "role": { "documentation": "The interest rate on borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r409" ] }, "ifrs-full_BorrowingsInterestRateBasis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BorrowingsInterestRateBasis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Borrowings, interest rate basis", "terseLabel": "Annual interest rate basis" } }, "en": { "role": { "documentation": "The basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r409" ] }, "biox_BorrowingsRepaymentNumberOfSemiAnnualInstallments": { "xbrltype": "integerItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "BorrowingsRepaymentNumberOfSemiAnnualInstallments", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "documentation": "The number of semi-annual installments in which the borrowings are to be repaid.", "label": "Borrowings Repayment, number of Semi-Annual Installments", "terseLabel": "Number of semi-annual installments" } } }, "auth_ref": [] }, "ifrs-full_BottomOfRangeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BottomOfRangeMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Bottom of range [Member]", "terseLabel": "Minimum" } }, "en": { "role": { "documentation": "This member stands for the bottom of a range." } } }, "auth_ref": [ "r71", "r102", "r121", "r131", "r201", "r356", "r357", "r409" ] }, "ifrs-full_BusinessCombinationsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BusinessCombinationsAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionConsiderationForAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Business combinations [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r134", "r252" ] }, "ifrs-full_BusinessCombinationsDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BusinessCombinationsDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionConsiderationForAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Business combinations [domain]" } }, "en": { "role": { "documentation": "This member stands for the standard value for the 'Business combinations' axis if no other member is used." } } }, "auth_ref": [ "r134", "r136", "r252" ] }, "biox_BusinessInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "BusinessInformationAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureGeneralInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Business Information [Abstract]", "terseLabel": "Business information" } } }, "auth_ref": [] }, "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r9", "r14", "r49", "r54", "r58", "r59", "r60", "r63", "r64", "r135", "r153", "r154", "r212", "r216", "r234", "r238", "r241", "r242", "r243", "r245", "r246", "r253", "r259", "r260" ] }, "ifrs-full_CarryingAmountMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CarryingAmountMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "label": "Carrying amount [member]" } } }, "auth_ref": [ "r14", "r54", "r58", "r60", "r63", "r135", "r153", "r154", "r216", "r238", "r241", "r243", "r245", "r253", "r259", "r260" ] }, "ifrs-full_Cash": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Cash", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionCashAndCashEquivalentsDetails": { "parentTag": "ifrs-full_CashAndCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionCashAndCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "label": "Cash", "terseLabel": "Cash at bank and on hand" } }, "en": { "role": { "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]" } } }, "auth_ref": [ "r403" ] }, "ifrs-full_CashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashAndCashEquivalents", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails": { "parentTag": "biox_AssetsSubjectToForeclosureGrossCarryingAmount", "weight": 1.0, "order": 6.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 7.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionCashAndCashEquivalentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionCashAndCashEquivalentsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "terseLabel": "Cash and cash equivalents", "totalLabel": "Cash and cash equivalents" } }, "en": { "role": { "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]" } } }, "auth_ref": [ "r72", "r93", "r202", "r299" ] }, "ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents if different from statement of financial position", "periodEndLabel": "Cash and cash equivalents as of the end of the period", "periodStartLabel": "Cash and cash equivalents as of beginning of the period" } }, "en": { "role": { "documentation": "The amount of cash and cash equivalents in the statement of cash flows when different from the amount of cash and cash equivalents in the statement of financial position. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r403" ] }, "biox_CashAndEquivalentsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "CashAndEquivalentsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for cash and cash equivalents.", "label": "Cash and cash equivalents [member]", "terseLabel": "Cash and cash equivalents" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) financing activities", "totalLabel": "Net cash flows used in financing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity, from continuing and discontinued operations." } } }, "auth_ref": [ "r65", "r73" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "FINANCING ACTIVITIES" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivitiesContinuingOperations", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) financing activities, continuing operations", "totalLabel": "Net cash flows used in financing activities from continuing operations" } }, "en": { "role": { "documentation": "The cash flows from (used in) the entity's financing activities, related to continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Cash flows from (used in) financing activities]" } } }, "auth_ref": [ "r141" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) financing activities, discontinued operations", "terseLabel": "Net cash flows (used in) generated by financing activities from discontinued operations" } }, "en": { "role": { "documentation": "The cash flows from (used in) the entity's financing activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) financing activities]" } } }, "auth_ref": [ "r141" ] }, "ifrs-full_CashFlowsFromUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) investing activities", "totalLabel": "Net cash flows used in investing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents, from continuing and discontinued operations." } } }, "auth_ref": [ "r65", "r73" ] }, "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "INVESTMENT ACTIVITIES" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivitiesContinuingOperations", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) investing activities, continuing operations", "totalLabel": "Net cash flows used in investing activities from continuing operations" } }, "en": { "role": { "documentation": "The cash flows from (used in) the entity's investing activities, related to continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Cash flows from (used in) investing activities]" } } }, "auth_ref": [ "r141" ] }, "ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) investing activities, discontinued operations", "terseLabel": "Net cash flows used in investing activities from discontinued operations" } }, "en": { "role": { "documentation": "The cash flows from (used in) the entity's investing activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) investing activities]" } } }, "auth_ref": [ "r141" ] }, "ifrs-full_CashFlowsFromUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivities", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) operating activities", "totalLabel": "Net cash flows generated by (used in) operating activities" } } }, "auth_ref": [ "r65", "r73" ] }, "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "OPERATING ACTIVITIES" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) operating activities, continuing operations", "totalLabel": "Net cash flows generated by operating activities from continuing operations" } }, "en": { "role": { "documentation": "The cash flows from (used in) the entity's operating activities, related to continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Cash flows from (used in) operating activities]" } } }, "auth_ref": [ "r141" ] }, "ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) operating activities, discontinued operations", "terseLabel": "Net cash flows used in operating activities from discontinued operations" } }, "en": { "role": { "documentation": "The cash flows from (used in) the entity's operating activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) operating activities]" } } }, "auth_ref": [ "r141" ] }, "biox_CashReclassifiedToAssetsSubjectToForeclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "CashReclassifiedToAssetsSubjectToForeclosure", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Amount of cash reclassified to assets subject to foreclosure.", "label": "Cash Reclassified To Assets Subject To Foreclosure", "terseLabel": "Cash reclassified to assets subject to foreclosure" } } }, "auth_ref": [] }, "ifrs-full_CategoriesOfRelatedPartiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CategoriesOfRelatedPartiesAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayablesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Categories of related parties [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r31", "r227" ] }, "ifrs-full_CategoriesOfRelatedPartiesDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CategoriesOfRelatedPartiesDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayablesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Categories of related parties [domain]" } }, "en": { "role": { "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used." } } }, "auth_ref": [ "r31", "r227" ] }, "biox_ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails": { "parentTag": "ifrs-full_OtherFinanceIncomeCost", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of changes in fair value of financial assets or liabilities and other financial results", "label": "Change in Fair Value of Financial Assets or Liabilities or Other Financial Results", "terseLabel": "Changes in fair value of financial assets or liabilities and other financial results" } } }, "auth_ref": [] }, "biox_ChangeInNetRealizableValueOfAgricultural": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ChangeInNetRealizableValueOfAgricultural", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "documentation": "Change in the net realizable value of agricultural.", "label": "Change In The Net Realizable Value Of Agricultural", "terseLabel": "Changes in the net realizable value of agricultural products after harvest" } } }, "auth_ref": [] }, "biox_ChangesInNonControllingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ChangesInNonControllingInterestMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "documentation": "The member stands for the changes in non-controlling interest.", "label": "Changes in non-controlling interests" } } }, "auth_ref": [] }, "ifrs-full_ClassesOfAssetsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfAssetsAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "label": "Classes of assets [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r43", "r44", "r101", "r113", "r190", "r230", "r270" ] }, "ifrs-full_ClassesOfAssetsDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfAssetsDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "label": "Classes of assets [domain]" } }, "en": { "role": { "documentation": "This member stands for a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of assets' axis if no other member is used." } } }, "auth_ref": [ "r43", "r101", "r113", "r190", "r230", "r270" ] }, "ifrs-full_ClassesOfFinancialAssetsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfFinancialAssetsAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Classes of financial assets [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r128", "r159", "r160", "r180", "r181", "r281" ] }, "ifrs-full_ClassesOfFinancialAssetsDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfFinancialAssetsDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Classes of financial assets [domain]" } }, "en": { "role": { "documentation": "This member stands for aggregated classes of financial assets. It also represents the standard value for the 'Classes of financial assets' axis if no other member is used. [Refer: Financial assets]" } } }, "auth_ref": [ "r128", "r159", "r160", "r180", "r181", "r281" ] }, "ifrs-full_ClassesOfFinancialLiabilitiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfFinancialLiabilitiesAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementLiquidityRiskDetails" ], "lang": { "en-us": { "role": { "label": "Classes of financial liabilities [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r159", "r160", "r180", "r181" ] }, "ifrs-full_ClassesOfFinancialLiabilitiesDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfFinancialLiabilitiesDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementLiquidityRiskDetails" ], "lang": { "en-us": { "role": { "label": "Classes of financial liabilities [domain]" } }, "en": { "role": { "documentation": "This member stands for aggregated classes financial liabilities. It also represents the standard value for the 'Classes of financial liabilities' axis if no other member is used. [Refer: Financial liabilities]" } } }, "auth_ref": [ "r159", "r160", "r180", "r181" ] }, "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Classes of intangible assets other than goodwill [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r55", "r239" ] }, "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Classes of intangible assets other than goodwill [domain]" } }, "en": { "role": { "documentation": "This member stands for the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used." } } }, "auth_ref": [ "r55", "r239" ] }, "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfPropertyPlantAndEquipmentAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Classes of property, plant and equipment [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r15", "r217" ] }, "ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfPropertyPlantAndEquipmentDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Classes of property, plant and equipment [domain]" } }, "en": { "role": { "documentation": "This member stands for the standard value for the 'Classes of property, plant and equipment' axis if no other member is used." } } }, "auth_ref": [ "r15", "r217" ] }, "ifrs-full_ClassesOfShareCapitalAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfShareCapitalAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Classes of share capital [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r198", "r274", "r318" ] }, "ifrs-full_ClassesOfShareCapitalDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfShareCapitalDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Classes of share capital [domain]" } }, "en": { "role": { "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used." } } }, "auth_ref": [ "r198", "r274", "r318" ] }, "ifrs-full_ClassificationOfAssetsAsHeldForSaleMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassificationOfAssetsAsHeldForSaleMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Classification of assets as held for sale [member]", "terseLabel": "Classification of assets as held for sale" } }, "en": { "role": { "documentation": "This member stands for classification of assets as held for sale. [Refer: Non-current assets held for sale [member]]" } } }, "auth_ref": [ "r331", "r373" ] }, "biox_CommissionsAndRoyalties": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "CommissionsAndRoyalties", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of commissions and royalties.", "label": "Commissions and Royalties", "terseLabel": "Commissions and royalties" } } }, "auth_ref": [] }, "biox_CommissionsAndRoyaltiesExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "CommissionsAndRoyaltiesExpenses", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of commissions and royalties expenses.", "label": "Commissions and Royalties Expenses", "terseLabel": "Commissions and royalties" } } }, "auth_ref": [] }, "biox_ComponentsOfConsolidatedStatementsOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ComponentsOfConsolidatedStatementsOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "documentation": "n/a", "label": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION" } } }, "auth_ref": [] }, "ifrs-full_ComponentsOfEquityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComponentsOfEquityAxis", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Components of equity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r288" ] }, "ifrs-full_ComponentsOfEquityDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComponentsOfEquityDomain", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Components of equity [domain]" } }, "en": { "role": { "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used." } } }, "auth_ref": [ "r288" ] }, "ifrs-full_ComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComprehensiveIncome", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Comprehensive income", "totalLabel": "Total comprehensive (loss) / profit" } }, "en": { "role": { "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners." } } }, "auth_ref": [ "r78", "r80", "r88", "r229", "r248", "r283", "r322", "r354" ] }, "ifrs-full_ComprehensiveIncomeFromContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComprehensiveIncomeFromContinuingOperations", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Comprehensive income from continuing operations", "totalLabel": "Total comprehensive (loss)/ profit from continuing operations" } }, "en": { "role": { "documentation": "The comprehensive income from continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Comprehensive income]" } } }, "auth_ref": [ "r407" ] }, "biox_ComprehensiveIncomeFromContinuingOperationsAttributableToAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ComprehensiveIncomeFromContinuingOperationsAttributableToAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "documentation": "N/A", "label": "Comprehensive Income From Continuing Operations Attributable To Abstract", "terseLabel": "Total comprehensive (loss)/ profit from continuing operations attributable to:" } } }, "auth_ref": [] }, "ifrs-full_ComprehensiveIncomeFromContinuingOperationsAttributableToNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComprehensiveIncomeFromContinuingOperationsAttributableToNoncontrollingInterests", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": "ifrs-full_ComprehensiveIncomeFromContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Comprehensive income from continuing operations, attributable to non-controlling interests", "terseLabel": "Non-controlling interests" } }, "en": { "role": { "documentation": "The comprehensive income from continuing operations attributable to non-controlling interests. [Refer: Comprehensive income from continuing operations; Non-controlling interests]" } } }, "auth_ref": [ "r407" ] }, "ifrs-full_ComprehensiveIncomeFromContinuingOperationsAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComprehensiveIncomeFromContinuingOperationsAttributableToOwnersOfParent", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": "ifrs-full_ComprehensiveIncomeFromContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Comprehensive income from continuing operations, attributable to owners of parent", "terseLabel": "Equity holders of the parent" } }, "en": { "role": { "documentation": "The comprehensive income from continuing operations attributable to owners of the parent. [Refer: Comprehensive income from continuing operations]" } } }, "auth_ref": [ "r407" ] }, "ifrs-full_ComprehensiveIncomeFromDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComprehensiveIncomeFromDiscontinuedOperations", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Comprehensive income from discontinued operations", "totalLabel": "Total comprehensive loss from discontinued operations" } }, "en": { "role": { "documentation": "The comprehensive income from discontinued operations. [Refer: Discontinued operations [member]; Comprehensive income]" } } }, "auth_ref": [ "r407" ] }, "ifrs-full_ComprehensiveIncomeFromDiscontinuedOperationsAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComprehensiveIncomeFromDiscontinuedOperationsAttributableToOwnersOfParent", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": "ifrs-full_ComprehensiveIncomeFromDiscontinuedOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Comprehensive income from discontinued operations, attributable to owners of parent", "terseLabel": "Equity holders of the parent" } }, "en": { "role": { "documentation": "The comprehensive income from discontinued operations attributable to owners of the parent. [Refer: Comprehensive income from discontinued operations]" } } }, "auth_ref": [ "r407" ] }, "biox_ComprehensiveIncomeFromDiscontinuingOperationsAttributableToAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ComprehensiveIncomeFromDiscontinuingOperationsAttributableToAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "documentation": "N/A", "label": "Comprehensive Income From Discontinuing Operations Attributable To Abstract", "terseLabel": "Total comprehensive loss from discontinued operations attributable to:" } } }, "auth_ref": [] }, "ifrs-full_ComputerEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComputerEquipmentMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "label": "Equipment and computer software [member]", "terseLabel": "Equipment and computer software" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing computer equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r386" ] }, "ifrs-full_ComputerSoftwareMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComputerSoftwareMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Software", "terseLabel": "Software" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets representing computer software. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r340" ] }, "biox_ConsiderationForAcquisitionCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ConsiderationForAcquisitionCurrent", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionConsiderationForAcquisitionDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionConsiderationForAcquisitionDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of consideration payable for acquisition classified as current.", "label": "Consideration for Acquisition, Current", "totalLabel": "Total current consideration for acquisition" } } }, "auth_ref": [] }, "biox_ConsiderationForAcquisitionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ConsiderationForAcquisitionMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Consideration for acquisition.", "label": "Consideration For Acquisition [Member]", "terseLabel": "Consideration for acquisition" } } }, "auth_ref": [] }, "biox_ConsiderationForAcquisitionNonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ConsiderationForAcquisitionNonCurrent", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionConsiderationForAcquisitionDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionConsiderationForAcquisitionDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of consideration payable for acquisition classified as non-current.", "label": "Consideration for Acquisition, Non-Current", "totalLabel": "Total non-current consideration for acquisition" } } }, "auth_ref": [] }, "biox_ConsiderationForAcquisitionOfAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ConsiderationForAcquisitionOfAssetsCurrent", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails": { "parentTag": "ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale", "weight": 1.0, "order": 5.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "documentation": "The amount of consideration for acquisition of assets recognised as of balance sheet date, classified as current.", "label": "Consideration for Acquisition of Assets, Current", "terseLabel": "Consideration for acquisition" } } }, "auth_ref": [] }, "biox_ConsiderationForAcquisitionOfAssetsNonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ConsiderationForAcquisitionOfAssetsNonCurrent", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "documentation": "The amount of consideration for acquisition of assets recognised as of balance sheet date, classified as non-current.", "label": "Consideration for Acquisition of Assets, Non Current", "terseLabel": "Consideration for acquisition" } } }, "auth_ref": [] }, "biox_ConsiderationOfferedFromNoteholders": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ConsiderationOfferedFromNoteholders", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNarrativeDetails", "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetLossFromForeclosureDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of consideration offered from noteholders.", "label": "Consideration Offered From Noteholders", "terseLabel": "Consideration offered from noteholders" } } }, "auth_ref": [] }, "ifrs-full_ConstructionInProgressMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ConstructionInProgressMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Buildings in progress", "terseLabel": "Buildings in progress" } }, "en": { "role": { "documentation": "This member stands for expenditure capitalised during the construction of items of property, plant and equipment that are not yet available for use (ie not yet in the location and condition necessary for it to be capable of operating in the manner intended by the management). [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r386" ] }, "biox_Contingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "Contingencies", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of contingencies.", "label": "Contingencies", "terseLabel": "Contingencies" } } }, "auth_ref": [] }, "biox_ContingenciesCommitmentsAndRestrictionsOnDistributionOfProfitsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ContingenciesCommitmentsAndRestrictionsOnDistributionOfProfitsAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS" } } }, "auth_ref": [] }, "biox_ContingentConsiderationInBusinessCombinationEquityInstrumentIssued": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ContingentConsiderationInBusinessCombinationEquityInstrumentIssued", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails": { "parentTag": "biox_NonCashFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of payment of contingent consideration in equity instruments in a business combination as part of non-cash transaction.", "label": "Contingent Consideration in Business Combination, Equity Instrument Issued", "negatedLabel": "Contingent consideration payment with own shares (Note 5.12)" } } }, "auth_ref": [] }, "ifrs-full_ContingentConsiderationMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ContingentConsiderationMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementLiquidityRiskDetails" ], "lang": { "en-us": { "role": { "label": "Consideration for acquisition of assets", "verboseLabel": "Consideration for acquisition" } }, "en": { "role": { "documentation": "This member stands for an obligation of the acquirer to transfer additional assets or equity interests to the former owners of an acquiree as part of the exchange for control of the acquiree if specified future events occur or conditions are met." } } }, "auth_ref": [ "r405" ] }, "ifrs-full_ContinuingAndDiscontinuedOperationsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ContinuingAndDiscontinuedOperationsAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNarrativeDetails", "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetIncomeFromDiscontinuedOperationsDetails", "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetLossFromForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesNarrativeDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails", "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails", "http://www.biocerescrops.com/role/DisclosureTaxationNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Continuing and discontinued operations [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r144" ] }, "ifrs-full_ContinuingOperationsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ContinuingOperationsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNarrativeDetails", "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetIncomeFromDiscontinuedOperationsDetails", "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetLossFromForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesNarrativeDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails", "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails", "http://www.biocerescrops.com/role/DisclosureTaxationNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Continuing operations, unless line item indicates otherwise [member]" } }, "en": { "role": { "documentation": "This member stands for components of the entity that are not discontinued operations. A component of an entity comprises operations and cash flows that can be clearly distinguished, operationally and for financial reporting purposes, from the rest of the entity. This meaning may be overridden for line items which are either intrinsically related to discontinued operations (or disposal groups held for sale), or which are typically reported for the aggregate of continuing and discontinued. This member also represents the standard value for the 'Continuing and discontinued operations' axis if no other member is used. [Refer: Discontinued operations [member]; Aggregate continuing and discontinued operations [member]]" } } }, "auth_ref": [ "r144" ] }, "ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Trademarks and patents", "terseLabel": "Trademarks and patents" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets representing copyrights, patents and other industrial property rights, service and operating rights. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r341" ] }, "biox_CorporateBondsSeriesViiiClassBMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "CorporateBondsSeriesViiiClassBMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands Series VIII corporate bonds, Class B.", "label": "Corporate Bonds, Series VIII, Class B [Member]", "terseLabel": "Corporate Bonds, Series VIII, Class B" } } }, "auth_ref": [] }, "ifrs-full_CostOfSales": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CostOfSales", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails": { "parentTag": "ifrs-full_GrossProfit", "weight": -1.0, "order": 2.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetIncomeFromDiscontinuedOperationsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesNarrativeDetails", "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Cost of sales", "negatedLabel": "Cost of sales" } } }, "auth_ref": [ "r282", "r330" ] }, "biox_CostOfSalesAfterReclassificationOfDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "CostOfSalesAfterReclassificationOfDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of reclassification of cost of sales to discontinued operations.", "label": "Cost of sales, After Reclassification of Discontinued Operations", "terseLabel": "Cost of sales" } } }, "auth_ref": [] }, "ifrs-full_CostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CostOfSalesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "label": "Cost of sales [member]", "terseLabel": "Production costs" } } }, "auth_ref": [ "r411", "r414" ] }, "biox_CropNutritionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "CropNutritionMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails", "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Crop nutrition.", "label": "Crop nutrition", "terseLabel": "Crop nutrition" } } }, "auth_ref": [] }, "biox_CropProtectionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "CropProtectionMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Crop protection.", "label": "Crop protection", "terseLabel": "Crop protection" } } }, "auth_ref": [] }, "srt_CurrencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "CurrencyAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "label": "Currency [Axis]" } } }, "auth_ref": [] }, "ifrs-full_CurrencyRiskMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrencyRiskMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "Currency risk" } }, "en": { "role": { "documentation": "This member stands for a type of market risk representing the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. [Refer: Classes of financial instruments [domain]]" } } }, "auth_ref": [ "r122", "r123", "r124", "r125", "r164" ] }, "ifrs-full_CurrentAccrualsAndCurrentDeferredIncomeIncludingCurrentContractLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentAccrualsAndCurrentDeferredIncomeIncludingCurrentContractLiabilitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Current accruals and current deferred income including current contract liabilities [abstract]", "terseLabel": "Current" } } }, "auth_ref": [] }, "ifrs-full_CurrentAdvances": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentAdvances", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails": { "parentTag": "ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Current advances received, representing current contract liabilities for performance obligations satisfied at point in time", "terseLabel": "Advances from customers" } }, "en": { "role": { "documentation": "The amount of current advances received representing current contract liabilities for performance obligations satisfied at a point in time. [Refer: Advances received, representing contract liabilities for performance obligations satisfied at point in time]" } } }, "auth_ref": [ "r416", "r417" ] }, "ifrs-full_CurrentAdvancesToSuppliers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentAdvancesToSuppliers", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": "ifrs-full_OtherCurrentReceivables", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Current advances to suppliers", "terseLabel": "Prepayments to suppliers" } }, "en": { "role": { "documentation": "The amount of current advances made to suppliers before goods or services are received." } } }, "auth_ref": [ "r414" ] }, "ifrs-full_CurrentAgriculturalProduce": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentAgriculturalProduce", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Current agricultural produce", "terseLabel": "Agricultural products" } }, "en": { "role": { "documentation": "A classification of current inventory representing the amount of harvested produce of the entity's biological assets. [Refer: Biological assets; Inventories]" } } }, "auth_ref": [ "r389" ] }, "ifrs-full_CurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Total current assets", "totalLabel": "Total current assets" } }, "en": { "role": { "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]" } } }, "auth_ref": [ "r84", "r310", "r354" ] }, "ifrs-full_CurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentAssetsAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "CURRENT ASSETS", "terseLabel": "Current", "verboseLabel": "Current assets" } } }, "auth_ref": [] }, "biox_CurrentContingentConsiderationRecognisedAsOfAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "CurrentContingentConsiderationRecognisedAsOfAcquisitionDate", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionConsiderationForAcquisitionDetails": { "parentTag": "biox_ConsiderationForAcquisitionCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionConsiderationForAcquisitionDetails" ], "lang": { "en-us": { "role": { "documentation": "Current amount, at acquisition date, of contingent consideration arrangements recognised as consideration transferred in a business combination.", "label": "Current Contingent Consideration Recognised As Of Acquisition Date", "terseLabel": "Consideration for acquisition of assets, current" } } }, "auth_ref": [] }, "ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentDeferredIncomeIncludingCurrentContractLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 4.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current deferred income including current contract liabilities", "terseLabel": "Deferred revenue and advances from customers", "totalLabel": "Deferred revenue and advances from customers" } }, "en": { "role": { "documentation": "The amount of current deferred income including current contract liabilities. [Refer: Deferred income including contract liabilities]" } } }, "auth_ref": [ "r416", "r417" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "ifrs-full_CurrentInventoriesInTransit": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentInventoriesInTransit", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Current inventories in transit", "terseLabel": "Goods in transit" } }, "en": { "role": { "documentation": "A classification of current inventory representing the amount of inventories in transit. [Refer: Inventories]" } } }, "auth_ref": [ "r389" ] }, "ifrs-full_CurrentLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentLeaseLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails": { "parentTag": "ifrs-full_LeaseLiabilities", "weight": 1.0, "order": 2.0 }, "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails": { "parentTag": "ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current lease liabilities", "terseLabel": "Lease liabilities", "verboseLabel": "Current" } }, "en": { "role": { "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r110" ] }, "ifrs-full_CurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current liabilities", "totalLabel": "Total current liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period." } } }, "auth_ref": [ "r86", "r311", "r354" ] }, "ifrs-full_CurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentLiabilitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionConsiderationForAcquisitionDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "CURRENT LIABILITIES.", "terseLabel": "Current liabilities", "verboseLabel": "CURRENT LIABILITIES" } } }, "auth_ref": [] }, "ifrs-full_CurrentMaterialsAndSuppliesToBeConsumedInProductionProcessOrRenderingServices": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentMaterialsAndSuppliesToBeConsumedInProductionProcessOrRenderingServices", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Current materials and supplies to be consumed in production process or rendering services", "terseLabel": "Supplies" } }, "en": { "role": { "documentation": "A classification of current inventory representing the amount of materials and supplies to be consumed in a production process or while rendering services. [Refer: Inventories]" } } }, "auth_ref": [ "r389" ] }, "ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayablesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Current payables on social security and taxes other than income tax", "terseLabel": "Taxes" } }, "en": { "role": { "documentation": "The amount of current payables on social security and taxes other than incomes tax. [Refer: Payables on social security and taxes other than income tax]" } } }, "auth_ref": [ "r417" ] }, "ifrs-full_CurrentPrepaidExpenses": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentPrepaidExpenses", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": "ifrs-full_OtherCurrentReceivables", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Current prepaid expenses", "terseLabel": "Prepaid expenses and other receivables" } }, "en": { "role": { "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised." } } }, "auth_ref": [ "r414" ] }, "ifrs-full_CurrentProvisionsForEmployeeBenefits": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentProvisionsForEmployeeBenefits", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 5.0 }, "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails": { "parentTag": "ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale", "weight": 1.0, "order": 6.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionEmployeeBenefitsAndSocialSecurityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionEmployeeBenefitsAndSocialSecurityDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Employee Benefits and Social Security, Current", "terseLabel": "Employee benefits and social security", "totalLabel": "Employee benefits and social security" } }, "en": { "role": { "documentation": "The amount of current provisions for employee benefits. [Refer: Provisions for employee benefits]" } } }, "auth_ref": [ "r278", "r313" ] }, "ifrs-full_CurrentTaxAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentTaxAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current tax assets", "terseLabel": "Recoverable income tax" } }, "en": { "role": { "documentation": "The excess of amount paid for current tax in respect of current and prior periods over the amount due for those periods. Current tax is the amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period." } } }, "auth_ref": [ "r302" ] }, "ifrs-full_CurrentTaxAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentTaxAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current tax assets, non-current", "terseLabel": "Recoverable income tax" } }, "en": { "role": { "documentation": "The non-current amount of current tax assets. [Refer: Current tax assets]" } } }, "auth_ref": [ "r302" ] }, "ifrs-full_CurrentTaxExpenseIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentTaxExpenseIncome", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationTaxesOnIncomeDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationTaxesOnIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Current tax expense (income)", "negatedLabel": "Current tax expense" } } }, "auth_ref": [ "r332", "r374" ] }, "ifrs-full_CurrentTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentTaxLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current tax liabilities", "terseLabel": "Income tax payable" } }, "en": { "role": { "documentation": "The amount of current tax for current and prior periods to the extent unpaid. Current tax is the amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period." } } }, "auth_ref": [ "r302" ] }, "ifrs-full_CurrentTradeReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentTradeReceivables", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails": { "parentTag": "biox_AssetsSubjectToForeclosureGrossCarryingAmount", "weight": 1.0, "order": 7.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current trade receivables", "terseLabel": "Trade debtors", "verboseLabel": "Trade receivables" } }, "en": { "role": { "documentation": "The amount of current trade receivables. [Refer: Trade receivables]" } } }, "auth_ref": [ "r375", "r379", "r381" ] }, "ifrs-full_CustomerrelatedIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CustomerrelatedIntangibleAssetsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Customer loyalty", "terseLabel": "Customer loyalty" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets representing assets related to customers. Such assets may include customer lists, order or production backlog, customer contracts and related customer relationships as well as non-contractual customer relationships." } } }, "auth_ref": [ "r391" ] }, "biox_DebtSecuredCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "DebtSecuredCurrent", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "documentation": "Amount of secured debt, current.", "label": "Debt Secured, Current", "terseLabel": "Secured notes" } } }, "auth_ref": [] }, "ifrs-full_DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsOtherThanGoodwill", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Decrease through classified as held for sale, intangible assets other than goodwill", "negatedLabel": "Subject to foreclosure" } }, "en": { "role": { "documentation": "The decrease in intangible assets other than goodwill resulting from classification as held for sale or inclusion in a disposal group classified as held for sale. [Refer: Disposal groups classified as held for sale [member]; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r51", "r236" ] }, "biox_DecreaseThroughClassifiedAsHeldForSaleInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "DecreaseThroughClassifiedAsHeldForSaleInventory", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "The decrease in inventory through classification as held for sale or inclusion in a disposal group classified as held for sale.", "label": "Decrease Through Classified As Held For Sale, Inventory", "terseLabel": "Subject to foreclosure" } } }, "auth_ref": [] }, "biox_DecreaseThroughClassifiedAsHeldForSaleLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "DecreaseThroughClassifiedAsHeldForSaleLeaseLiabilities", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "documentation": "The decrease in lease liabilities through classification as held for sale or inclusion in a disposal group classified as held for sale.", "label": "Decrease Through Classified As Held For Sale, Lease Liabilities", "negatedLabel": "Subject to foreclosure (Note 4)" } } }, "auth_ref": [] }, "ifrs-full_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Decrease through classified as held for sale, property, plant and equipment", "negatedLabel": "Subjects to foreclosure" } }, "en": { "role": { "documentation": "The decrease in property, plant and equipment through classification as held for sale or inclusion in a disposal group classified as held for sale. [Refer: Disposal groups classified as held for sale [member]; Property, plant and equipment; Disposal groups classified as held for sale [member]]" } } }, "auth_ref": [ "r11", "r214" ] }, "ifrs-full_DecreaseThroughClassifiedAsHeldForSaleRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DecreaseThroughClassifiedAsHeldForSaleRightofuseAssets", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "label": "Decrease through classified as held for sale, right-of-use assets", "negatedLabel": "Subject to foreclosure (Note 4)" } }, "en": { "role": { "documentation": "The decrease in right-of-use assets through classification as held for sale or inclusion in a disposal group classified as held for sale. [Refer: Disposal groups classified as held for sale [member]; Right-of-use assets; Disposal groups classified as held for sale [member]]" } } }, "auth_ref": [ "r388" ] }, "biox_DecreaseThroughTreasuryShareTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "DecreaseThroughTreasuryShareTransactions", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "documentation": "The decrease in equity resulting from treasury share transactions. [Refer: Equity; Treasury shares]", "label": "Decrease Through Treasury Share Transactions", "terseLabel": "Sale of own shares" } } }, "auth_ref": [] }, "ifrs-full_DeferredTaxAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DeferredTaxAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Deferred tax assets", "terseLabel": "Deferred tax assets" } }, "en": { "role": { "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]" } } }, "auth_ref": [ "r6", "r210", "r303", "r308" ] }, "ifrs-full_DeferredTaxExpenseIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DeferredTaxExpenseIncome", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationTaxesOnIncomeDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationTaxesOnIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Deferred tax expense (income)", "negatedLabel": "Deferred tax" } }, "en": { "role": { "documentation": "The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]" } } }, "auth_ref": [ "r7", "r211" ] }, "ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DeferredTaxExpenseIncomeRecognisedInProfitOrLoss", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationMovementOnDeferredIncomeTaxDetails" ], "lang": { "en-us": { "role": { "label": "Deferred tax expense (income) recognised in profit or loss", "verboseLabel": "Charge for the period" } } }, "auth_ref": [ "r7", "r211" ] }, "ifrs-full_DeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DeferredTaxLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Deferred tax liabilities", "terseLabel": "Deferred tax liabilities" } }, "en": { "role": { "documentation": "The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]" } } }, "auth_ref": [ "r6", "r210", "r303", "r308" ] }, "ifrs-full_DeferredTaxLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DeferredTaxLiabilityAsset", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationMovementOnDeferredIncomeTaxDetails" ], "lang": { "en-us": { "role": { "label": "Deferred tax liability (asset)", "periodEndLabel": "Total net deferred tax", "periodStartLabel": "Beginning of the period deferred tax" } }, "en": { "role": { "documentation": "The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]" } } }, "auth_ref": [ "r6", "r210" ] }, "ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Deferred tax relating to items credited (charged) directly to equity", "terseLabel": "Charge for the period" } }, "en": { "role": { "documentation": "The amount of deferred tax related to items credited (charged) directly to equity. [Refer: Deferred tax expense (income)]" } } }, "auth_ref": [ "r3", "r207" ] }, "ifrs-full_DepreciationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DepreciationPropertyPlantAndEquipment", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 2.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Depreciation, property, plant and equipment", "negatedLabel": "Depreciation of the period", "terseLabel": "Depreciation of property, plant and equipment" } } }, "auth_ref": [ "r12", "r16", "r215" ] }, "biox_DepreciationRightOfUseAssetsExchangeDifferences": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "DepreciationRightOfUseAssetsExchangeDifferences", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of effect of exchange differences on the deprecation of right of use assets.", "label": "Depreciation right of use assets, exchange differences", "terseLabel": "Exchange differences" } } }, "auth_ref": [] }, "ifrs-full_DepreciationRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DepreciationRightofuseAssets", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 6.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 17.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 19.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails", "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation, right-of-use assets", "terseLabel": "Depreciation of leased assets", "verboseLabel": "Depreciation of the period" } } }, "auth_ref": [ "r111", "r188" ] }, "biox_DescriptionOfAccountingPolicyForBasisOfMeasurementTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "DescriptionOfAccountingPolicyForBasisOfMeasurementTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPreparationPolicies" ], "lang": { "en-us": { "role": { "documentation": "The description of the entity's accounting policy for the basis of measurement, preparation, and presentation of the financial statements.", "label": "Basis of measurement" } } }, "auth_ref": [] }, "biox_DescriptionOfAccountingPolicyForChangesInAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "DescriptionOfAccountingPolicyForChangesInAccountingPoliciesTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPreparationPolicies" ], "lang": { "en-us": { "role": { "documentation": "The description of the entity's changes in accounting policies.", "label": "Changes in accounting policies" } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPreparationPolicies" ], "lang": { "en-us": { "role": { "label": "Foreign currency" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for foreign currency translation." } } }, "auth_ref": [ "r415" ] }, "ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPreparationPolicies" ], "lang": { "en-us": { "role": { "label": "Functional currency" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for the currency of the primary economic environment in which the entity operates." } } }, "auth_ref": [ "r415" ] }, "biox_DescriptionOfAccountingPolicyForPresentationCurrencyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "DescriptionOfAccountingPolicyForPresentationCurrencyTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPreparationPolicies" ], "lang": { "en-us": { "role": { "documentation": "The description of the entity's accounting policy for the currency used in presenting financial statements to regulatory agencies.", "label": "Presentation currency" } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations", "presentation": [ "http://www.biocerescrops.com/role/DisclosureNewStandardsAmendmentsAndInterpretationsIssuedByIasb" ], "lang": { "en-us": { "role": { "label": "Disclosure of expected impact of initial application of new standards or interpretations [text block]", "terseLabel": "NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB" } } }, "auth_ref": [ "r76", "r204" ] }, "ifrs-full_DilutedEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DilutedEarningsLossPerShare", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Diluted earnings (loss) per share", "terseLabel": "Diluted (loss)/profit attributable to ordinary equity holders of the parent", "verboseLabel": "Diluted loss attributable to ordinary equity holders of the parent" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r37", "r38" ] }, "ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DilutedEarningsLossPerShareFromContinuingOperations", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Diluted earnings (loss) per share from continuing operations", "terseLabel": "Diluted (loss)/profit attributable to ordinary equity holders of the parent from continuing operations", "verboseLabel": "Diluted loss attributable to ordinary equity holders of the parent" } }, "en": { "role": { "documentation": "Diluted earnings (loss) per share from continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Diluted earnings (loss) per share]" } } }, "auth_ref": [ "r37", "r38" ] }, "ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DilutedEarningsLossPerShareFromDiscontinuedOperations", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Diluted earnings (loss) per share from discontinued operations", "terseLabel": "Diluted loss attributable to ordinary equity holders of the parent from discontinued operations", "verboseLabel": "Diluted loss attributable to ordinary equity holders of the parent" } }, "en": { "role": { "documentation": "Diluted earnings (loss) per share from discontinued operations. [Refer: Diluted earnings (loss) per share; Discontinued operations [member]]" } } }, "auth_ref": [ "r38", "r39" ] }, "biox_DisclosureOfAccountingStandardsAndBasisOfPresentationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "DisclosureOfAccountingStandardsAndBasisOfPresentationTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPreparation" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure on accounting standards and basis of presentation.", "label": "Disclosure Of Accounting Standards And Basis Of Presentation [Text Block]", "terseLabel": "ACCOUNTING STANDARDS AND BASIS OF PREPARATION" } } }, "auth_ref": [] }, "biox_DisclosureOfAccumulatedAmortizationOfIntangibleAssets.TextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "DisclosureOfAccumulatedAmortizationOfIntangibleAssets.TextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "he disclosure of detailed information about accumulated amortization of intangible assets.", "label": "Disclosure of accumulated amortization of intangible assets. [text block]", "terseLabel": "Schedule of accumulated amortization of intangibles" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNarrativeDetails", "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetIncomeFromDiscontinuedOperationsDetails", "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetLossFromForeclosureDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of analysis of single amount of discontinued operations [line items]", "terseLabel": "ASSETS SUBJECT TO FORECLOSURE AND DISCONTINUED OPERATIONS" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNarrativeDetails", "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetIncomeFromDiscontinuedOperationsDetails", "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetLossFromForeclosureDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of analysis of single amount of discontinued operations [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the analysis of the single amount of discontinued operations." } } }, "auth_ref": [ "r140" ] }, "ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesNarrativeDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of attribution of expenses by nature to their function [line items]", "terseLabel": "Expenses classified by nature and function", "verboseLabel": "Cost of sales" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesNarrativeDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of attribution of expenses by nature to their function [table]" } } }, "auth_ref": [ "r411", "r414" ] }, "biox_DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of salaries and social security payables.", "label": "Disclosure of Benefits and Social Security Payables [Table Text Block]", "terseLabel": "Schedule of employee benefits and social security" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfBusinessCombinationsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfBusinessCombinationsLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionConsiderationForAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about business combination", "verboseLabel": "Consideration for acquisition" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfBusinessCombinationsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfBusinessCombinationsTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionConsiderationForAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about business combination [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of business combinations." } } }, "auth_ref": [ "r134", "r252" ] }, "biox_DisclosureOfCarryingValueOfBorrowingsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "DisclosureOfCarryingValueOfBorrowingsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about carrying value of borrowings.", "label": "Disclosure of carrying value of borrowings explanatory", "terseLabel": "Schedule of carrying value of borrowings" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfCashAndCashEquivalentsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of cash and cash equivalents [text block]", "terseLabel": "Schedule of cash and cash equivalents" } }, "en": { "role": { "documentation": "The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r410" ] }, "ifrs-full_DisclosureOfCashFlowStatementExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfCashFlowStatementExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformation" ], "lang": { "en-us": { "role": { "label": "Disclosure of cash flow statement [text block]", "terseLabel": "CASH FLOW INFORMATION" } }, "en": { "role": { "documentation": "The entire disclosure for a statement of cash flows." } } }, "auth_ref": [ "r74" ] }, "biox_DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of investments in joint ventures and affiliates.", "label": "Disclosure of Changes in Investment in Joint Ventures and Affiliates [Table Text Block]", "terseLabel": "Schedule of changes in joint ventures" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfClassesOfShareCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfClassesOfShareCapitalAbstract", "lang": { "en-us": { "role": { "label": "EQUITY INFORMATION" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfClassesOfShareCapitalLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfClassesOfShareCapitalLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of classes of share capital [line items]", "terseLabel": "EQUITY INFORMATION" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfClassesOfShareCapitalTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfClassesOfShareCapitalTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of classes of share capital [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to classes of share capital." } } }, "auth_ref": [ "r198", "r274", "r318" ] }, "ifrs-full_DisclosureOfCommitmentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfCommitmentsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureContingenciesCommitmentsAndRestrictionsOnDistributionOfProfits" ], "lang": { "en-us": { "role": { "label": "Disclosure of commitments [text block]", "verboseLabel": "CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS" } }, "en": { "role": { "documentation": "The disclosure of commitments." } } }, "auth_ref": [ "r410" ] }, "biox_DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationTables" ], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of compensation of directors and other members of key management personnel.", "label": "Disclosure of Compensation of Directors and Other Members of Key Management Personnel [Table Text Block]", "verboseLabel": "Schedule of compensation of directors and other members of key management personnel" } } }, "auth_ref": [] }, "biox_DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of components of Consolidated Statements of Financial Position.", "label": "Disclosure Of Components Of Consolidated Statements Of Financial Position", "terseLabel": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION" } } }, "auth_ref": [] }, "biox_DisclosureOfConsiderationForAcquisitionTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "DisclosureOfConsiderationForAcquisitionTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of information pertaining to consideration for acquisition.", "label": "Disclosure of Consideration for Acquisition [Table Text Block]", "terseLabel": "Schedule of consideration for acquisition" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfCostOfSalesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfCostOfSalesExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of cost of sales [text block]", "terseLabel": "Schedule of cost of sales" } } }, "auth_ref": [ "r410" ] }, "ifrs-full_DisclosureOfDeferredTaxesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfDeferredTaxesExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of deferred taxes [text block]", "verboseLabel": "Schedule of net deferred tax" } }, "en": { "role": { "documentation": "The disclosure of deferred taxes. [Refer: Deferred tax liabilities; Deferred tax assets]" } } }, "auth_ref": [ "r410" ] }, "biox_DisclosureOfDepreciationExpenseTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "DisclosureOfDepreciationExpenseTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of depreciation.", "label": "Disclosure of depreciation expense [text block]", "terseLabel": "Schedule of property, plant and equipment accumulated depreciation" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [text block]", "terseLabel": "Schedule of borrowings" } }, "en": { "role": { "documentation": "The disclosure of detailed information about borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r409" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [line items]", "terseLabel": "Borrowings:" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of borrowings." } } }, "auth_ref": [ "r409" ] }, "biox_DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.", "label": "Disclosure of Detailed Information about Research and Development Expense [Line Items]", "terseLabel": "Costs and expenses" } } }, "auth_ref": [] }, "biox_DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseTable": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "Schedule disclosing information related to details of research and development expense.", "label": "Disclosure of Detailed Information about Research and Development Expense [Table]" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of disaggregation of revenue from contracts with customers [text block]", "terseLabel": "Schedule of revenue from contracts with customers" } } }, "auth_ref": [ "r105", "r184" ] }, "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRevenueFromContractsWithCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of disaggregation of revenue from contracts with customers [line items]", "terseLabel": "Revenue" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRevenueFromContractsWithCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of disaggregation of revenue from contracts with customers [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the disaggregation of revenue from contracts with customers." } } }, "auth_ref": [ "r105", "r184" ] }, "ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfDiscontinuedOperationsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of discontinued operations [text block]", "terseLabel": "Schedule of assets subject to foreclosure and discontinued operations" } }, "en": { "role": { "documentation": "The disclosure of discontinued operations. [Refer: Discontinued operations [member]]" } } }, "auth_ref": [ "r410" ] }, "ifrs-full_DisclosureOfEarningsPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfEarningsPerShareExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShare" ], "lang": { "en-us": { "role": { "label": "Disclosure of earnings per share [text block]", "verboseLabel": "EARNING PER SHARE" } }, "en": { "role": { "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r42" ] }, "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfEntitysReportableSegmentsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformation" ], "lang": { "en-us": { "role": { "label": "Disclosure of entity's operating segments [text block]", "terseLabel": "SEGMENT INFORMATION" } }, "en": { "role": { "documentation": "The entire disclosure for operating segments." } } }, "auth_ref": [ "r179" ] }, "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEventsOccurringAfterReportingPeriod" ], "lang": { "en-us": { "role": { "label": "Disclosure of events after reporting period [text block]", "terseLabel": "EVENTS OCCURRING AFTER THE REPORTING PERIOD" } }, "en": { "role": { "documentation": "The entire disclosure for events after the reporting period." } } }, "auth_ref": [ "r1" ] }, "ifrs-full_DisclosureOfExpensesByNatureExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfExpensesByNatureExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of expenses by nature [text block]", "terseLabel": "Schedule of expenses classified by nature and function" } } }, "auth_ref": [ "r410" ] }, "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfAssetsLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of fair value measurement of assets [line items]", "terseLabel": "Fair value by hierarchy" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfAssetsTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of fair value measurement of assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the fair value measurement of assets." } } }, "auth_ref": [ "r101", "r270" ] }, "ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfFairValueOfFinancialInstrumentsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of fair value of financial instruments [text block]", "terseLabel": "Schedule of fair value by hierarchy" } }, "en": { "role": { "documentation": "The disclosure of the fair value of financial instruments. [Refer: Classes of financial instruments [domain]; At fair value [member]]" } } }, "auth_ref": [ "r410" ] }, "ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfFinanceIncomeExpenseExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of finance income (cost) [text block]", "terseLabel": "Schedule of net financial cost" } } }, "auth_ref": [ "r410" ] }, "ifrs-full_DisclosureOfFinancialAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfFinancialAssetsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial assets [text block]", "terseLabel": "Schedule of financial assets by category" } }, "en": { "role": { "documentation": "The disclosure of financial assets. [Refer: Financial assets]" } } }, "auth_ref": [ "r161", "r254" ] }, "ifrs-full_DisclosureOfFinancialAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfFinancialAssetsLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial assets [line items]", "terseLabel": "Financial assets by category" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFinancialAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfFinancialAssetsTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to financial assets." } } }, "auth_ref": [ "r161", "r254" ] }, "ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfFinancialLiabilitiesExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial liabilities [text block]", "terseLabel": "Schedule financial liabilities by category" } }, "en": { "role": { "documentation": "The disclosure of financial liabilities. [Refer: Financial liabilities]" } } }, "auth_ref": [ "r161", "r254" ] }, "ifrs-full_DisclosureOfFinancialLiabilitiesLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfFinancialLiabilitiesLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial liabilities [line items]", "terseLabel": "Financial liabilities by category" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFinancialLiabilitiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfFinancialLiabilitiesTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial liabilities [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to financial liabilities." } } }, "auth_ref": [ "r161", "r254" ] }, "ifrs-full_DisclosureOfFinancialRiskManagementExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfFinancialRiskManagementExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagement" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial risk management [text block]", "terseLabel": "FINANCIAL INSTRUMENTS - RISK MANAGEMENT" } }, "en": { "role": { "documentation": "The disclosure of the entity's financial risk management practices and policies." } } }, "auth_ref": [ "r410" ] }, "ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureGeneralInformation" ], "lang": { "en-us": { "role": { "label": "Disclosure of general information about financial statements [text block]", "terseLabel": "GENERAL INFORMATION" } }, "en": { "role": { "documentation": "The entire disclosure for general information about financial statements." } } }, "auth_ref": [ "r193", "r290" ] }, "ifrs-full_DisclosureOfIncomeTaxExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfIncomeTaxExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxation" ], "lang": { "en-us": { "role": { "label": "Disclosure of income tax [text block]", "terseLabel": "TAXATION" } }, "en": { "role": { "documentation": "The entire disclosure for income taxes." } } }, "auth_ref": [ "r8" ] }, "biox_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of information about components of consolidated statement of comprehensive income.", "label": "Disclosure of Information About Components of Consolidated Statements of Comprehensive Income [Text Block]", "terseLabel": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensation" ], "lang": { "en-us": { "role": { "label": "Disclosure of information about key management personnel [text block]", "terseLabel": "KEY MANAGEMENT PERSONNEL COMPENSATION" } }, "en": { "role": { "documentation": "The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r410" ] }, "ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of initial application of standards or interpretations [line items]", "terseLabel": "Lease liability" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of initial application of standards or interpretations [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the initial application of standards or interpretations." } } }, "auth_ref": [ "r75", "r203" ] }, "ifrs-full_DisclosureOfIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfIntangibleAssetsLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about intangible assets [line items]", "terseLabel": "Intangible assets" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfIntangibleAssetsTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about intangible assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of intangible assets." } } }, "auth_ref": [ "r55", "r239" ] }, "biox_DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesTables" ], "lang": { "en-us": { "role": { "documentation": "Information pertains to disclosure of investments in associates and joint ventures.", "label": "Disclosure of Investments in Joint Ventures and Affiliates [Table Text Block]", "terseLabel": "Schedule of investments in joint ventures and associates" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfJointVenturesLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfJointVenturesLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesAssetsAndLiabilitiesDetails", "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesShareOfProfitDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of joint ventures [line items]", "terseLabel": "CASH FLOW INFORMATION" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfJointVenturesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfJointVenturesTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesAssetsAndLiabilitiesDetails", "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesShareOfProfitDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of joint ventures [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to joint ventures." } } }, "auth_ref": [ "r35", "r36", "r97", "r265" ] }, "ifrs-full_DisclosureOfLeasesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfLeasesExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeases" ], "lang": { "en-us": { "role": { "label": "Disclosure of leases [text block]", "terseLabel": "LEASES" } }, "en": { "role": { "documentation": "The entire disclosure for leases." } } }, "auth_ref": [ "r117", "r118" ] }, "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of nature and extent of risks arising from financial instruments [text block]", "terseLabel": "Schedule of net exposure" } }, "en": { "role": { "documentation": "The disclosure of information that enables users of financial statements to evaluate the nature and extent of risks arising from financial instruments to which the entity is exposed. [Refer: Classes of financial instruments [domain]]" } } }, "auth_ref": [ "r149" ] }, "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract", "lang": { "en-us": { "role": { "label": "EVENTS OCCURRING AFTER THE REPORTING PERIOD" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperations" ], "lang": { "en-us": { "role": { "label": "Disclosure of non-current assets held for sale and discontinued operations [text block]", "terseLabel": "ASSETS SUBJECT TO FORECLOSURE AND DISCONTINUED OPERATIONS" } }, "en": { "role": { "documentation": "The entire disclosure for non-current assets held for sale and discontinued operations." } } }, "auth_ref": [ "r144" ] }, "ifrs-full_DisclosureOfOperatingSegmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfOperatingSegmentsAbstract", "lang": { "en-us": { "role": { "label": "SEGMENT INFORMATION" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfOperatingSegmentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfOperatingSegmentsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of operating segments [text block]", "terseLabel": "Schedule of operating results group's reporting segments" } }, "en": { "role": { "documentation": "The disclosure of operating segments. [Refer: Operating segments [member]]" } } }, "auth_ref": [ "r168" ] }, "ifrs-full_DisclosureOfOperatingSegmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfOperatingSegmentsLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of operating segments [line items]", "terseLabel": "SEGMENT INFORMATION" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfOperatingSegmentsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfOperatingSegmentsTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of operating segments [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to operating segments." } } }, "auth_ref": [ "r168" ] }, "biox_DisclosureOfOtherFinancialAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "DisclosureOfOtherFinancialAssetsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of other financial assets.", "label": "Disclosure of other financial assets explanatory", "terseLabel": "Schedule of other financial assets" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfOtherOperatingIncomeExpenseExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of other operating income (expense) [text block]", "terseLabel": "Schedule of other income or expenses, net" } } }, "auth_ref": [ "r410" ] }, "biox_DisclosureOfOtherReceivablesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "DisclosureOfOtherReceivablesTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about other receivables.", "label": "Disclosure of Other Receivables [Table Text Block]", "terseLabel": "Schedule of other receivables" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfPerformanceObligationsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfPerformanceObligationsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of performance obligations [text block]", "terseLabel": "Schedule of deferred revenue and advances from customers" } }, "en": { "role": { "documentation": "The disclosure of performance obligations in contracts with customers. [Refer: Performance obligations [domain]]" } } }, "auth_ref": [ "r107", "r186" ] }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfPropertyPlantAndEquipmentLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [line items]", "terseLabel": "Property, plant and equipment" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfPropertyPlantAndEquipmentTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of property, plant and equipment." } } }, "auth_ref": [ "r15", "r217" ] }, "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of quantitative information about right-of-use assets [line items]", "terseLabel": "Right-of-use leased asset" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of quantitative information about right-of-use assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to right-of-use assets." } } }, "auth_ref": [ "r113", "r190" ] }, "ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of reconciliation of changes in biological assets [line items]", "terseLabel": "Inventories", "verboseLabel": "Biological assets" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInBiologicalAssetsTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of reconciliation of changes in biological assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the reconciliation of changes in biological assets." } } }, "auth_ref": [ "r63", "r245" ] }, "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInGoodwillExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of reconciliation of changes in goodwill [text block]", "terseLabel": "Schedule of carrying amount of goodwill" } }, "en": { "role": { "documentation": "The disclosure of the reconciliation of changes in goodwill. [Refer: Goodwill]" } } }, "auth_ref": [ "r135", "r253" ] }, "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInGoodwillLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of reconciliation of changes in goodwill [line items]", "terseLabel": "Goodwill" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInGoodwillTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of reconciliation of changes in goodwill [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the reconciliation of changes in goodwill." } } }, "auth_ref": [ "r135", "r253" ] }, "ifrs-full_DisclosureOfRelatedPartyExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfRelatedPartyExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactions" ], "lang": { "en-us": { "role": { "label": "Disclosure of related party [text block]", "verboseLabel": "SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS" } }, "en": { "role": { "documentation": "The entire disclosure for related parties." } } }, "auth_ref": [ "r33" ] }, "ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfResearchAndDevelopmentExpenseExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of research and development expense [text block]", "terseLabel": "Schedule of R&D classified by nature" } } }, "auth_ref": [ "r410" ] }, "ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract", "lang": { "en-us": { "role": { "label": "FINANCIAL INSTRUMENTS - RISK MANAGEMENT" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementLiquidityRiskDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of risk management strategy related to hedge accounting [line items]", "terseLabel": "FINANCIAL INSTRUMENTS - RISK MANAGEMENT" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementLiquidityRiskDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of risk management strategy related to hedge accounting [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the risk management strategy in relation to hedge accounting." } } }, "auth_ref": [ "r146", "r256", "r280" ] }, "ifrs-full_DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17LineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17LineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of sensitivity analysis to changes in risk variables that arise from contracts within scope of IFRS 17 [line items]", "terseLabel": "Currency risk" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of sensitivity analysis to changes in risk variables that arise from contracts within scope of IFRS 17 [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the sensitivity analysis to changes in risk variables that arise from contracts within the scope of IFRS 17." } } }, "auth_ref": [ "r126" ] }, "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformation" ], "lang": { "en-us": { "role": { "label": "Disclosure of share capital, reserves and other equity interest [text block]", "terseLabel": "EQUITY INFORMATION" } }, "en": { "role": { "documentation": "The entire disclosure for share capital, reserves and other equity interest." } } }, "auth_ref": [ "r199", "r275", "r319" ] }, "biox_DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of share of profit / (loss) joint ventures and affiliates.", "label": "Disclosure of Share of Profit or Loss in Joint Ventures and Affiliates [Table Text Block]", "terseLabel": "Schedule of share of profit or loss of joint ventures and associates" } } }, "auth_ref": [] }, "biox_DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "Definition: Tabular disclosure of components of trade and other payables.", "label": "Disclosure Of Trade And Other Payables Components [Table Text Block]", "terseLabel": "Schedule of trade and other payable" } } }, "auth_ref": [] }, "biox_DisclosureOfTradeReceivablesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "DisclosureOfTradeReceivablesTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of current and non-current trade receivables.", "label": "Disclosure of Trade Receivables [Table Text Block]", "terseLabel": "Schedule of trade receivables" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesAbstract", "lang": { "en-us": { "role": { "label": "SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of transactions between related parties [text block]", "verboseLabel": "Schedule of transactions between the group and related parties, and the related balances owed" } }, "en": { "role": { "documentation": "The disclosure of transactions between the entity and its related parties. [Refer: Total for all related parties [member]]" } } }, "auth_ref": [ "r26", "r222" ] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayablesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of transactions between related parties [line items]", "terseLabel": "Components of Consolidated Statement of Financial Position", "verboseLabel": "SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayablesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of transactions between related parties [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to transactions between related parties." } } }, "auth_ref": [ "r31", "r227" ] }, "biox_Disclosureofrightofuseleasedassetsandleaseliabilitytabletextblock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "Disclosureofrightofuseleasedassetsandleaseliabilitytabletextblock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesTables" ], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of roll forward of right of use leased assets and lease liability", "label": "Disclosure Of Right Of Use Leased Assets And Lease Liability [Table Text Block]", "terseLabel": "Schedule of right of use leased assets and lease liability from beginning of year to end of year" } } }, "auth_ref": [] }, "ifrs-full_DiscontinuedOperationsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DiscontinuedOperationsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNarrativeDetails", "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetIncomeFromDiscontinuedOperationsDetails", "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetLossFromForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesNarrativeDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails", "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails", "http://www.biocerescrops.com/role/DisclosureTaxationNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Discontinued operations [member]", "terseLabel": "Discontinued operations" } }, "en": { "role": { "documentation": "This member stands for a component of an entity that either has been disposed of or is classified as held for sale, and that: (a) represents a separate major line of business or geographical area of operations; (b) is part of a single co-ordinated plan to dispose of a separate major line of business or geographical area of operations; or (c) is a subsidiary acquired exclusively with a view to resale. A component of an entity comprises operations and cash flows that can be clearly distinguished, operationally and for financial reporting purposes, from the rest of the entity. [Refer: Total for all subsidiaries [member]]" } } }, "auth_ref": [ "r144" ] }, "ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisposalGroupsClassifiedAsHeldForSaleMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNarrativeDetails", "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetIncomeFromDiscontinuedOperationsDetails", "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetLossFromForeclosureDetails" ], "lang": { "en-us": { "role": { "label": "Disposal groups classified as held for sale [member]", "terseLabel": "Assets subject to foreclosure" } }, "en": { "role": { "documentation": "This member stands for groups of assets, which are to be disposed of together as a group in a single transaction, and the liabilities directly associated with those assets that will be transferred in the transaction." } } }, "auth_ref": [ "r144", "r408" ] }, "ifrs-full_DisposalsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisposalsPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Disposals, property, plant and equipment", "negatedTerseLabel": "Disposals" } }, "en": { "role": { "documentation": "The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r11", "r214" ] }, "ifrs-full_DisposalsRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisposalsRightofuseAssets", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "label": "Disposals, right-of-use assets", "negatedLabel": "Disposals" } }, "en": { "role": { "documentation": "The decrease in right-of-use assets resulting from disposals. [Refer: Right-of-use assets]" } } }, "auth_ref": [ "r388" ] }, "ifrs-full_DividendsPaid": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DividendsPaid", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Dividends recognised as distributions to owners", "negatedLabel": "Distribution of dividends by subsidiary" } }, "en": { "role": { "documentation": "The amount of dividends recognised as distributions to owners." } } }, "auth_ref": [ "r194", "r276", "r289" ] }, "ifrs-full_DividendsPaidClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DividendsPaidClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Dividends paid, classified as financing activities", "negatedLabel": "Cash dividend distributed by subsidiary" } }, "en": { "role": { "documentation": "The cash outflow for dividends paid by the entity, classified as financing activities." } } }, "auth_ref": [ "r69" ] }, "biox_DocumentAndEntityInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "DocumentAndEntityInformationAbstract", "lang": { "en-us": { "role": { "label": "Document and Entity Information [Abstract]" } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentType", "presentation": [ "http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "ifrs-full_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "EARNING PER SHARE", "terseLabel": "(Loss)/Profit per share" } } }, "auth_ref": [] }, "ifrs-full_EarningsPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EarningsPerShareExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareTables" ], "lang": { "en-us": { "role": { "label": "Earnings per share [text block]", "terseLabel": "Schedule of earnings per share" } }, "en": { "role": { "documentation": "The disclosure of earnings per share." } } }, "auth_ref": [ "r37" ] }, "biox_EcoseedIntegratedProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "EcoseedIntegratedProductsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for information pertaining to Eco seed integrated products.", "label": "Eco seed integrated products", "terseLabel": "Integrated seed products" } } }, "auth_ref": [] }, "biox_EffectInProfitAndLossDueToDesignateDevaluationOrAppreciationOfUsDollar": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "EffectInProfitAndLossDueToDesignateDevaluationOrAppreciationOfUsDollar", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "The effect on profit and loss as a result of an increase in a designated risk component that was reasonably possible at the end of the reporting period. Excludes defined benefit plan obligation", "label": "Effect In Profit and Loss Due to Designate Devaluation or Appreciation of US Dollar", "terseLabel": "Effect in profit and loss due to designate devaluation or appreciation of US dollar" } } }, "auth_ref": [] }, "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Effect of exchange rate changes on cash and cash equivalents", "terseLabel": "Effect of exchange rate changes on cash and equivalents" } }, "en": { "role": { "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r67", "r68" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r384" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityRegistrantName", "presentation": [ "http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r384" ] }, "ifrs-full_Equity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Equity", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Equity", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total equity" } }, "en": { "role": { "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities." } } }, "auth_ref": [ "r77", "r79", "r98", "r99", "r100", "r228", "r247", "r268", "r269", "r279", "r307", "r314" ] }, "ifrs-full_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EquityAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "EQUITY.", "verboseLabel": "EQUITY" } } }, "auth_ref": [] }, "ifrs-full_EquityAndLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EquityAndLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Equity and liabilities", "totalLabel": "Total equity and liabilities" } }, "en": { "role": { "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]" } } }, "auth_ref": [ "r307" ] }, "ifrs-full_EquityAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EquityAttributableToOwnersOfParent", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Equity attributable to owners of parent", "terseLabel": "Equity attributable to owners of the parent" } }, "en": { "role": { "documentation": "The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest." } } }, "auth_ref": [ "r306" ] }, "ifrs-full_EquityAttributableToOwnersOfParentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EquityAttributableToOwnersOfParentMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Equity / (deficit) attributable to owners of the parent" } }, "en": { "role": { "documentation": "This member stands for equity attributable to the owners of the parent." } } }, "auth_ref": [ "r288" ] }, "biox_EquityCompensationPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "EquityCompensationPlanMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Member stands for equity compensation plan.", "label": "Equity Compensation Plan [Member]", "terseLabel": "Equity compensation plan" } } }, "auth_ref": [] }, "biox_ExpensesRecovery": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ExpensesRecovery", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails": { "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of recovered expenses.", "label": "Expenses Recovery", "terseLabel": "Expenses recovery" } } }, "auth_ref": [] }, "biox_FeeAndCommissionExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "FeeAndCommissionExpenses", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails": { "parentTag": "ifrs-full_FinanceCosts", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of expense relating to fees and commissions.", "label": "Fee And Commission Expenses", "negatedLabel": "Financial commissions" } } }, "auth_ref": [] }, "ifrs-full_FinanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "FinanceCosts", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "label": "Finance costs", "negatedTotalLabel": "Financial costs" } } }, "auth_ref": [ "r324" ] }, "biox_FinanceCostsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "FinanceCostsAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available", "label": "Finance Costs [Abstract]", "terseLabel": "Financial costs" } } }, "auth_ref": [] }, "ifrs-full_FinanceIncomeCost": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "FinanceIncomeCost", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetIncomeFromDiscontinuedOperationsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Finance income (cost)", "verboseLabel": "Financial cost" } } }, "auth_ref": [ "r419" ] }, "ifrs-full_FinanceIncomeReceivedClassifiedAsOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "FinanceIncomeReceivedClassifiedAsOperatingActivities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Finance income received, classified as operating activities", "terseLabel": "Interest collected" } } }, "auth_ref": [ "r402" ] }, "ifrs-full_FinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "FinancialAssets", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Financial assets.", "terseLabel": "Financial assets" } }, "en": { "role": { "documentation": "The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose the entity\u2019s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. [Refer: Classes of financial instruments [domain]; Financial liabilities]" } } }, "auth_ref": [ "r148", "r153", "r154", "r156", "r259", "r260", "r262", "r364" ] }, "ifrs-full_FinancialAssetsAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "FinancialAssetsAtFairValue", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "label": "Financial assets, at fair value", "terseLabel": "Financial assets at fair value" } }, "en": { "role": { "documentation": "The fair value of financial assets. [Refer: At fair value [member]; Financial assets]" } } }, "auth_ref": [ "r148" ] }, "ifrs-full_FinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "FinancialLiabilities", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementLiquidityRiskDetails" ], "lang": { "en-us": { "role": { "label": "Financial liabilities.", "verboseLabel": "Financial liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Classes of financial instruments [domain]; Financial assets; Derivatives [member]]" } } }, "auth_ref": [ "r148" ] }, "ifrs-full_FinancialLiabilitiesAtAmortisedCostMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "FinancialLiabilitiesAtAmortisedCostMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Amortized cost", "terseLabel": "Amortized cost" } }, "en": { "role": { "documentation": "This member stands for the financial liabilities measured at amortised cost class. [Refer: Financial liabilities at amortised cost]" } } }, "auth_ref": [ "r162", "r182", "r255" ] }, "ifrs-full_FinancialLiabilitiesAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "FinancialLiabilitiesAtFairValue", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "label": "Financial liability, at fair value", "terseLabel": "Financial liability at fair value" } }, "en": { "role": { "documentation": "The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]" } } }, "auth_ref": [ "r148" ] }, "biox_FinancialLiabilitiesWithRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "FinancialLiabilitiesWithRelatedParties", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails": { "parentTag": "biox_NonCashFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of financial liabilities with related parties that was incurred, settled, or modified.", "label": "Financial Liabilities With Related Parties", "negatedLabel": "Financial liabilities with related parties" } } }, "auth_ref": [] }, "ifrs-full_FixturesAndFittingsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "FixturesAndFittingsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Fixture and fittings", "terseLabel": "Fixture and fittings" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing fixtures and fittings that are not permanently attached to real property. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r335" ] }, "biox_ForeignCurrencyTranslationOnInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ForeignCurrencyTranslationOnInventory", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation on inventory", "label": "Foreign Currency Translation on Inventory", "negatedLabel": "Foreign currency translation" } } }, "auth_ref": [] }, "biox_FreightAndHaulageExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "FreightAndHaulageExpenses", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 5.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of freight and haulage expenses.", "label": "Freight and Haulage Expenses", "terseLabel": "Freight and haulage" } } }, "auth_ref": [] }, "ifrs-full_FuelAndEnergyExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "FuelAndEnergyExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 9.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Fuel and energy expense", "terseLabel": "Energy and fuel" } } }, "auth_ref": [ "r414" ] }, "ifrs-full_GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromDiscontinuedOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNarrativeDetails", "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetLossFromForeclosureDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Gain (loss) recognised on measurement to fair value less costs to sell or on disposal of assets or disposal groups constituting discontinued operation", "terseLabel": "Loss related to foreclosure", "verboseLabel": "Net loss from foreclosure" } } }, "auth_ref": [ "r139" ] }, "ifrs-full_GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Gains (losses) on change in fair value less costs to sell of biological assets for current period", "negatedLabel": "Changes in the net realizable value of agricultural products after harvest" } } }, "auth_ref": [ "r61" ] }, "biox_GainsLossesOnDisposalsOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "GainsLossesOnDisposalsOfIntangibleAssets", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails": { "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails" ], "lang": { "en-us": { "role": { "documentation": "The gains (losses) on disposals of intangible assets.", "label": "Gains (Losses) on Disposals of Intangible Assets", "terseLabel": "Result of intangible sales" } } }, "auth_ref": [] }, "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GainsLossesOnExchangeDifferencesOnTranslationNetOfTax", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Gains (losses) on exchange differences on translation, net of tax", "terseLabel": "Foreign exchange differences on translation of foreign operations" } }, "en": { "role": { "documentation": "The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, net of tax, before reclassification adjustments. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r328" ] }, "ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Gains (losses) on fair value adjustment attributable to price changes, biological assets", "negatedLabel": "Initial recognition and changes in the fair value of biological assets" } } }, "auth_ref": [ "r343", "r344" ] }, "ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GainsLossesOnFairValueAdjustmentBiologicalAssets", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails", "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Gains (losses) on fair value adjustment, biological assets", "terseLabel": "Initial recognition and changes in the fair value of biological assets at the point of harvest", "verboseLabel": "Initial recognition and changes in the fair value of biological assets at the point of harvest" } } }, "auth_ref": [ "r62", "r244" ] }, "ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails": { "parentTag": "ifrs-full_OtherFinanceIncomeCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "label": "Gains (losses) recognised in profit or loss on exchange differences, fair value measurement, assets", "terseLabel": "Exchange differences generated by assets" } }, "en": { "role": { "documentation": "The gains (losses) on exchange differences, recognised in profit or loss, on the fair value measurement of assets. [Refer: At fair value [member]]" } } }, "auth_ref": [ "r404" ] }, "ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails": { "parentTag": "ifrs-full_OtherFinanceIncomeCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "label": "Gains (losses) recognised in profit or loss on exchange differences, fair value measurement, liabilities", "terseLabel": "Exchange differences generated by liabilities" } }, "en": { "role": { "documentation": "The gains (losses) on exchange differences, recognised in profit or loss, on the fair value measurement of liabilities. [Refer: At fair value [member]]" } } }, "auth_ref": [ "r404" ] }, "biox_GeneralInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "GeneralInformationAbstract", "lang": { "en-us": { "role": { "documentation": "No Definition Available", "label": "GENERAL INFORMATION" } } }, "auth_ref": [] }, "biox_GoodsAndServicesIncludingRightOfUseLicenseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "GoodsAndServicesIncludingRightOfUseLicenseMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for goods and services, including rights of use license.", "label": "Goods And Services, Including Right Of Use License [Member]", "terseLabel": "Sale of goods and services" } } }, "auth_ref": [] }, "biox_GoodsAndServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "GoodsAndServicesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRevenueFromContractsWithCustomersDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for goods and services.", "label": "Goods And Services [Member]", "terseLabel": "Sale of goods and services" } } }, "auth_ref": [] }, "ifrs-full_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 2.0 }, "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails": { "parentTag": "biox_AssetsSubjectToForeclosureGrossCarryingAmount", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Goodwill", "terseLabel": "Goodwill" } }, "en": { "role": { "documentation": "The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Total for all business combinations [member]]" } } }, "auth_ref": [ "r46", "r48", "r135", "r231", "r233", "r253", "r293" ] }, "ifrs-full_GrossCarryingAmountMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GrossCarryingAmountMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "label": "Gross carrying amount [member]", "terseLabel": "Gross carrying amount", "verboseLabel": "Right-of-use leased asset" } } }, "auth_ref": [ "r9", "r49", "r59", "r64", "r135", "r154", "r156", "r212", "r234", "r242", "r246", "r260", "r262", "r364" ] }, "biox_GrossFinancialDebtQuarterlyLimits": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "GrossFinancialDebtQuarterlyLimits", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of gross financial debt on a quarterly basis.", "label": "Gross Financial Debt Quarterly Limits", "terseLabel": "Gross financial debt quarterly limits" } } }, "auth_ref": [] }, "ifrs-full_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Gross profit", "totalLabel": "Gross profit per segment" } } }, "auth_ref": [ "r377" ] }, "biox_IfrsBalanceSheetLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "IfrsBalanceSheetLocationAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Information by location in statement of financial position where disaggregated cumulative balance has been reported.", "label": "Ifrs Balance Sheet Location [Axis]" } } }, "auth_ref": [] }, "biox_IfrsBalanceSheetLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "IfrsBalanceSheetLocationDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Location in statement of financial position where disaggregated cumulative balance has been reported.", "label": "Ifrs Balance Sheet Location [Domain]" } } }, "auth_ref": [] }, "biox_IfrsDebtInstrumentTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "IfrsDebtInstrumentTerm", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails" ], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "IFRS Debt instrument term", "terseLabel": "Maturity term" } } }, "auth_ref": [] }, "biox_IfrsResearchAndDevelopmentExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "IfrsResearchAndDevelopmentExpenseMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research And Development Expense [Member]", "terseLabel": "Research and development expenses" } } }, "auth_ref": [] }, "biox_IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Ifrs Schedule Of Components Of Income Tax Expense Benefit [Table Text Block]", "terseLabel": "Schedule of current tax" } } }, "auth_ref": [] }, "biox_IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "IFRS Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Schedule of reconciliation of the statutory tax rate to the effective tax rate" } } }, "auth_ref": [] }, "biox_IfrsScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "IfrsScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Ifrs Schedule of Inventory Current Table Text Block", "terseLabel": "Schedule of inventories" } } }, "auth_ref": [] }, "biox_IfrsStockRepurchasedDuringPeriodShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "IfrsStockRepurchasedDuringPeriodShares", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased.", "label": "Ifrs Stock Repurchased During Period Shares", "terseLabel": "Number of own shares repurchased" } } }, "auth_ref": [] }, "biox_ImpairmentOfReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ImpairmentOfReceivables", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of impairment loss recognised in profit or loss, trade receivables relating to production costs selling, general and administrative expenses.", "label": "Impairment Of Receivables", "terseLabel": "Impairment of receivables" } } }, "auth_ref": [] }, "biox_ImportAndExportExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ImportAndExportExpenses", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of import and export expenses.", "label": "Import and Export Expenses", "terseLabel": "Import and export expenses" } } }, "auth_ref": [] }, "ifrs-full_IncomeFromContinuingOperationsAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncomeFromContinuingOperationsAttributableToOwnersOfParent", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": "ifrs-full_ProfitLossFromContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Income from continuing operations attributable to owners of parent", "terseLabel": "Equity holders of the parent" } }, "en": { "role": { "documentation": "The amount of income from continuing operations attributable to owners of the parent. [Refer: Continuing operations, unless line item indicates otherwise [member]]" } } }, "auth_ref": [ "r142" ] }, "ifrs-full_IncomeFromDiscontinuedOperationsAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncomeFromDiscontinuedOperationsAttributableToOwnersOfParent", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": "ifrs-full_ProfitLossFromDiscontinuedOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Income from discontinued operations attributable to owners of parent", "terseLabel": "Equity holders of the parent" } } }, "auth_ref": [ "r142" ] }, "ifrs-full_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME" } } }, "auth_ref": [] }, "biox_IncomeTaxDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "IncomeTaxDisclosureLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationIncomeTaxExpenseWasCalculatedByApplyingTaxRateInForceDetails", "http://www.biocerescrops.com/role/DisclosureTaxationNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.", "label": "Income Tax Disclosure [Line Items]", "terseLabel": "TAXATION", "verboseLabel": "Tax Jurisdiction" } } }, "auth_ref": [] }, "biox_IncomeTaxDisclosureTable": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "IncomeTaxDisclosureTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationIncomeTaxExpenseWasCalculatedByApplyingTaxRateInForceDetails", "http://www.biocerescrops.com/role/DisclosureTaxationNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Schedule disclosing information related to income tax disclosures.", "label": "Income Tax Disclosure [Table]" } } }, "auth_ref": [] }, "ifrs-full_IncomeTaxExpenseContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncomeTaxExpenseContinuingOperations", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromContinuingOperations", "weight": -1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetIncomeFromDiscontinuedOperationsDetails": { "parentTag": "biox_ProfitLossFromDiscontinuedOperationsBeforeGainLossOnDisposal", "weight": -1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/DisclosureTaxationTaxesOnIncomeDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetIncomeFromDiscontinuedOperationsDetails", "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails", "http://www.biocerescrops.com/role/DisclosureTaxationTaxesOnIncomeDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Tax expense (income), continuing operations", "negatedLabel": "Income tax", "negatedTotalLabel": "Income tax expenses" } } }, "auth_ref": [ "r2", "r4", "r5", "r34", "r94", "r167", "r206", "r208", "r209", "r326" ] }, "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureUnauditedInterimCondensedConsolidatedStatementsOfCashFlowsCalc2": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) in cash and cash equivalents before effect of exchange rate changes", "totalLabel": "Net decrease in cash and cash equivalents" } }, "en": { "role": { "documentation": "The increase (decrease) in cash and cash equivalents before the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]" } } }, "auth_ref": [ "r72", "r202" ] }, "biox_IncreaseDecreaseInCashAndCashEquivalentsContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "IncreaseDecreaseInCashAndCashEquivalentsContinuingOperations", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureUnauditedInterimCondensedConsolidatedStatementsOfCashFlowsCalc2": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Net decrease in cash and cash equivalents from continuing operations", "label": "Increase (Decrease) In Cash And Cash Equivalents, Continuing operations", "terseLabel": "Net decrease in cash and cash equivalents from continuing operations" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureUnauditedInterimCondensedConsolidatedStatementsOfCashFlowsCalc2": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) in cash and cash equivalents, discontinued operations", "terseLabel": "Net (decrease) / increase in cash and cash equivalents from discontinued operations" } }, "en": { "role": { "documentation": "The increase (decrease) in cash and cash equivalents from discontinued operations. [Refer: Cash and cash equivalents; Discontinued operations [member]]" } } }, "auth_ref": [ "r406" ] }, "ifrs-full_IncreaseDecreaseInFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseInFinancialAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) in financial assets", "terseLabel": "Investment in financial assets" } }, "en": { "role": { "documentation": "The increase (decrease) in financial assets. [Refer: Financial assets]" } } }, "auth_ref": [ "r153", "r154", "r259", "r260" ] }, "ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughAcquisitionOfSubsidiary", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) through acquisition of subsidiary, equity", "terseLabel": "Contingent consideration payment" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from the acquisition of subsidiaries. [Refer: Total for all subsidiaries [member]]" } } }, "auth_ref": [ "r412" ] }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationMovementOnDeferredIncomeTaxDetails" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) through net exchange differences, deferred tax liability (asset)", "terseLabel": "Conversion difference" } }, "en": { "role": { "documentation": "The increase (decrease) in deferred tax liability (asset) resulting from the net exchange differences arising when the financial statements are translated from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Deferred tax liability (asset)]" } } }, "auth_ref": [ "r385" ] }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) through net exchange differences, intangible assets other than goodwill", "terseLabel": "Foreign currency translation" } }, "en": { "role": { "documentation": "The increase (decrease) in intangible assets other than goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r53" ] }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) through net exchange differences, property, plant and equipment", "terseLabel": "Foreign currency translation" } }, "en": { "role": { "documentation": "The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r13" ] }, "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) through share-based payment transactions, equity", "terseLabel": "Share-based incentives" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]" } } }, "auth_ref": [ "r286" ] }, "biox_IncreaseDecreaseThroughTransfersOrDisposalsIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "IncreaseDecreaseThroughTransfersOrDisposalsIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "The increase (decrease) in intangible assets other than goodwill resulting from transfers, or the decrease resulting from disposals.", "label": "Increase (Decrease) Through Transfers or Disposals, Intangible Assets Other Than Goodwill", "terseLabel": "Transfers/ Disposals" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) through transfers, property, plant and equipment", "terseLabel": "Transfers" } }, "en": { "role": { "documentation": "The increase (decrease) in property, plant and equipment resulting from transfers. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r388" ] }, "ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughTreasuryShareTransactions", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) through treasury share transactions, equity", "terseLabel": "Purchase of own shares" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from treasury share transactions. [Refer: Equity; Treasury shares]" } } }, "auth_ref": [ "r287" ] }, "biox_InflationEffectsOnCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "InflationEffectsOnCashAndCashEquivalents", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The effect of inflation effects on cash and cash equivalents.", "label": "Inflation Effects on Cash and Cash Equivalents", "terseLabel": "Inflation effects on cash and cash equivalents" } } }, "auth_ref": [] }, "biox_InformationTechnologyExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "InformationTechnologyExpenses", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 16.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 21.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of information technology expenses.", "label": "Information Technology Expenses", "terseLabel": "Information technology expenses" } } }, "auth_ref": [] }, "biox_InsumosAgroqumicosMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "InsumosAgroqumicosMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Insumos Agroqumicos.", "label": "Insumos Agroqumicos S.A." } } }, "auth_ref": [] }, "ifrs-full_InsuranceExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "InsuranceExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "label": "Insurance expense", "terseLabel": "Insurance" } } }, "auth_ref": [ "r414" ] }, "biox_InsuranceExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "InsuranceExpenses", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of expense arising from purchased insurance.", "label": "Insurance Expenses", "terseLabel": "Insurance" } } }, "auth_ref": [] }, "ifrs-full_IntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IntangibleAssetsOtherThanGoodwill", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails": { "parentTag": "biox_AssetsSubjectToForeclosureGrossCarryingAmount", "weight": 1.0, "order": 3.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Intangible assets", "periodEndLabel": "Balance at end of the period", "periodStartLabel": "Balance at beginning of the period", "terseLabel": "Intangible assets" } }, "en": { "role": { "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]" } } }, "auth_ref": [ "r54", "r238", "r293" ] }, "ifrs-full_InterestCostsCapitalised": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "InterestCostsCapitalised", "calculation": { "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails": { "parentTag": "biox_NonCashInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "label": "Interest costs capitalised", "terseLabel": "Capitalization of interest on buildings in progress" } }, "en": { "role": { "documentation": "The amount of interest costs that an entity incurs in connection with the borrowing of funds that are directly attributable to the acquisition, construction or production of a qualifying asset and which form part of the cost of that asset." } } }, "auth_ref": [ "r414" ] }, "ifrs-full_InterestExpenseOnOtherFinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "InterestExpenseOnOtherFinancialLiabilities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails": { "parentTag": "ifrs-full_FinanceCosts", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "label": "Interest expense on other financial liabilities", "negatedLabel": "Interest expenses" } } }, "auth_ref": [ "r414" ] }, "ifrs-full_InterestPaidClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "InterestPaidClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Interest paid, classified as financing activities", "negatedLabel": "Interest payments" } }, "en": { "role": { "documentation": "The cash outflow for interest paid, classified as financing activities." } } }, "auth_ref": [ "r69" ] }, "ifrs-full_Inventories": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Inventories", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 3.0 }, "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails": { "parentTag": "biox_AssetsSubjectToForeclosureGrossCarryingAmount", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current inventories", "terseLabel": "Inventories" } }, "en": { "role": { "documentation": "The amount of current inventories. [Refer: Inventories]" } } }, "auth_ref": [ "r19", "r200", "r297", "r379" ] }, "biox_InventoriesBeforeClosingInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "InventoriesBeforeClosingInventory", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of inventory before closing inventory (ie., Opening inventory plus purchases).", "label": "Inventories Before Closing Inventory", "terseLabel": "Subtotal" } } }, "auth_ref": [] }, "biox_InventoriesExcludingAgriculturalProduce": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "InventoriesExcludingAgriculturalProduce", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of current inventories excluding agricultural produce.", "label": "Inventories, Excluding Agricultural Produce", "terseLabel": "Net of agricultural products" } } }, "auth_ref": [] }, "ifrs-full_InventoriesTotal": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "InventoriesTotal", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesDetails" ], "lang": { "en-us": { "role": { "label": "Inventories.", "negatedPeriodEndLabel": "Inventories as of the end of the period", "periodStartLabel": "Inventories as of the beginning of the period" } }, "en": { "role": { "documentation": "The amount of assets: (a) held for sale in the ordinary course of business; (b) in the process of production for such sale; or (c) in the form of materials or supplies to be consumed in the production process or in the rendering of services. Inventories encompass goods purchased and held for resale including, for example, merchandise purchased by a retailer and held for resale, or land and other property held for resale. Inventories also encompass finished goods produced, or work in progress being produced, by the entity and include materials and supplies awaiting use in the production process. [Refer: Current finished goods; Current merchandise; Current work in progress; Land]" } } }, "auth_ref": [ "r297" ] }, "biox_InventoryProductionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "InventoryProductionCosts", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of manufacturing costs capitalized to inventory during the period.", "label": "Inventory Production Costs", "terseLabel": "Production costs" } } }, "auth_ref": [] }, "ifrs-full_InvestmentAccountedForUsingEquityMethod": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "InvestmentAccountedForUsingEquityMethod", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesChangesInJointVenturesInvestmentsDetails" ], "lang": { "en-us": { "role": { "label": "Investments accounted for using equity method", "periodEndLabel": "As of the end of the period", "periodStartLabel": "As of the beginning of the period" } }, "en": { "role": { "documentation": "The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]]" } } }, "auth_ref": [ "r95", "r169", "r267", "r295" ] }, "ifrs-full_InvestmentFundsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "InvestmentFundsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "label": "Mutual funds" } }, "en": { "role": { "documentation": "This member stands for investment funds." } } }, "auth_ref": [ "r355" ] }, "biox_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails": { "parentTag": "biox_NonCashInvestingActivities", "weight": 1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails": { "parentTag": "biox_RelatedPartyTransactions", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of investment in kind in other related parties, non cash transactions investment activities.", "label": "Investment in Kind in Other Related Parties, Non Cash Transactions Investment Activities", "terseLabel": "Investment in-kind in other related parties (Note 15)", "verboseLabel": "In-kind contributions" } } }, "auth_ref": [] }, "biox_InvestmentPropertiesIncludingSubjectToForeclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "InvestmentPropertiesIncludingSubjectToForeclosure", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails": { "parentTag": "biox_AssetsSubjectToForeclosureGrossCarryingAmount", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of property (land or a building - or part of a building - or both) held (by the owner or by the lessee as a right-of-use asset) to earn rentals or for capital appreciation or both, including subject to foreclosure.", "label": "Investment Properties Including Subject to Foreclosure", "terseLabel": "Investment properties" } } }, "auth_ref": [] }, "ifrs-full_InvestmentProperty": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "InvestmentProperty", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Investment property", "terseLabel": "Investment properties" } }, "en": { "role": { "documentation": "The amount of property (land or a building - or part of a building - or both) held (by the owner or by the lessee as a right-of-use asset) to earn rentals or for capital appreciation or both, rather than for: (a) use in the production or supply of goods or services or for administrative purposes; or (b) sale in the ordinary course of business." } } }, "auth_ref": [ "r58", "r60", "r241", "r243", "r292" ] }, "ifrs-full_InvestmentsAccountedForUsingEquityMethodAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "InvestmentsAccountedForUsingEquityMethodAbstract", "lang": { "en-us": { "role": { "label": "JOINT VENTURES AND ASSOCIATES" } } }, "auth_ref": [] }, "biox_InvestmentsAccountedForUsingEquityMethodAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "InvestmentsAccountedForUsingEquityMethodAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesAssetsAndLiabilitiesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "documentation": "The amount of investments accounted for using the equity method, asset position.", "label": "Investments Accounted For Using Equity Method, Assets", "terseLabel": "Investments in joint ventures and associates", "verboseLabel": "Assets in joint ventures and associates" } } }, "auth_ref": [] }, "biox_InvestmentsAccountedForUsingEquityMethodLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "InvestmentsAccountedForUsingEquityMethodLiability", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesAssetsAndLiabilitiesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "documentation": "The amount of investments accounted for using the equity method, liability position.", "label": "Investments accounted for using equity method, liability", "terseLabel": "Joint ventures and associates", "verboseLabel": "Liabilities in joint ventures and associates" } } }, "auth_ref": [] }, "biox_InvestmentsHeldInTrustMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "InvestmentsHeldInTrustMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for investments held in trust.", "label": "Investments Held In Trust [Member]", "terseLabel": "Trusts" } } }, "auth_ref": [] }, "biox_InvestmentsInJointVenturesAndAssociatesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "InvestmentsInJointVenturesAndAssociatesTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociates" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure on investments in joint ventures and associates.", "label": "Investments In Joint Ventures And Associates [Text Block]", "terseLabel": "JOINT VENTURES AND ASSOCIATES" } } }, "auth_ref": [] }, "ifrs-full_IssuedCapitalMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IssuedCapitalMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Issued capital" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing issued capital." } } }, "auth_ref": [ "r288" ] }, "biox_JointVenturesAndAssociatesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "JointVenturesAndAssociatesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayablesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for information pertaining to Joint Ventures and Associates.", "label": "Joint ventures and associates", "terseLabel": "Trade debtors - Joint ventures and associates", "verboseLabel": "Joint ventures and associates" } } }, "auth_ref": [] }, "ifrs-full_JointVenturesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "JointVenturesAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesAssetsAndLiabilitiesDetails", "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesShareOfProfitDetails" ], "lang": { "en-us": { "role": { "label": "Joint ventures [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r35", "r36", "r97", "r265" ] }, "ifrs-full_JointVenturesDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "JointVenturesDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesAssetsAndLiabilitiesDetails", "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesShareOfProfitDetails" ], "lang": { "en-us": { "role": { "label": "Joint ventures [domain]" } }, "en": { "role": { "documentation": "This member stands for the standard value for the 'Joint ventures' axis if no other member is used." } } }, "auth_ref": [ "r35", "r36", "r97", "r265" ] }, "ifrs-full_JointVenturesWhereEntityIsVenturerMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "JointVenturesWhereEntityIsVenturerMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Joint ventures [member]", "terseLabel": "Joint ventures and associates" } }, "en": { "role": { "documentation": "This member stands for joint ventures in which the entity is a joint venturer. A venturer is a party to a joint venture and has joint control over that joint venture. [Refer: Total for all joint ventures [member]]" } } }, "auth_ref": [ "r28", "r224" ] }, "biox_KeyManagementPersonnelBenefitsLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "KeyManagementPersonnelBenefitsLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionEmployeeBenefitsAndSocialSecurityDetails": { "parentTag": "ifrs-full_CurrentProvisionsForEmployeeBenefits", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionEmployeeBenefitsAndSocialSecurityDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of current liability related to key management personnel.", "label": "Key Management Personnel Benefits Liability, Current", "terseLabel": "Key management personnel" } } }, "auth_ref": [] }, "ifrs-full_KeyManagementPersonnelCompensation": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "KeyManagementPersonnelCompensation", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationSummaryOfCompensationOfDirectorsAndOtherMembersDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationSummaryOfCompensationOfDirectorsAndOtherMembersDetails" ], "lang": { "en-us": { "role": { "label": "Key management personnel compensation.", "totalLabel": "Total" } } }, "auth_ref": [ "r24", "r220" ] }, "biox_KeyManagementPersonnelCompensationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "KeyManagementPersonnelCompensationAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "KEY MANAGEMENT PERSONNEL COMPENSATION" } } }, "auth_ref": [] }, "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "KeyManagementPersonnelCompensationSharebasedPayment", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationSummaryOfCompensationOfDirectorsAndOtherMembersDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationSummaryOfCompensationOfDirectorsAndOtherMembersDetails" ], "lang": { "en-us": { "role": { "label": "Key management personnel compensation, share-based payment", "terseLabel": "Share-based incentives" } } }, "auth_ref": [ "r23" ] }, "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationSummaryOfCompensationOfDirectorsAndOtherMembersDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationSummaryOfCompensationOfDirectorsAndOtherMembersDetails" ], "lang": { "en-us": { "role": { "label": "Key management personnel compensation, short-term employee benefits", "verboseLabel": "Salaries, social security and other benefits" } } }, "auth_ref": [ "r22" ] }, "ifrs-full_KeyManagementPersonnelOfEntityOrParentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "KeyManagementPersonnelOfEntityOrParentMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Key management personnel [member]", "terseLabel": "Key management personnel" } }, "en": { "role": { "documentation": "This member stands for those persons having authority and responsibility for planning, directing and controlling the activities of the entity, directly or indirectly, including any director (whether executive or otherwise) of that entity." } } }, "auth_ref": [ "r29", "r225" ] }, "ifrs-full_LandAndBuildingsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LandAndBuildingsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "label": "Land and buildings [member]", "terseLabel": "Land and buildings" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing land and depreciable buildings and similar structures for use in operations. [Refer: Buildings; Land; Property, plant and equipment]" } } }, "auth_ref": [ "r333" ] }, "ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LaterThanOneYearAndNotLaterThanThreeYearsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementLiquidityRiskDetails" ], "lang": { "en-us": { "role": { "label": "Between one and three periods" } }, "en": { "role": { "documentation": "This member stands for a time band of later than one year and not later than three years." } } }, "auth_ref": [ "r366", "r367", "r369" ] }, "ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LaterThanThreeMonthsAndNotLaterThanOneYearMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementLiquidityRiskDetails" ], "lang": { "en-us": { "role": { "label": "3 to 12 months" } }, "en": { "role": { "documentation": "This member stands for a time band of later than three months and not later than one year." } } }, "auth_ref": [ "r365" ] }, "ifrs-full_LeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LeaseLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Lease liabilities", "periodEndLabel": "Total", "periodStartLabel": "Book value at the beginning of the period", "totalLabel": "Total" } }, "en": { "role": { "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration." } } }, "auth_ref": [ "r110" ] }, "ifrs-full_LeaseLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LeaseLiabilitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Lease liabilities [abstract]", "terseLabel": "Lease Liabilities" } } }, "auth_ref": [] }, "biox_LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "documentation": "Lease liabilities additions from interest expense, exchange differences and inflation effects.", "label": "Lease Liabilities, Interest Expense, Exchange Differences And Inflation Effects", "terseLabel": "Interest expenses, exchange differences and inflation effects" } } }, "auth_ref": [] }, "ifrs-full_LeaseLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LeaseLiabilitiesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementLiquidityRiskDetails" ], "lang": { "en-us": { "role": { "label": "Lease liability", "verboseLabel": "Leasing liabilities" } }, "en": { "role": { "documentation": "This member stands for lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r351", "r352" ] }, "biox_LeasesLiabilitiesAdditions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "LeasesLiabilitiesAdditions", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of additional liabilities during the period.", "label": "Leases Liabilities Additions", "terseLabel": "Additions of the period" } } }, "auth_ref": [] }, "ifrs-full_Level1OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Level1OfFairValueHierarchyMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "label": "Level 1" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date." } } }, "auth_ref": [ "r18", "r45", "r47", "r99", "r232", "r269" ] }, "ifrs-full_Level2OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Level2OfFairValueHierarchyMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "label": "Level 2" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly." } } }, "auth_ref": [ "r45", "r47", "r99", "r232", "r269" ] }, "ifrs-full_LevelsOfFairValueHierarchyAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LevelsOfFairValueHierarchyAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "label": "Levels of fair value hierarchy [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r18", "r99", "r269" ] }, "ifrs-full_LevelsOfFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LevelsOfFairValueHierarchyDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "label": "Levels of fair value hierarchy [domain]" } }, "en": { "role": { "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used." } } }, "auth_ref": [ "r18", "r99", "r269" ] }, "ifrs-full_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Liabilities", "totalLabel": "Total liabilities" } }, "en": { "role": { "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r98", "r99", "r100", "r168", "r173", "r268", "r269", "r307" ] }, "ifrs-full_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LiabilitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "LIABILITIES.", "terseLabel": "LIABILITIES" } } }, "auth_ref": [] }, "ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails": { "parentTag": "ifrs-full_NetAssetsLiabilities", "weight": -1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNarrativeDetails", "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Liabilities included in disposal groups classified as held for sale", "terseLabel": "Liabilities subject to foreclosure", "totalLabel": "Total liabilities subject to foreclosure" } }, "en": { "role": { "documentation": "The amount of liabilities included in disposal groups classified as held for sale. [Refer: Liabilities; Disposal groups classified as held for sale [member]]" } } }, "auth_ref": [ "r143", "r304" ] }, "ifrs-full_LiquidityRiskMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LiquidityRiskMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementLiquidityRiskDetails" ], "lang": { "en-us": { "role": { "label": "Liquidity risk" } }, "en": { "role": { "documentation": "This member stands for the risk that an entity will encounter difficulty in meeting obligations associated with financial liabilities that are settled by delivering cash or another financial asset. [Refer: Financial assets; Financial liabilities]" } } }, "auth_ref": [ "r122", "r123", "r124", "r363" ] }, "biox_LoanReceivableNonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "LoanReceivableNonCurrent", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": "ifrs-full_OtherNoncurrentReceivables", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the non current amount of loan receivable.", "label": "Loan Receivable Non Current", "terseLabel": "Loans receivables" } } }, "auth_ref": [] }, "ifrs-full_LongtermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LongtermBorrowings", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails": { "parentTag": "ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale", "weight": 1.0, "order": 3.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current portion of non-current borrowings", "terseLabel": "Borrowings" } }, "en": { "role": { "documentation": "The non-current portion of non-current borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r416" ] }, "biox_LossMakingEntitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "LossMakingEntitiesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationIncomeTaxExpenseWasCalculatedByApplyingTaxRateInForceDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for loss-making entities.", "label": "Loss-Making Entities [Member]", "terseLabel": "Loss-making entities" } } }, "auth_ref": [] }, "biox_LossPerShareFromDiscontinuedOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "LossPerShareFromDiscontinuedOperationsAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available", "label": "Loss Per Share From Discontinued Operations [Abstract]", "terseLabel": "Loss per share from discontinued operations" } } }, "auth_ref": [] }, "biox_LossProfitPerShareForPeriodAttributableToEquityHoldersAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "LossProfitPerShareForPeriodAttributableToEquityHoldersAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available", "label": "(Loss)Profit Per Share For The Period Attributable To Equity Holders [Abstract]", "terseLabel": "(Loss)/Profit per share for the period attributable to equity holders" } } }, "auth_ref": [] }, "biox_LossProfitPerShareFromContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "LossProfitPerShareFromContinuingOperationsAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available", "label": "(Loss) Profit Per Share From Continuing Operations [Abstract]", "terseLabel": "(Loss)/Profit per share from continuing operations" } } }, "auth_ref": [] }, "biox_LowOrNullTaxationJurisdictionsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "LowOrNullTaxationJurisdictionsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationIncomeTaxExpenseWasCalculatedByApplyingTaxRateInForceDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for low or null taxation jurisdictions.", "label": "Low or Null Taxation Jurisdictions [Member]", "terseLabel": "Low or null taxation jurisdictions" } } }, "auth_ref": [] }, "ifrs-full_MachineryMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "MachineryMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "label": "Machinery and equipment [member]", "terseLabel": "Machinery and equipment" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing long-lived, depreciable machinery used in operations. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r334" ] }, "biox_MaintenanceExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "MaintenanceExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of expenses incurred for the day-to-day servicing of assets, which may include the cost of labour, consumables or small parts.", "label": "Maintenance Expense", "terseLabel": "Maintenance" } } }, "auth_ref": [] }, "ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "MajorComponentsOfTaxExpenseIncomeAbstract", "lang": { "en-us": { "role": { "label": "TAXATION" } } }, "auth_ref": [] }, "ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "MaturityAnalysisForNonderivativeFinancialLiabilities", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of maturity analysis for non-derivative financial liabilities [text block]", "terseLabel": "Schedule of contractual maturities of financial liabilities" } }, "en": { "role": { "documentation": "The disclosure of a maturity analysis for non-derivative financial liabilities (including issued financial guarantee contracts) that shows the remaining contractual maturities. [Refer: Derivative financial liabilities]" } } }, "auth_ref": [ "r157", "r263" ] }, "ifrs-full_MaturityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "MaturityAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementLiquidityRiskDetails" ], "lang": { "en-us": { "role": { "label": "Maturity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r108", "r114", "r115", "r119", "r120", "r121", "r127", "r147", "r158", "r183", "r187", "r191", "r192", "r257", "r309", "r338", "r366" ] }, "ifrs-full_MaturityDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "MaturityDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementLiquidityRiskDetails" ], "lang": { "en-us": { "role": { "label": "Maturity [domain]" } }, "en": { "role": { "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used." } } }, "auth_ref": [ "r108", "r114", "r115", "r119", "r120", "r121", "r127", "r147", "r183", "r187", "r191", "r192", "r257", "r309", "r338", "r366", "r368" ] }, "ifrs-full_MeasurementAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "MeasurementAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Measurement [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r57", "r63", "r98", "r245", "r268" ] }, "ifrs-full_MeasurementDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "MeasurementDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Measurement [domain]" } }, "en": { "role": { "documentation": "This member stands for all types of measurement. It also represents the standard value for the 'Measurement' axis if no other member is used." } } }, "auth_ref": [ "r57", "r63", "r98", "r245", "r268" ] }, "biox_MicrobiologicalProductsInProgressMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "MicrobiologicalProductsInProgressMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands microbiological products in progress.", "label": "Microbiological Products In Progress [Member]", "terseLabel": "Microbiological products in progress" } } }, "auth_ref": [] }, "biox_MicrobiologicalProductsProducedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "MicrobiologicalProductsProducedMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for information pertaining to microbiological products produced.", "label": "Manufactured products" } } }, "auth_ref": [] }, "biox_MicrobiologicalResaleProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "MicrobiologicalResaleProductsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for information pertaining to Microbiological resale products.", "label": "Resale products" } } }, "auth_ref": [] }, "biox_MicrobiologyProductMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "MicrobiologyProductMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for information pertaining to microbiology products.", "label": "Microbiology product", "terseLabel": "Microbiological products" } } }, "auth_ref": [] }, "biox_MinimumNumberOfCountriesWhereEntityMarketedAgriculturalInputs": { "xbrltype": "integerItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "MinimumNumberOfCountriesWhereEntityMarketedAgriculturalInputs", "presentation": [ "http://www.biocerescrops.com/role/DisclosureGeneralInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "The minimum number of countries where the entity has marketed agricultural inputs.", "label": "Minimum Number of Countries Where Entity Marketed Agricultural Inputs", "terseLabel": "Number of countries where Group's agricultural inputs are marketed" } } }, "auth_ref": [] }, "biox_MinimumPercentageOfOutstandingPrincipalRequiredToAmendBondTerms": { "xbrltype": "percentItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "MinimumPercentageOfOutstandingPrincipalRequiredToAmendBondTerms", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "documentation": "The minimum percentage of outstanding principal required to amend the bond terms.", "label": "Minimum Percentage Of Outstanding Principal Required To Amend Bond Terms", "terseLabel": "Outstanding principal (percentage)" } } }, "auth_ref": [] }, "biox_MiscellaneousExpenseOfIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "MiscellaneousExpenseOfIncomeExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 18.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 24.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of miscellaneous expense of income expense.", "label": "Miscellaneous Expense of Income Expense", "terseLabel": "Miscellaneous" } } }, "auth_ref": [] }, "biox_MutualFundsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "MutualFundsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionCashAndCashEquivalentsDetails": { "parentTag": "ifrs-full_CashAndCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionCashAndCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of an investment program funded by shareholders that trades in diversified holdings and is professionally managed.", "label": "Mutual Funds At Carrying Value", "terseLabel": "Mutual funds" } } }, "auth_ref": [] }, "biox_MutualFundsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "MutualFundsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for mutual funds.", "label": "Mutual Funds [Member]", "terseLabel": "Mutual funds" } } }, "auth_ref": [] }, "ifrs-full_NetAssetsLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NetAssetsLiabilities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetLossFromForeclosureDetails" ], "lang": { "en-us": { "role": { "label": "Assets (liabilities)", "terseLabel": "Net assets reclassified as subject to foreclosure", "totalLabel": "Net assets subject to foreclosure" } }, "en": { "role": { "documentation": "The amount of assets less the amount of liabilities." } } }, "auth_ref": [ "r353", "r414" ] }, "biox_NetDebtToEarningsBeforeIncomeTaxDepreciationAndAmortizationRatioThreshold": { "xbrltype": "decimalItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "NetDebtToEarningsBeforeIncomeTaxDepreciationAndAmortizationRatioThreshold", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "documentation": "The net debt to EBITDA (earnings before income tax, depreciation and amortization) threshold per debt agreement. The ratio must less than the amount to maintain debt covenant compliance.", "label": "Net Debt To Earnings Before Income Tax, Depreciation And Amortization Ratio Threshold", "terseLabel": "Net Financial Debt to EBITDA ratio" } } }, "auth_ref": [] }, "biox_NetGainOnInflationEffectOnMonetary": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "NetGainOnInflationEffectOnMonetary", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails": { "parentTag": "ifrs-full_OtherFinanceIncomeCost", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "documentation": "Net gain of inflation effect on monetary items.", "label": "Net Gain on Inflation Effect on Monetary", "terseLabel": "Net gain of inflation effect on monetary items" } } }, "auth_ref": [] }, "biox_NewStandardsAmendmentsAndInterpretationsIssuedByIasbAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "NewStandardsAmendmentsAndInterpretationsIssuedByIasbAbstract", "lang": { "en-us": { "role": { "documentation": "n/a", "label": "NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB" } } }, "auth_ref": [] }, "biox_NonCashFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "NonCashFinancingActivities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of non cash financing activities.", "label": "Non Cash Financing Activities", "totalLabel": "Financing activities" } } }, "auth_ref": [] }, "biox_NonCashFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "NonCashFinancingActivitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Non Cash Financing Activities [Abstract]", "terseLabel": "Financing activities" } } }, "auth_ref": [] }, "biox_NonCashInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "NonCashInvestingActivities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of non cash investing activities.", "label": "Non Cash Investing Activities", "totalLabel": "Investment activities" } } }, "auth_ref": [] }, "biox_NonCashInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "NonCashInvestingActivitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Investment activities.", "terseLabel": "Investment activities" } } }, "auth_ref": [] }, "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NonadjustingEventsAfterReportingPeriodAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNarrativeDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Non-adjusting events after reporting period [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r0", "r205" ] }, "ifrs-full_NonadjustingEventsAfterReportingPeriodDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NonadjustingEventsAfterReportingPeriodDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNarrativeDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Non-adjusting events after reporting period [domain]" } }, "en": { "role": { "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used." } } }, "auth_ref": [ "r0", "r205" ] }, "ifrs-full_NoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncontrollingInterests", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-controlling interests.", "terseLabel": "Non-controlling interest" } }, "en": { "role": { "documentation": "The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Total for all subsidiaries [member]]" } } }, "auth_ref": [ "r81", "r82", "r305" ] }, "ifrs-full_NoncontrollingInterestsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncontrollingInterestsMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Non-controlling Interests" } }, "en": { "role": { "documentation": "This member stands for equity in a subsidiary not attributable, directly or indirectly, to the parent." } } }, "auth_ref": [ "r288" ] }, "ifrs-full_NoncurrentAccrualsAndNoncurrentDeferredIncomeIncludingNoncurrentContractLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentAccrualsAndNoncurrentDeferredIncomeIncludingNoncurrentContractLiabilitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Non-current accruals and non-current deferred income including non-current contract liabilities [abstract]", "terseLabel": "Non-current" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current assets", "totalLabel": "Total non-current assets" } }, "en": { "role": { "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]" } } }, "auth_ref": [ "r85", "r310", "r354" ] }, "ifrs-full_NoncurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentAssetsAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "NON-CURRENT ASSETS..", "terseLabel": "NON-CURRENT ASSETS", "verboseLabel": "Non-current assets" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNarrativeDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current assets or disposal groups classified as held for sale or as held for distribution to owners", "terseLabel": "Assets subject to foreclosure", "verboseLabel": "Assets subject to foreclosure after remeasurement" } }, "en": { "role": { "documentation": "The amount of non-current assets or disposal groups classified as held for sale or as held for distribution to owners. [Refer: Non-current assets or disposal groups classified as held for distribution to owners; Non-current assets or disposal groups classified as held for sale]" } } }, "auth_ref": [ "r300" ] }, "ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwnersAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwnersAbstract", "lang": { "en-us": { "role": { "label": "ASSETS SUBJECT TO FORECLOSURE AND DISCONTINUED OPERATIONS" } } }, "auth_ref": [] }, "biox_NoncurrentContingentConsiderationRecognisedAsOfAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "NoncurrentContingentConsiderationRecognisedAsOfAcquisitionDate", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionConsiderationForAcquisitionDetails": { "parentTag": "biox_ConsiderationForAcquisitionNonCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionConsiderationForAcquisitionDetails" ], "lang": { "en-us": { "role": { "documentation": "Noncurrent amount, at acquisition date, of contingent consideration arrangements recognised as consideration transferred in a business combination.", "label": "NonCurrent Contingent Consideration Recognised As Of Acquisition Date", "terseLabel": "Consideration for acquisition of assets, non-current" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentContractLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentContractLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails": { "parentTag": "ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale", "weight": 1.0, "order": 2.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 8.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current contract liabilities", "terseLabel": "Deferred revenue and advances from customers", "totalLabel": "Deferred revenue and advances from customers" } }, "en": { "role": { "documentation": "The amount of non-current contract liabilities. [Refer: Contract liabilities]" } } }, "auth_ref": [ "r103" ] }, "ifrs-full_NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails": { "parentTag": "ifrs-full_NoncurrentContractLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Non-current contract liabilities for performance obligations satisfied over time", "terseLabel": "Deferred revenue" } }, "en": { "role": { "documentation": "The amount of non-current contract liabilities for performance obligations satisfied over time. [Refer: Contract liabilities for performance obligations satisfied over time]" } } }, "auth_ref": [ "r416", "r417" ] }, "ifrs-full_NoncurrentLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentLeaseLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails": { "parentTag": "ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale", "weight": 1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails": { "parentTag": "ifrs-full_LeaseLiabilities", "weight": 1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current lease liabilities", "terseLabel": "Lease liabilities", "verboseLabel": "Non-current" } }, "en": { "role": { "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r110" ] }, "ifrs-full_NoncurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current liabilities", "totalLabel": "Total non-current liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]" } } }, "auth_ref": [ "r87", "r311", "r354" ] }, "ifrs-full_NoncurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentLiabilitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionConsiderationForAcquisitionDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "NON-CURRENT LIABILITIES.", "terseLabel": "Non-current liabilities", "verboseLabel": "NON-CURRENT LIABILITIES" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentPayables", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayablesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Trade and other non-current payables", "terseLabel": "Trade and other payables" } }, "en": { "role": { "documentation": "The amount of non-current trade payables and non-current other payables. [Refer: Other non-current payables; Non-current trade payables]" } } }, "auth_ref": [ "r301" ] }, "ifrs-full_NoncurrentPayablesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentPayablesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Trade and other non-current payables [abstract]", "terseLabel": "Non current" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentPayablesToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentPayablesToRelatedParties", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Non-current payables to related parties", "terseLabel": "Trade creditors - Joint ventures and associates" } }, "en": { "role": { "documentation": "The amount of non-current payables due to related parties. [Refer: Total for all related parties [member]; Payables to related parties]" } } }, "auth_ref": [ "r417" ] }, "ifrs-full_NoncurrentPayablesToTradeSuppliers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentPayablesToTradeSuppliers", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Non-current trade payables", "terseLabel": "Trade creditors" } }, "en": { "role": { "documentation": "The non-current amount of payment due to suppliers for goods and services used in the entity's business. [Refer: Trade payables]" } } }, "auth_ref": [ "r417" ] }, "ifrs-full_NoncurrentPortionOfNoncurrentBondsIssued": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentPortionOfNoncurrentBondsIssued", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Non-current portion of non-current bonds issued", "terseLabel": "Corporate bonds", "verboseLabel": "Corporate Bonds" } }, "en": { "role": { "documentation": "The non-current portion of non-current bonds issued. [Refer: Bonds issued]" } } }, "auth_ref": [ "r414" ] }, "ifrs-full_NoncurrentTradeReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentTradeReceivables", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current trade receivables", "terseLabel": "Trade receivables", "verboseLabel": "Trade debtors" } }, "en": { "role": { "documentation": "The amount of non-current trade receivables. [Refer: Trade receivables]" } } }, "auth_ref": [ "r375", "r381" ] }, "ifrs-full_NotLaterThanThreeMonthsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NotLaterThanThreeMonthsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementLiquidityRiskDetails" ], "lang": { "en-us": { "role": { "label": "Up to 3 months" } }, "en": { "role": { "documentation": "This member stands for a time band of not later than three months." } } }, "auth_ref": [ "r414" ] }, "ifrs-full_NotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NotionalAmount", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails" ], "lang": { "en-us": { "role": { "label": "Notional amount", "verboseLabel": "Principal amount" } }, "en": { "role": { "documentation": "The nominal or face amount of a financial instrument, used to calculate payments made on that instrument." } } }, "auth_ref": [ "r414" ] }, "biox_NumberOfCategoriesOfDilutiveShares": { "xbrltype": "integerItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "NumberOfCategoriesOfDilutiveShares", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails" ], "lang": { "en-us": { "role": { "documentation": "The number of categories of dilutive potential shares.", "label": "Number of Categories of Dilutive Shares", "terseLabel": "Number of categories of dilutive potential shares" } } }, "auth_ref": [] }, "biox_NumberOfInstrumentsIssuable": { "xbrltype": "decimalItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "NumberOfInstrumentsIssuable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionConsiderationForAcquisitionDetails" ], "lang": { "en-us": { "role": { "documentation": "The number of instruments or interests issuable at acquisition date for equity interests of the acquirer transferred as consideration in a business combination.", "label": "Number Of Instruments Issuable", "terseLabel": "Number of shares to be issued related to merger outstanding" } } }, "auth_ref": [] }, "biox_NumberOfInstrumentsOrInterestsIssuedOnTreasuryShares": { "xbrltype": "decimalItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "NumberOfInstrumentsOrInterestsIssuedOnTreasuryShares", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionConsiderationForAcquisitionDetails" ], "lang": { "en-us": { "role": { "documentation": "The number of instruments or interests issued for equity interests of the acquirer transferred as consideration in a business combination for the treasury shares.", "label": "Number of instruments or interests issued on treasury shares", "terseLabel": "Number of shares issued related to merger from treasury shares" } } }, "auth_ref": [] }, "ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NumberOfInstrumentsOrInterestsIssuedOrIssuable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionConsiderationForAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Number of instruments or interests issued or issuable", "terseLabel": "The number of new shares issued related to merger" } }, "en": { "role": { "documentation": "The number of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration in a business combination." } } }, "auth_ref": [ "r133" ] }, "ifrs-full_NumberOfOutstandingShareOptions": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NumberOfOutstandingShareOptions", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Number of share options outstanding in share-based payment arrangement", "verboseLabel": "Number of total converted options outstanding" } }, "en": { "role": { "documentation": "The number of share options outstanding in a share-based payment arrangement." } } }, "auth_ref": [ "r129", "r130", "r131", "r249", "r250" ] }, "ifrs-full_NumberOfSharesAuthorised": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NumberOfSharesAuthorised", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Number of shares authorised", "terseLabel": "Number of shares authorized" } }, "en": { "role": { "documentation": "The number of shares authorised." } } }, "auth_ref": [ "r195", "r271", "r315" ] }, "ifrs-full_NumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NumberOfSharesIssued", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Number of shares issued", "terseLabel": "Number of shares issued" } }, "en": { "role": { "documentation": "The number of shares issued by the entity." } } }, "auth_ref": [ "r412" ] }, "ifrs-full_NumberOfSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NumberOfSharesOutstanding", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Number of shares outstanding", "terseLabel": "Number of shares outstanding" } }, "en": { "role": { "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]" } } }, "auth_ref": [ "r197", "r273", "r317" ] }, "ifrs-full_OfficeEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OfficeEquipmentMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Office equipment", "terseLabel": "Office equipment" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing equipment used to support office functions, not specifically used in the production process. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r336" ] }, "biox_OfficeSupplies": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "OfficeSupplies", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of expenses that the entity classifies as office supplies with respect to the research and development.", "label": "Office Supplies", "terseLabel": "Office supplies" } } }, "auth_ref": [] }, "biox_OfficeSuppliesAndRegistrationFees": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "OfficeSuppliesAndRegistrationFees", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 19.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of office supplies and registration fees relating to production costs.", "label": "Office Supplies And Registration Fees", "terseLabel": "Office supplies and registrations fees" } } }, "auth_ref": [] }, "ifrs-full_OrdinarySharesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OrdinarySharesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Ordinary shares [member]", "terseLabel": "Ordinary shares" } }, "en": { "role": { "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments." } } }, "auth_ref": [ "r418" ] }, "ifrs-full_OtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherComprehensiveIncome", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Other comprehensive income", "verboseLabel": "Other comprehensive (loss)/profit" } } }, "auth_ref": [ "r92", "r285", "r321", "r328" ] }, "biox_OtherComprehensiveIncomeFromContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "OtherComprehensiveIncomeFromContinuingOperations", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "documentation": "The amount of other comprehensive income from continuing operations.", "label": "Other Comprehensive Income From Continuing Operations", "totalLabel": "Other comprehensive loss from continuing operations" } } }, "auth_ref": [] }, "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": "biox_OtherComprehensiveIncomeFromContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other comprehensive income that will be reclassified to profit or loss, net of tax", "totalLabel": "Items that may be subsequently reclassified to loss" } }, "en": { "role": { "documentation": "The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r382", "r383" ] }, "ifrs-full_OtherCurrentFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherCurrentFinancialAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Other current financial assets", "terseLabel": "Other financial assets", "verboseLabel": "Other financial assets-Current" } }, "en": { "role": { "documentation": "The amount of current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets; Current financial assets]" } } }, "auth_ref": [ "r294" ] }, "ifrs-full_OtherCurrentPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherCurrentPayables", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayablesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Other current payables", "terseLabel": "Miscellaneous" } }, "en": { "role": { "documentation": "The amount of current payables that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r416" ] }, "ifrs-full_OtherCurrentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherCurrentReceivables", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 5.0 }, "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails": { "parentTag": "biox_AssetsSubjectToForeclosureGrossCarryingAmount", "weight": 1.0, "order": 8.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Other current receivables", "terseLabel": "Other receivables", "totalLabel": "Other receivables - current" } }, "en": { "role": { "documentation": "The amount of current other receivables. [Refer: Other receivables]" } } }, "auth_ref": [ "r375", "r381" ] }, "biox_OtherCurrentReceivablesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "OtherCurrentReceivablesOther", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": "ifrs-full_OtherCurrentReceivables", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of other current receivables, other.", "label": "Other Current Receivables, Other", "terseLabel": "Miscellaneous" } } }, "auth_ref": [] }, "ifrs-full_OtherFinanceIncomeCost": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherFinanceIncomeCost", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetIncomeFromDiscontinuedOperationsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other finance income (cost)", "terseLabel": "Other financial results", "totalLabel": "Other financial results" } } }, "auth_ref": [ "r419" ] }, "biox_OtherFinanceResultsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "OtherFinanceResultsAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Other Finance Results [Abstract]", "terseLabel": "Other financial results" } } }, "auth_ref": [] }, "biox_OtherFinancialAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "OtherFinancialAssetsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for financial assets that the entity does not separately disclose in the same statement or note.", "label": "Other financial assets" } } }, "auth_ref": [] }, "biox_OtherIncomeOrExpensesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "OtherIncomeOrExpensesNet", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails": { "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of other income or expenses net.", "label": "Other Income Or Expenses Net", "terseLabel": "Others" } } }, "auth_ref": [] }, "ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Other inflows (outflows) of cash, classified as financing activities", "terseLabel": "Other financial payments" } }, "en": { "role": { "documentation": "Inflows (outflows) of cash, classified as financing activities, that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r66" ] }, "biox_OtherInvestmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "OtherInvestmentMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for other investment member.", "label": "Other investments", "terseLabel": "Other investments" } } }, "auth_ref": [] }, "ifrs-full_OtherLongtermProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherLongtermProvisions", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current provisions", "terseLabel": "Provisions" } }, "en": { "role": { "documentation": "The amount of non-current provisions other than provisions for employee benefits. [Refer: Non-current provisions]" } } }, "auth_ref": [ "r278", "r313" ] }, "biox_OtherNonCurrentReceivablesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "OtherNonCurrentReceivablesOther", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": "ifrs-full_OtherNoncurrentReceivables", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents other non-current receivables.", "label": "Other Non-Current Receivables Other", "terseLabel": "Miscellaneous" } } }, "auth_ref": [] }, "ifrs-full_OtherNoncurrentFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherNoncurrentFinancialAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Other non-current financial assets", "terseLabel": "Other financial assets", "verboseLabel": "Other financial assets - Non-current" } }, "en": { "role": { "documentation": "The amount of non-current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets]" } } }, "auth_ref": [ "r294" ] }, "ifrs-full_OtherNoncurrentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherNoncurrentReceivables", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 9.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Other non-current receivables", "terseLabel": "Other receivables", "totalLabel": "Other receivables - non-current" } }, "en": { "role": { "documentation": "The amount of non-current other receivables. [Refer: Other receivables]" } } }, "auth_ref": [ "r375", "r381" ] }, "ifrs-full_OtherOperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherOperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetIncomeFromDiscontinuedOperationsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other operating income (expense)", "terseLabel": "Other income or expenses, net", "totalLabel": "Total" } } }, "auth_ref": [ "r419" ] }, "ifrs-full_OtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherReceivables", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Other receivables", "terseLabel": "Deferred checks" } }, "en": { "role": { "documentation": "The amount receivable by the entity that it does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r375", "r381" ] }, "biox_OtherReceivablesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "OtherReceivablesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for receivables that the entity does not separately disclose in the same statement or note.", "label": "Other receivables [member]", "terseLabel": "Other receivables" } } }, "auth_ref": [] }, "ifrs-full_OtherRelatedPartiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherRelatedPartiesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Other related parties [member]", "terseLabel": "Other related parties" } }, "en": { "role": { "documentation": "This member stands for related parties that the entity does not separately disclose in the same statement or note. [Refer: Total for all related parties [member]]" } } }, "auth_ref": [ "r30", "r226" ] }, "ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "Other tax effects for reconciliation between accounting profit and tax expense (income)", "negatedLabel": "Others" } }, "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that the entity does not separately disclose in the same statement or note. [Refer: Accounting profit; Applicable tax rate]" } } }, "auth_ref": [ "r4", "r208" ] }, "biox_OwnSharesTradingPremiumMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "OwnSharesTradingPremiumMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "documentation": "The member stands for the own shares trading premium.", "label": "Own shares trading premium" } } }, "auth_ref": [] }, "ifrs-full_ParValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ParValuePerShare", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Par value per share", "terseLabel": "Par value per share" } }, "en": { "role": { "documentation": "The nominal value per share." } } }, "auth_ref": [ "r196", "r272", "r316" ] }, "ifrs-full_ParentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ParentMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Parent company", "terseLabel": "Parent company" } }, "en": { "role": { "documentation": "This member stands for an entity that controls one or more entities." } } }, "auth_ref": [ "r27", "r223" ] }, "biox_PayablesSalariesSocialSecurityBenefitsAndOther": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "PayablesSalariesSocialSecurityBenefitsAndOther", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of payables to related party pertaining to salaries, social security benefits and other.", "label": "Payables, Salaries, Social Security Benefits And Other", "negatedLabel": "Salaries, social security benefits and other benefits" } } }, "auth_ref": [] }, "ifrs-full_PaymentsForDevelopmentProjectExpenditure": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PaymentsForDevelopmentProjectExpenditure", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments for development project expenditure", "negatedLabel": "Capitalized development expenditures" } }, "en": { "role": { "documentation": "The cash outflow for expenditure related to development projects." } } }, "auth_ref": [ "r396" ] }, "biox_PaymentsOfLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "PaymentsOfLeaseLiabilities", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "documentation": "The cash outflow for payment of lease liabilities.", "label": "Payments Of Lease Liabilities", "terseLabel": "Payments of the period" } } }, "auth_ref": [] }, "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments of lease liabilities, classified as financing activities", "negatedLabel": "Leased assets payments" } }, "en": { "role": { "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r350" ] }, "ifrs-full_PaymentsToAcquireOrRedeemEntitysShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PaymentsToAcquireOrRedeemEntitysShares", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments to acquire or redeem entity's shares", "negatedLabel": "Purchase of own shares" } }, "en": { "role": { "documentation": "The cash outflow to acquire or redeem entity's shares." } } }, "auth_ref": [ "r347" ] }, "biox_PercentageOfEstimatedOrAppreciationOfDevaluationOfOtherCurrency": { "xbrltype": "percentItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "PercentageOfEstimatedOrAppreciationOfDevaluationOfOtherCurrency", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "Represent the percentage of that a devaluation or an appreciation of the US Dollar against other currencies.", "label": "Percentage of Estimated or an Appreciation of the Devaluation of Other Currency", "terseLabel": "Percentage of that a devaluation or an appreciation of the US Dollar other currencies" } } }, "auth_ref": [] }, "biox_PercentageOfGrossMarginAndTotalRevenue": { "xbrltype": "percentItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "PercentageOfGrossMarginAndTotalRevenue", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of gross margin and total revenue of the period during the entity.", "label": "Percentage Of Gross Margin And Total Revenue", "terseLabel": "% Gross margin" } } }, "auth_ref": [] }, "biox_PercentageOfInitialRepayment": { "xbrltype": "percentItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "PercentageOfInitialRepayment", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of initial repayment to be made at settlement date.", "label": "Percentage Of Initial Repayment", "terseLabel": "Initial repayment percentage" } } }, "auth_ref": [] }, "ifrs-full_PreferenceSharesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PreferenceSharesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Preference shares [member]", "terseLabel": "Preference shares" } }, "en": { "role": { "documentation": "This member stands for equity instruments that are senior in some aspects to ordinary shares, but subordinate to debt instruments in terms of claim. [Refer: Ordinary shares [member]]" } } }, "auth_ref": [ "r418" ] }, "biox_PrepaymentPremiumFees": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "PrepaymentPremiumFees", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails": { "parentTag": "ifrs-full_OtherFinanceIncomeCost", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of prepayment premium fees.", "label": "Prepayment Premium Fees", "terseLabel": "Prepayment premium fee" } } }, "auth_ref": [] }, "ifrs-full_PresentationOfLeasesForLesseeAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PresentationOfLeasesForLesseeAbstract", "lang": { "en-us": { "role": { "label": "LEASES" } } }, "auth_ref": [] }, "biox_ProFarmGroupInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ProFarmGroupInc.Member", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Pro farm Group, Inc.", "label": "Pro farm Group, Inc. [Member]", "terseLabel": "Pro farm Group, Inc." } } }, "auth_ref": [] }, "biox_ProFarmGroupIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ProFarmGroupIncMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionConsiderationForAcquisitionDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Pro Farm Group, Inc.", "label": "Pro Farm Group, Inc" } } }, "auth_ref": [] }, "biox_ProFarmTechnologiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ProFarmTechnologiesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Pro Farm Technologies.", "label": "Pro Farm Technologies [Member]", "terseLabel": "Pro Farm Technologies" } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProceedsFromBorrowingsClassifiedAsFinancingActivities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from borrowings, classified as financing activities", "terseLabel": "Proceeds from borrowings" } }, "en": { "role": { "documentation": "The cash inflow from borrowings obtained. [Refer: Borrowings]" } } }, "auth_ref": [ "r348" ] }, "biox_ProceedsFromFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ProceedsFromFinancialAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The cash inflow (outflow) generated from financial assets that the entity classifies as investing activities.", "label": "Investment in financial assets", "terseLabel": "Proceeds from financial assets" } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProceedsFromSaleOrIssueOfTreasuryShares", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from sale or issue of treasury shares", "terseLabel": "Sales of own shares" } }, "en": { "role": { "documentation": "The cash inflow from the sale or issuing of treasury shares. [Refer: Sale or issue of treasury shares; Treasury shares]" } } }, "auth_ref": [ "r397" ] }, "ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from sales of property, plant and equipment, classified as investing activities", "terseLabel": "Proceeds from sale of property, plant and equipment" } }, "en": { "role": { "documentation": "The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r346" ] }, "biox_ProductionCostAndSellingGeneralAndAdministrativeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ProductionCostAndSellingGeneralAndAdministrativeExpenseMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for the amount of expense relating to production costs and selling, general and administrative activities of the entity. This member is used to attribute an expense by nature to a functional line item in the statement of profit or loss.", "label": "Production Cost and Selling, General and Administrative Expense [Member]", "terseLabel": "Total" } } }, "auth_ref": [] }, "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of production cost relating to inventory and selling, general and administrative expenses.", "label": "Production Costs and Selling General and Administrative Expenses", "totalLabel": "Total" } } }, "auth_ref": [] }, "ifrs-full_ProductsAndServicesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProductsAndServicesAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRevenueFromContractsWithCustomersDetails", "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Products and services [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r176", "r358", "r372" ] }, "ifrs-full_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRevenueFromContractsWithCustomersDetails", "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Products and services [domain]" } }, "en": { "role": { "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used." } } }, "auth_ref": [ "r176", "r358", "r372" ] }, "biox_ProfessionalFeesAndOutsourcedServicesExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ProfessionalFeesAndOutsourcedServicesExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of Professional fees and outsourced services expense.", "label": "Professional Fees and Outsourced Services Expense", "terseLabel": "Professional fees and outsourced services" } } }, "auth_ref": [] }, "ifrs-full_ProfessionalFeesExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfessionalFeesExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "label": "Professional fees expense", "terseLabel": "Professional fees and outsourced services" } } }, "auth_ref": [ "r414" ] }, "biox_ProfessionalFeesExpenseRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ProfessionalFeesExpenseRelatedParties", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 13.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of professional fee expense with related parties.", "label": "Professional Fees Expense, Related Parties", "terseLabel": "Professional fees related parties" } } }, "auth_ref": [] }, "ifrs-full_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 2.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 24.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Result for the year", "terseLabel": "(Loss)/Profit for the period", "totalLabel": "(Loss) / Profit of the period", "verboseLabel": "Loss of the period" } }, "en": { "role": { "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r78", "r80", "r168", "r171", "r229", "r248", "r284", "r320", "r354", "r359" ] }, "biox_ProfitLossAttributableToContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ProfitLossAttributableToContinuingOperationsAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "documentation": "This disclosure represents profit/loss from continuing operations.", "label": "Profit Loss Attributable To Continuing Operations Abstract", "terseLabel": "(Loss) / Profit from continuing operations attributable to:" } } }, "auth_ref": [] }, "biox_ProfitLossAttributableToDiscontinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ProfitLossAttributableToDiscontinuingOperationsAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "documentation": "This disclosure represents profit/loss from discontinuing operations.", "label": "Profit Loss Attributable To Discontinuing Operations Abstract", "terseLabel": "Loss from discontinued operations attributable to:" } } }, "auth_ref": [] }, "ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Profit (loss), attributable to ordinary equity holders of parent entity", "terseLabel": "Loss for the period attributable to equity holders attributable to equity holders of the parent (basic EPS)" } }, "en": { "role": { "documentation": "The profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r40" ] }, "ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Profit (loss), attributable to ordinary equity holders of parent entity [abstract]", "terseLabel": "Numerator" } } }, "auth_ref": [] }, "ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Profit (loss), attributable to ordinary equity holders of parent entity, used in calculating diluted earnings per share", "terseLabel": "Loss for the period attributable to equity holders attributable to equity holders of the parent (diluted EPS)" } }, "en": { "role": { "documentation": "The profit (loss) attributable to ordinary equity holders of the parent entity, adjusted for the effects of all dilutive potential ordinary shares. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r40" ] }, "ifrs-full_ProfitLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossBeforeTax", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromContinuingOperations", "weight": 1.0, "order": 2.0 }, "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetIncomeFromDiscontinuedOperationsDetails": { "parentTag": "biox_ProfitLossFromDiscontinuedOperationsBeforeGainLossOnDisposal", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetIncomeFromDiscontinuedOperationsDetails", "http://www.biocerescrops.com/role/DisclosureTaxationIncomeTaxExpenseWasCalculatedByApplyingTaxRateInForceDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Profit (loss) before tax", "terseLabel": "Earning before income tax-rate", "totalLabel": "(Loss) / Profit before income tax", "verboseLabel": "Income (Loss) before income tax" } } }, "auth_ref": [ "r138", "r370", "r371", "r376", "r377" ] }, "ifrs-full_ProfitLossFromContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossFromContinuingOperations", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 2.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Profit (loss) from continuing operations", "totalLabel": "(Loss) / Profit of the period from continuing operations" } }, "en": { "role": { "documentation": "The profit (loss) from continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Profit (loss)]" } } }, "auth_ref": [ "r90", "r168", "r171", "r320" ] }, "ifrs-full_ProfitLossFromContinuingOperationsAttributableToNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossFromContinuingOperationsAttributableToNoncontrollingInterests", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": "ifrs-full_ProfitLossFromContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Profit (loss) from continuing operations attributable to non-controlling interests", "terseLabel": "Non-controlling interests" } }, "en": { "role": { "documentation": "The profit (loss) from continuing operations attributable to non-controlling interests. [Refer: Profit (loss) from continuing operations; Non-controlling interests]" } } }, "auth_ref": [ "r361", "r362" ] }, "ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Profit (loss) from continuing operations attributable to ordinary equity holders of parent entity, used in calculating basic earnings per share", "terseLabel": "Loss for the period from continuing operations attributable to equity holders of the parent (basic EPS)" } }, "en": { "role": { "documentation": "The profit (loss) from continuing operations attributable to ordinary equity holders of the parent entity. [Refer: Continuing operations, unless line item indicates otherwise [member]; Profit (loss) from continuing operations]" } } }, "auth_ref": [ "r40" ] }, "ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Profit (loss) from continuing operations attributable to ordinary equity holders of parent entity, used in calculating diluted earnings per share", "terseLabel": "Loss for the period from continuing operations attributable to equity holders of the parent (diluted EPS)" } }, "en": { "role": { "documentation": "The profit (loss) from continuing operations attributable to ordinary equity holders of the parent entity, adjusted for the effects of all dilutive potential ordinary shares. [Refer: Profit (loss) from continuing operations]" } } }, "auth_ref": [ "r40" ] }, "ifrs-full_ProfitLossFromDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossFromDiscontinuedOperations", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 25.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Profit (loss) from discontinued operations", "negatedLabel": "Loss of the period from discontinued operations", "totalLabel": "Loss of the period from discontinued operations" } } }, "auth_ref": [ "r91", "r137", "r327", "r329" ] }, "ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Profit (loss) from discontinued operations attributable to ordinary equity holders of parent entity, used in calculating basic earnings per share", "terseLabel": "Loss for the period from discontinued operations attributable to equity holders of the parent (basic EPS)" } } }, "auth_ref": [ "r40" ] }, "ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Profit (loss) from discontinued operations attributable to ordinary equity holders of parent entity, used in calculating diluted earnings per share", "terseLabel": "Loss for the period from discontinued operations attributable to equity holders of the parent (diluted EPS)" } } }, "auth_ref": [ "r40" ] }, "biox_ProfitLossFromDiscontinuedOperationsBeforeGainLossOnDisposal": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ProfitLossFromDiscontinuedOperationsBeforeGainLossOnDisposal", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromDiscontinuedOperations", "weight": 1.0, "order": 2.0 }, "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetIncomeFromDiscontinuedOperationsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetIncomeFromDiscontinuedOperationsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "documentation": "The profit (loss) from discontinued operations before gain (loss) on disposal.", "label": "Profit (Loss) From Discontinued Operations Before Gain (Loss) On Disposal", "terseLabel": "Profit / (Loss) of the period from discontinued operations", "totalLabel": "(Loss)/ Profit for the period from discontinued operations" } } }, "auth_ref": [] }, "ifrs-full_ProfitLossFromOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossFromOperatingActivities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetIncomeFromDiscontinuedOperationsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Profit (loss) from operating activities", "terseLabel": "Operating profit (loss)", "totalLabel": "Operating profit" } } }, "auth_ref": [ "r339", "r419" ] }, "biox_ProfitMakingEntitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ProfitMakingEntitiesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationIncomeTaxExpenseWasCalculatedByApplyingTaxRateInForceDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for profit-making entities.", "label": "Profit-Making Entities [Member]", "terseLabel": "Profit-making entities" } } }, "auth_ref": [] }, "ifrs-full_PropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails": { "parentTag": "biox_AssetsSubjectToForeclosureGrossCarryingAmount", "weight": 1.0, "order": 2.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Property, plant and equipment", "periodEndLabel": "As of the end of period", "periodStartLabel": "As of the beginning of period", "terseLabel": "Property, plant and equipment" } }, "en": { "role": { "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]" } } }, "auth_ref": [ "r14", "r216", "r291" ] }, "biox_PublicityAndAdvertisingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "PublicityAndAdvertisingExpenses", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of publicity and advertising expenses.", "label": "Publicity and Advertising Expenses", "terseLabel": "Publicity and advertising" } } }, "auth_ref": [] }, "ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Purchase of intangible assets, classified as investing activities", "negatedLabel": "Purchase of intangible assets" } }, "en": { "role": { "documentation": "The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r345" ] }, "biox_PurchaseOfInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "PurchaseOfInventory", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of inventory purchased during the year.", "label": "Purchase of inventory", "terseLabel": "Purchases of the period" } } }, "auth_ref": [] }, "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Purchase of property, plant and equipment, classified as investing activities", "negatedLabel": "Purchase of property, plant and equipment" } }, "en": { "role": { "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r345" ] }, "biox_PurchasesOfGoodsAndServicesReceivedRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "PurchasesOfGoodsAndServicesReceivedRelatedPartyTransactions", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails": { "parentTag": "biox_RelatedPartyTransactions", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of goods purchased and the amount of services received by the entity in related party transactions.", "label": "Purchases of Goods and Services Received Related Party Transactions", "negatedLabel": "Purchases of goods and services" } } }, "auth_ref": [] }, "ifrs-full_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RangeAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Range [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r71", "r102", "r121", "r131", "r201", "r356", "r357", "r409" ] }, "ifrs-full_RangeDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RangeDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Range [domain]" } }, "en": { "role": { "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used." } } }, "auth_ref": [ "r71", "r102", "r121", "r131", "r201", "r356", "r357", "r409" ] }, "biox_RatioAsOfSeptember302025Member": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "RatioAsOfSeptember302025Member", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to ratio as of September 30, 2025", "label": "Ratio As Of September 30, 2025 [Member]", "terseLabel": "Ratio as of September 30, 2025" } } }, "auth_ref": [] }, "biox_RatioAsOfSeptember302027Member": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "RatioAsOfSeptember302027Member", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to ratio as of September 30, 2027", "label": "Ratio As Of September 30, 2027 [Member]", "terseLabel": "Ratio as of September 30, 2027" } } }, "auth_ref": [] }, "biox_ReceivablesFromTaxCreditsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ReceivablesFromTaxCreditsCurrent", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": "ifrs-full_OtherCurrentReceivables", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of current tax credit receivables.", "label": "Receivables from Tax Credits, Current", "terseLabel": "Taxes" } } }, "auth_ref": [] }, "biox_ReceivablesFromTaxCreditsNonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ReceivablesFromTaxCreditsNonCurrent", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": "ifrs-full_OtherNoncurrentReceivables", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of non-current tax credit receivables.", "label": "Receivables from Tax Credits, Non-Current", "terseLabel": "Taxes" } } }, "auth_ref": [] }, "biox_RefinancingOfCorporateBondsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "RefinancingOfCorporateBondsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for refinancing of corporate bonds.", "label": "Refinancing Of Corporate Bonds [Member]", "terseLabel": "Corporate Bonds" } } }, "auth_ref": [] }, "biox_RelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "RelatedPartyTransactions", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The total amount of related party transactions.", "label": "Related Party Transactions", "totalLabel": "Total" } } }, "auth_ref": [] }, "ifrs-full_RepairsAndMaintenanceExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RepairsAndMaintenanceExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "label": "Repairs and maintenance expense", "terseLabel": "Maintenance" } } }, "auth_ref": [ "r419" ] }, "ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RepaymentsOfBorrowingsClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Repayments of borrowings, classified as financing activities", "negatedLabel": "Repayment of borrowings and financed payments" } }, "en": { "role": { "documentation": "The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]" } } }, "auth_ref": [ "r349" ] }, "ifrs-full_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "biox_TotalResearchAndDevelopmentExpenseIncurred", "weight": 1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetIncomeFromDiscontinuedOperationsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Research and development expense", "negatedLabel": "Research and development expenses", "totalLabel": "Total" } } }, "auth_ref": [ "r56", "r240" ] }, "biox_ResearchAndDevelopmentExpenseCapitalized": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ResearchAndDevelopmentExpenseCapitalized", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "biox_TotalResearchAndDevelopmentExpenseIncurred", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of research and development expense capitalized.", "label": "Research and Development Expense Capitalized", "terseLabel": "R&D capitalized (Note 5.7)" } } }, "auth_ref": [] }, "ifrs-full_ReserveOfEquityComponentOfConvertibleInstrumentsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ReserveOfEquityComponentOfConvertibleInstrumentsMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Convertible instruments" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing components of convertible instruments classified as equity." } } }, "auth_ref": [ "r413" ] }, "ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ReserveOfExchangeDifferencesOnTranslationMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Foreign currency translation reserve" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing accumulated exchange differences on the translation of financial statements recognised in other comprehensive income. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r20", "r218", "r378" ] }, "biox_ResultForInflationEffectOnMonetaryItemsAndOtherFinanceResults": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ResultForInflationEffectOnMonetaryItemsAndOtherFinanceResults", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount that represents the inflation effect on monetary items and other finance results.", "label": "Result for Inflation Effect on Monetary Items And Other Finance Results", "negatedLabel": "Result of inflation effect on monetary items and other finance results" } } }, "auth_ref": [] }, "ifrs-full_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RetainedEarningsMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Retained deficit" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit." } } }, "auth_ref": [ "r288", "r378" ] }, "biox_RevaluationOfPropertyPlantAndEquipmentAndEffectOfTaxRateChangeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "RevaluationOfPropertyPlantAndEquipmentAndEffectOfTaxRateChangeMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "documentation": "This member stands for revaluation of PP&E and effect of tax rate change.", "label": "Revaluation of PP&E and effect of tax rate change" } } }, "auth_ref": [] }, "ifrs-full_Revenue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Revenue", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails": { "parentTag": "ifrs-full_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Revenues", "terseLabel": "Total" } } }, "auth_ref": [ "r89", "r138", "r165", "r170", "r176", "r177", "r178", "r323", "r354", "r376", "r377" ] }, "ifrs-full_RevenueAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RevenueAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Revenue [abstract]", "verboseLabel": "Revenues from contracts with customers" } } }, "auth_ref": [] }, "ifrs-full_RevenueFromContractsWithCustomers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RevenueFromContractsWithCustomers", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetIncomeFromDiscontinuedOperationsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRevenueFromContractsWithCustomersDetails", "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Revenue from contracts with customers", "terseLabel": "Revenues from contracts with customers", "verboseLabel": "Sale of goods and services" } } }, "auth_ref": [ "r104", "r105", "r184" ] }, "ifrs-full_RevenueFromRoyalties": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RevenueFromRoyalties", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRevenueFromContractsWithCustomersDetails", "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Royalty income", "terseLabel": "Royalties" } } }, "auth_ref": [ "r414" ] }, "ifrs-full_RevenueFromSaleOfAgriculturalProduce": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RevenueFromSaleOfAgriculturalProduce", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails": { "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails" ], "lang": { "en-us": { "role": { "label": "Revenue from sale of agricultural produce", "terseLabel": "Net result from commercialization of agricultural products" } } }, "auth_ref": [ "r414" ] }, "biox_RevenueFromSaleOfGoodsAndRenderingOfServicesRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "RevenueFromSaleOfGoodsAndRenderingOfServicesRelatedPartyTransactions", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails": { "parentTag": "biox_RelatedPartyTransactions", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of revenue arising from the sale of goods and rendering of services in related party transactions.", "label": "Revenue from Sale of Goods and Rendering of Services, Related Party Transactions", "verboseLabel": "Sales of goods and services" } } }, "auth_ref": [] }, "biox_RgRsOxWheatMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "RgRsOxWheatMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for RG/RS/OX wheat.", "label": "RG/RS/OX Wheat [member]", "terseLabel": "RG/RS/OX Wheat in progress" } } }, "auth_ref": [] }, "biox_RightOfUseLeasedAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "RightOfUseLeasedAssetsTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of right-of-use leased assets.", "label": "Right Of Use Leased Assets [Table Text Block]", "terseLabel": "Schedule of right-of-use leased assets" } } }, "auth_ref": [] }, "ifrs-full_RightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RightofuseAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails": { "parentTag": "biox_AssetsSubjectToForeclosureGrossCarryingAmount", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Right-of-use assets", "periodEndLabel": "Book value at the end of the period", "periodStartLabel": "Book value at the beginning of the period", "terseLabel": "Right of use asset" } }, "en": { "role": { "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee." } } }, "auth_ref": [ "r109", "r112", "r189" ] }, "ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RiskExposureAssociatedWithInstrumentsSharingCharacteristic", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "Risk exposure associated with instruments sharing characteristic", "negatedLabel": "Risk exposure associated with instruments sharing characteristic" } }, "en": { "role": { "documentation": "The amount of risk exposure associated with financial instruments with a shared characteristic that identifies a concentration of risks. [Refer: Classes of financial instruments [domain]]" } } }, "auth_ref": [ "r163" ] }, "biox_RizobacterArgentinaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "RizobacterArgentinaMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Rizobacter Argentina S.A.", "label": "Rizobacter Argentina S.A.", "verboseLabel": "Rizobacter Argentina S.A." } } }, "auth_ref": [] }, "biox_SalariesAccruedIncentivesVacationsAndSocialSecurityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "SalariesAccruedIncentivesVacationsAndSocialSecurityCurrent", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionEmployeeBenefitsAndSocialSecurityDetails": { "parentTag": "ifrs-full_CurrentProvisionsForEmployeeBenefits", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionEmployeeBenefitsAndSocialSecurityDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of current provisions for salaries, accrued incentives, vacations and social security.", "label": "Salaries, Accrued Incentives, Vacations and Social Security, Current", "terseLabel": "Salaries, accrued incentives, vacations and social security" } } }, "auth_ref": [] }, "biox_SalariesSocialSecurityBenefitsAndOtherBenefitsRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "SalariesSocialSecurityBenefitsAndOtherBenefitsRelatedPartyTransactions", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails": { "parentTag": "biox_RelatedPartyTransactions", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of salaries, social security benefits and other benefits.", "label": "Salaries, Social Security Benefits and Other Benefits, Related Party Transactions", "negatedLabel": "Salaries, social security benefits and other benefits" } } }, "auth_ref": [] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "auth_ref": [] }, "biox_ScheduleOfIncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ScheduleOfIncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income tax expense was calculated by applying the tax rate in force in the respective jurisdictions and entities.", "label": "Schedule of Income Tax Expense by Applying Applicable Tax Rate in Force in Respective Jurisdictions [Table Text Block]", "terseLabel": "Schedule of income tax expense calculated by applying the tax rate in force" } } }, "auth_ref": [] }, "biox_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities", "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationTables" ], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of significant non-cash transactions related to investing and financing activities.", "label": "Schedule of Significant Non-Cash Transactions Related to Investing and Financing Activities", "terseLabel": "Schedule of significant non-cash transactions related to investing and financing activities" } } }, "auth_ref": [] }, "biox_SecuredDebtCurrentRelatedParty": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "SecuredDebtCurrentRelatedParty", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of current secured debt in related party transactions.", "label": "Secured Debt Current, Related Party", "terseLabel": "Secured notes" } } }, "auth_ref": [] }, "biox_SecuredDebtsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "SecuredDebtsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementLiquidityRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for secured debts.", "label": "Secured Debts [Member]", "verboseLabel": "Secured notes" } } }, "auth_ref": [] }, "biox_SeedAndIntegratedProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "SeedAndIntegratedProductsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails", "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Seed and integrated products.", "label": "Seed and integrated products", "terseLabel": "Seed and integrated products" } } }, "auth_ref": [] }, "biox_SeedsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "SeedsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for information pertaining to seeds.", "label": "Seeds" } } }, "auth_ref": [] }, "ifrs-full_SegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SegmentsAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Segments [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r44", "r106", "r168", "r185", "r337", "r360" ] }, "ifrs-full_SegmentsDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SegmentsDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Segments [domain]" } }, "en": { "role": { "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Segments' axis if no other member is used." } } }, "auth_ref": [ "r44", "r106", "r175", "r185", "r337", "r360" ] }, "ifrs-full_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetIncomeFromDiscontinuedOperationsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Selling, general and administrative expense", "negatedLabel": "Selling, general and administrative expenses" } } }, "auth_ref": [ "r419" ] }, "ifrs-full_SellingGeneralAndAdministrativeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SellingGeneralAndAdministrativeExpenseMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "label": "Selling, general and administrative expense [member]", "terseLabel": "Selling, general and administrative expenses" } } }, "auth_ref": [ "r411", "r414" ] }, "biox_SeriesIxCorporateBondsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "SeriesIxCorporateBondsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for series IX corporate bonds.", "label": "Series IX Corporate Bonds [Member]", "terseLabel": "Series IX Corporate Bonds" } } }, "auth_ref": [] }, "biox_SeriesXCorporateBondsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "SeriesXCorporateBondsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for series X corporate bonds.", "label": "Series X Corporate Bonds [Member]", "terseLabel": "Series X corporate bonds" } } }, "auth_ref": [] }, "biox_ShareBasedIncentivesExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ShareBasedIncentivesExpenses", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 12.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of share-based incentives expenses.", "label": "Share Based Incentives Expenses", "terseLabel": "Share-based incentives" } } }, "auth_ref": [] }, "ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 2.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 16.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesChangesInJointVenturesInvestmentsDetails", "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesShareOfProfitDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Share of profit (loss) of associates and joint ventures accounted for using equity method", "negatedLabel": "Share of profit or loss of joint ventures and associates", "terseLabel": "Share of profit or loss of joint ventures and associates", "verboseLabel": "Share of profit or loss" } } }, "auth_ref": [ "r166", "r174", "r325" ] }, "ifrs-full_SharePremiumMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SharePremiumMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Share premium" } }, "en": { "role": { "documentation": "This member stands for the amount received or receivable from issuance of the entity's shares in excess of nominal value." } } }, "auth_ref": [ "r288" ] }, "biox_ShareholdersAndOtherRelatedPartiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "ShareholdersAndOtherRelatedPartiesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayablesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for shareholders and related parties that the entity does not separately disclose in the same statement or note.", "label": "Shareholders And Other Related Parties [Member]", "terseLabel": "Shareholders and other related parties" } } }, "auth_ref": [] }, "biox_SharesOfMoolecScienceS.a.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "SharesOfMoolecScienceS.a.Member", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Moolec Science S.A. shares.", "label": "Shares Of Moolec Science S.a. [Member]", "terseLabel": "Moolec Science S.A. shares", "verboseLabel": "Shares Of Moolec Science S.a." } } }, "auth_ref": [] }, "ifrs-full_ShorttermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ShorttermBorrowings", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 6.0 }, "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails": { "parentTag": "ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current borrowings", "terseLabel": "Borrowings" } }, "en": { "role": { "documentation": "The amount of current borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r416" ] }, "ifrs-full_ShorttermEmployeeBenefitsExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ShorttermEmployeeBenefitsExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 6.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Short-term employee benefits expense", "terseLabel": "Employee benefits and social securities" } } }, "auth_ref": [ "r414" ] }, "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SignificantInvestmentsInSubsidiariesAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails" ], "lang": { "en-us": { "role": { "label": "Subsidiaries [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r35", "r36", "r96", "r264" ] }, "ifrs-full_SignificantInvestmentsInSubsidiariesDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SignificantInvestmentsInSubsidiariesDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails" ], "lang": { "en-us": { "role": { "label": "Subsidiaries [domain]" } }, "en": { "role": { "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used." } } }, "auth_ref": [ "r35", "r36", "r96", "r264" ] }, "biox_SoftwareInProgressMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "SoftwareInProgressMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Software in progress.", "label": "Software In Progress [Member]", "terseLabel": "Software in progress" } } }, "auth_ref": [] }, "biox_SoybeanHb4Member": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "SoybeanHb4Member", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for information pertaining to Soybeans HB4.", "label": "Soybean HB4 and breeding program", "terseLabel": "HB4 technology and breeding program" } } }, "auth_ref": [] }, "ifrs-full_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS" } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "StatementOfChangesInEquityAbstract", "lang": { "en-us": { "role": { "label": "UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY" } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "StatementOfChangesInEquityLineItems", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Statement of changes in equity [line items]", "terseLabel": "Statement of changes in equity" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "StatementOfChangesInEquityTable", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Statement of changes in equity [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to changes in equity." } } }, "auth_ref": [ "r288" ] }, "ifrs-full_StatementOfComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "StatementOfComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "label": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME" } } }, "auth_ref": [] }, "ifrs-full_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION" } } }, "auth_ref": [] }, "biox_StatementOfNonCashTransactionsCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "StatementOfNonCashTransactionsCashFlowsAbstract", "lang": { "en-us": { "role": { "documentation": "It represents the information pertaining to non cash transactions in cash flow.", "label": "CASH FLOW INFORMATION" } } }, "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "StatementScenarioAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "auth_ref": [] }, "biox_StockOptionsAndShareBasedIncentivesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "StockOptionsAndShareBasedIncentivesMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Stock Options And Share Based Incentives.", "label": "Stock options and share based incentives" } } }, "auth_ref": [] }, "biox_SuppliesAndMaterials": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "SuppliesAndMaterials", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 10.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of current supplies and materials purchased for production.", "label": "Supplies and Materials", "terseLabel": "Supplies and materials" } } }, "auth_ref": [] }, "biox_SynertechIndustriasS.aMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "SynertechIndustriasS.aMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesAssetsAndLiabilitiesDetails", "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesShareOfProfitDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Synertech Industrias S.A.", "label": "Synertech Industrias S.A.", "terseLabel": "Synertech Industrias S.A." } } }, "auth_ref": [] }, "biox_TaxEffectOfDerecognitionOfTaxLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "TaxEffectOfDerecognitionOfTaxLossCarryforwards", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to derecognition of tax loss carryforwards.", "label": "Tax Effect Of Derecognition Of Tax Loss Carryforwards", "negatedLabel": "Derecognition of tax loss carryforwards" } } }, "auth_ref": [] }, "biox_TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible and revenues that are exempt from taxation in determining taxable profit (tax loss).", "label": "Tax Effect of Revenues Exempt from Taxation and Expenses Not Deductible in Determining Taxable Profit (Tax Loss)", "negatedLabel": "Non-deductible expenses" } } }, "auth_ref": [] }, "biox_TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to share of profit or loss of subsidies, joint ventures and associates.", "label": "Tax Effect of Share Of Profit Or Loss Of Subsidies, Joint Ventures And Associates", "negatedLabel": "Share of profit or loss of subsidiaries, joint ventures and associates" } } }, "auth_ref": [] }, "biox_TaxEffectOfStockOptionCharge": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "TaxEffectOfStockOptionCharge", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount representing the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to stock option charge.", "label": "Tax Effect Of Stock Option Charge", "negatedLabel": "Stock options charge" } } }, "auth_ref": [] }, "ifrs-full_TaxExpenseIncomeAtApplicableTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TaxExpenseIncomeAtApplicableTaxRate", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationIncomeTaxExpenseWasCalculatedByApplyingTaxRateInForceDetails", "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "Tax expense (income) at applicable tax rate", "negatedLabel": "Income tax expense by applying tax rate in force in the respective countries", "negatedTerseLabel": "Income tax" } }, "en": { "role": { "documentation": "The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]" } } }, "auth_ref": [ "r4", "r208" ] }, "biox_TaxInflationAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "TaxInflationAdjustment", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of Tax Inflation Adjustment", "label": "Tax Inflation Adjustment", "negatedLabel": "Tax inflation adjustment" } } }, "auth_ref": [] }, "biox_TaxJurisdictionAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "TaxJurisdictionAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationIncomeTaxExpenseWasCalculatedByApplyingTaxRateInForceDetails" ], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table.", "label": "Tax Jurisdiction [Axis]" } } }, "auth_ref": [] }, "biox_TaxJurisdictionDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "TaxJurisdictionDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationIncomeTaxExpenseWasCalculatedByApplyingTaxRateInForceDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for income taxes.", "label": "Tax Jurisdiction [Domain]" } } }, "auth_ref": [] }, "biox_TaxesOtherThanIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "TaxesOtherThanIncomeTaxes", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 23.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of taxes other income taxes.", "label": "Taxes Other Than Income Taxes", "terseLabel": "Taxes" } } }, "auth_ref": [] }, "ifrs-full_TopOfRangeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TopOfRangeMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Top of range [member]", "terseLabel": "Maximum" } }, "en": { "role": { "documentation": "This member stands for top of a range." } } }, "auth_ref": [ "r71", "r102", "r121", "r131", "r201", "r356", "r357", "r409" ] }, "biox_TotalResearchAndDevelopmentExpenseIncurred": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "TotalResearchAndDevelopmentExpenseIncurred", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of research and development costs that an entity incurs.", "label": "Total Research And Development Expense Incurred", "totalLabel": "Total" } } }, "auth_ref": [] }, "ifrs-full_TradeAndOtherCurrentPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TradeAndOtherCurrentPayables", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails": { "parentTag": "ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale", "weight": 1.0, "order": 8.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 9.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayablesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureAssetsSubjectToForeclosureAndDiscontinuedOperationsNetAssetsSubjectToForeclosureDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayablesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Trade and other current payables", "terseLabel": "Trade and other payables", "totalLabel": "Trade and other payable" } }, "en": { "role": { "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]" } } }, "auth_ref": [ "r301" ] }, "ifrs-full_TradeAndOtherCurrentPayablesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TradeAndOtherCurrentPayablesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Trade and other current payables [abstract]", "terseLabel": "Current" } } }, "auth_ref": [] }, "ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TradeAndOtherCurrentPayablesToRelatedParties", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayablesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Trade Payables, Related Party Transactions", "terseLabel": "Trade payable, related party" } }, "en": { "role": { "documentation": "The amount of current payables due to related parties. [Refer: Total for all related parties [member]; Payables to related parties]" } } }, "auth_ref": [ "r417" ] }, "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TradeAndOtherCurrentPayablesToTradeSuppliers", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayablesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Current trade payables", "terseLabel": "Trade creditors" } }, "en": { "role": { "documentation": "The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]" } } }, "auth_ref": [ "r380", "r417" ] }, "ifrs-full_TradeAndOtherCurrentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TradeAndOtherCurrentReceivables", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Trade and other current receivables", "terseLabel": "Trade receivables" } }, "en": { "role": { "documentation": "The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]" } } }, "auth_ref": [ "r277", "r298", "r312" ] }, "biox_TradeAndOtherPayablesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "TradeAndOtherPayablesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementLiquidityRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for trade and other payables.", "label": "Trade and other payables" } } }, "auth_ref": [] }, "ifrs-full_TradeAndOtherPayablesToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TradeAndOtherPayablesToRelatedParties", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Payables to related parties", "negatedLabel": "Trade and other payables" } }, "en": { "role": { "documentation": "The amount of payables due to related parties. [Refer: Total for all related parties [member]]" } } }, "auth_ref": [ "r417" ] }, "ifrs-full_TradeAndOtherPayablesToTradeSuppliers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TradeAndOtherPayablesToTradeSuppliers", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Trade payables", "negatedLabel": "Trade creditors" } }, "en": { "role": { "documentation": "The amount of payment due to suppliers for goods and services used in the entity's business." } } }, "auth_ref": [ "r417" ] }, "biox_TradeReceivablesFromRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "TradeReceivablesFromRelatedParties", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of trade receivables due from related parties.", "label": "Trade Receivables From Related Parties", "terseLabel": "Trade debtors" } } }, "auth_ref": [] }, "ifrs-full_TradeReceivablesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TradeReceivablesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Trade receivables", "terseLabel": "Trade receivables" } }, "en": { "role": { "documentation": "This member stands for trade receivables. [Refer: Trade receivables]" } } }, "auth_ref": [ "r152", "r155", "r258", "r261", "r364", "r414" ] }, "biox_TrademarksAndPatentsWithIndefiniteUsefulLivesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "TrademarksAndPatentsWithIndefiniteUsefulLivesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for trademarks and patents.", "label": "Trademarks And Patents With Indefinite Useful Lives [Member]", "terseLabel": "Trademarks and patents with indefinite useful lives" } } }, "auth_ref": [] }, "ifrs-full_TravelExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TravelExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 11.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Travel expense", "terseLabel": "Mobility and travel" } } }, "auth_ref": [ "r414" ] }, "ifrs-full_TreasurySharesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TreasurySharesMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Cost of own shares held" } }, "en": { "role": { "documentation": "This member stands for the entity\u2019s own equity instruments, held by the entity or other members of the consolidated group." } } }, "auth_ref": [ "r288" ] }, "biox_TrigallGeneticsS.a.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "TrigallGeneticsS.a.Member", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesAssetsAndLiabilitiesDetails", "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesShareOfProfitDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Trigall Genetics S.A.", "label": "Trigall Genetics S.A.", "terseLabel": "Trigall Genetics S.A." } } }, "auth_ref": [] }, "biox_TrustDebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "TrustDebtSecuritiesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Trust Debt Securities.", "label": "Trust debt securities", "terseLabel": "Trust debt securities" } } }, "auth_ref": [] }, "ifrs-full_TypesOfRisksAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TypesOfRisksAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementLiquidityRiskDetails" ], "lang": { "en-us": { "role": { "label": "Types of risks [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r21", "r122", "r123", "r124", "r126", "r145", "r150", "r151", "r219" ] }, "ifrs-full_TypesOfRisksDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TypesOfRisksDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementLiquidityRiskDetails" ], "lang": { "en-us": { "role": { "label": "Types of risks [domain]" } }, "en": { "role": { "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used." } } }, "auth_ref": [ "r21", "r122", "r123", "r124", "r126", "r145", "r150", "r151", "r219" ] }, "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TypesOfSharebasedPaymentArrangementsAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Types of share-based payment arrangements [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r132", "r251" ] }, "ifrs-full_TypesOfSharebasedPaymentArrangementsDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TypesOfSharebasedPaymentArrangementsDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Types of share-based payment arrangements [domain]" } }, "en": { "role": { "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used." } } }, "auth_ref": [ "r132", "r251" ] }, "currency_USD": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/currency/2025", "localname": "USD", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "label": "USD" } } }, "auth_ref": [] }, "ifrs-full_VehiclesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "VehiclesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "label": "Vehicles [member]", "terseLabel": "Vehicles" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing vehicles used in the entity's operations, specifically to include aircraft, motor vehicles and ships. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r386" ] }, "biox_VotesPerOrdinaryShare": { "xbrltype": "integerItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "VotesPerOrdinaryShare", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the number of votes for each ordinary share.", "label": "Votes Per Ordinary Share", "terseLabel": "Number of votes for each ordinary share" } } }, "auth_ref": [] }, "ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average lessee's incremental borrowing rate applied to lease liabilities recognised at date of initial application of IFRS 16", "terseLabel": "Incremental borrowing rate (as a percent)" } }, "en": { "role": { "documentation": "The weighted average lessee's incremental borrowing rate applied to lease liabilities recognised in the statement of financial position at the date of initial application of IFRS 16. The incremental borrowing rate is the rate of interest that a lessee would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment." } } }, "auth_ref": [ "r116" ] }, "biox_WeightedAverageNumberOfSharesDiluted": { "xbrltype": "sharesItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "WeightedAverageNumberOfSharesDiluted", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails" ], "lang": { "en-us": { "role": { "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares.", "label": "Weighted Average Number of Shares, Diluted", "terseLabel": "Weighted average number of shares (diluted EPS)" } } }, "auth_ref": [] }, "ifrs-full_WeightedAverageShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "WeightedAverageShares", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average number of ordinary shares outstanding", "verboseLabel": "Weighted average number of shares (basic EPS)" } }, "en": { "role": { "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor." } } }, "auth_ref": [ "r41" ] }, "ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average ordinary shares used in calculating basic and diluted earnings per share [abstract]", "terseLabel": "Denominator" } } }, "auth_ref": [] }, "biox_WorkingCapitalAdjustmentsOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20251231", "localname": "WorkingCapitalAdjustmentsOperatingActivitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Working capital adjustments" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "10", "IssueDate": "2025-01-01", "Paragraph": "21", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2025-en-r&anchor=para_21&doctype=Standard", "URIDate": "2025-03-27" }, "r1": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "10", "IssueDate": "2025-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI", "URIDate": "2025-03-27" }, "r2": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_79&doctype=Standard", "URIDate": "2025-03-27" }, "r3": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "81", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_a&doctype=Standard", "URIDate": "2025-03-27" }, "r4": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_c_i&doctype=Standard", "URIDate": "2025-03-27" }, "r5": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_c_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r6": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "81", "Subparagraph": "g", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_g_i&doctype=Standard", "URIDate": "2025-03-27" }, "r7": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "81", "Subparagraph": "g", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_g_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r8": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI", "URIDate": "2025-03-27" }, "r9": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_d&doctype=Standard", "URIDate": "2025-03-27" }, "r10": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e_i&doctype=Standard", "URIDate": "2025-03-27" }, "r11": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r12": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e_vii&doctype=Standard", "URIDate": "2025-03-27" }, "r13": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e_viii&doctype=Standard", "URIDate": "2025-03-27" }, "r14": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2025-03-27" }, "r15": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73&doctype=Standard", "URIDate": "2025-03-27" }, "r16": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "75", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_75_a&doctype=Standard", "URIDate": "2025-03-27" }, "r17": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "75", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_75_b&doctype=Standard", "URIDate": "2025-03-27" }, "r18": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "142", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_142&doctype=Standard", "URIDate": "2025-03-27" }, "r19": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "36", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2025-en-r&anchor=para_36_b&doctype=Standard", "URIDate": "2025-03-27" }, "r20": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "21", "IssueDate": "2025-01-01", "Paragraph": "52", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2025-en-r&anchor=para_52_b&doctype=Standard", "URIDate": "2025-03-27" }, "r21": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "21", "IssueDate": "2025-01-01", "Paragraph": "A19", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2025-en-r&anchor=para_A19_f&doctype=Standard", "URIDate": "2025-03-27" }, "r22": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2025-01-01", "Paragraph": "17", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_17_a&doctype=Standard", "URIDate": "2025-03-27" }, "r23": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2025-01-01", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2025-03-27" }, "r24": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2025-01-01", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_17&doctype=Standard", "URIDate": "2025-03-27" }, "r25": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2025-01-01", "Paragraph": "18", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2025-03-27" }, "r26": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2025-01-01", "Paragraph": "18", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_18&doctype=Standard", "URIDate": "2025-03-27" }, "r27": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2025-01-01", "Paragraph": "19", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_19_a&doctype=Standard", "URIDate": "2025-03-27" }, "r28": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2025-01-01", "Paragraph": "19", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_19_e&doctype=Standard", "URIDate": "2025-03-27" }, "r29": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2025-01-01", "Paragraph": "19", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_19_f&doctype=Standard", "URIDate": "2025-03-27" }, "r30": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2025-01-01", "Paragraph": "19", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_19_g&doctype=Standard", "URIDate": "2025-03-27" }, "r31": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2025-01-01", "Paragraph": "19", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_19&doctype=Standard", "URIDate": "2025-03-27" }, "r32": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2025-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_20&doctype=Standard", "URIDate": "2025-03-27" }, "r33": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2025-01-01", "Section": "Disclosures", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI", "URIDate": "2025-03-27" }, "r34": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "26", "IssueDate": "2025-01-01", "Paragraph": "35", "Subparagraph": "b", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2025-en-r&anchor=para_35_b_viii&doctype=Standard", "URIDate": "2025-03-27" }, "r35": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2025-01-01", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2025-03-27" }, "r36": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2025-01-01", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2025-03-27" }, "r37": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2025-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_66&doctype=Standard", "URIDate": "2025-03-27" }, "r38": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2025-01-01", "Paragraph": "67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_67&doctype=Standard", "URIDate": "2025-03-27" }, "r39": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2025-01-01", "Paragraph": "68", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_68&doctype=Standard", "URIDate": "2025-03-27" }, "r40": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2025-01-01", "Paragraph": "70", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_a&doctype=Standard", "URIDate": "2025-03-27" }, "r41": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2025-01-01", "Paragraph": "70", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_b&doctype=Standard", "URIDate": "2025-03-27" }, "r42": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2025-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI", "URIDate": "2025-03-27" }, "r43": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2025-01-01", "Paragraph": "126", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_126&doctype=Standard", "URIDate": "2025-03-27" }, "r44": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2025-01-01", "Paragraph": "130", "Subparagraph": "d", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_130_d_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r45": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2025-01-01", "Paragraph": "130", "Subparagraph": "f", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_130_f_i&doctype=Standard", "URIDate": "2025-03-27" }, "r46": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2025-01-01", "Paragraph": "134", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_134_a&doctype=Standard", "URIDate": "2025-03-27" }, "r47": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2025-01-01", "Paragraph": "134", "Subparagraph": "e", "Clause": "iiA", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_134_e_iiA&doctype=Standard", "URIDate": "2025-03-27" }, "r48": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2025-01-01", "Paragraph": "135", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_135_a&doctype=Standard", "URIDate": "2025-03-27" }, "r49": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "118", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_c&doctype=Standard", "URIDate": "2025-03-27" }, "r50": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e_i&doctype=Standard", "URIDate": "2025-03-27" }, "r51": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r52": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e_vi&doctype=Standard", "URIDate": "2025-03-27" }, "r53": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e_vii&doctype=Standard", "URIDate": "2025-03-27" }, "r54": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "118", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e&doctype=Standard", "URIDate": "2025-03-27" }, "r55": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "118", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118&doctype=Standard", "URIDate": "2025-03-27" }, "r56": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "126", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_126&doctype=Standard", "URIDate": "2025-03-27" }, "r57": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2025-01-01", "Paragraph": "32A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_32A&doctype=Standard", "URIDate": "2025-03-27" }, "r58": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2025-01-01", "Paragraph": "76", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_76&doctype=Standard", "URIDate": "2025-03-27" }, "r59": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2025-01-01", "Paragraph": "79", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_79_c&doctype=Standard", "URIDate": "2025-03-27" }, "r60": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2025-01-01", "Paragraph": "79", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_79_d&doctype=Standard", "URIDate": "2025-03-27" }, "r61": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2025-01-01", "Paragraph": "40", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_40&doctype=Standard", "URIDate": "2025-03-27" }, "r62": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2025-01-01", "Paragraph": "50", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_50_a&doctype=Standard", "URIDate": "2025-03-27" }, "r63": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2025-01-01", "Paragraph": "50", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_50&doctype=Standard", "URIDate": "2025-03-27" }, "r64": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_54_f&doctype=Standard", "URIDate": "2025-03-27" }, "r65": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_10&doctype=Standard", "URIDate": "2025-03-27" }, "r66": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "21", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_21&doctype=Standard", "URIDate": "2025-03-27" }, "r67": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_25&doctype=Standard", "URIDate": "2025-03-27" }, "r68": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_28&doctype=Standard", "URIDate": "2025-03-27" }, "r69": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "31", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_31&doctype=Standard", "URIDate": "2025-03-27" }, "r70": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35&doctype=Standard", "URIDate": "2025-03-27" }, "r71": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "44H", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_44H_b_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r72": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard", "URIDate": "2025-03-27" }, "r73": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "50", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_50_d&doctype=Standard", "URIDate": "2025-03-27" }, "r74": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Section": "Presentation of a statement of cash flows", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS07_g10-17_TI", "URIDate": "2025-03-27" }, "r75": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28&doctype=Standard", "URIDate": "2025-03-27" }, "r76": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "30", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2025-en-r&anchor=para_30_b&doctype=Standard", "URIDate": "2025-03-27" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2025-03-27" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "24", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2025-03-27" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_32_a_i&doctype=Standard", "URIDate": "2025-03-27" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_32_a_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "10", "IssueDate": "2025-01-01", "Paragraph": "22", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=10&code=ifrs-tx-2025-en-r&anchor=para_22&doctype=Standard", "URIDate": "2025-03-27" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "12", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_12_f&doctype=Standard", "URIDate": "2025-03-27" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "21", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_21_b_i&doctype=Standard", "URIDate": "2025-03-27" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ix", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "v", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_vi&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_vii&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B13", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B13", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B16", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B16&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B4", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B4", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B4_b&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "93", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_a&doctype=Standard", "URIDate": "2025-03-27" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "93", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_b&doctype=Standard", "URIDate": "2025-03-27" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "93", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_e&doctype=Standard", "URIDate": "2025-03-27" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "93", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93&doctype=Standard", "URIDate": "2025-03-27" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "14", "IssueDate": "2025-01-01", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2025-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2025-03-27" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2025-01-01", "Paragraph": "105", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_105&doctype=Standard", "URIDate": "2025-03-27" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2025-01-01", "Paragraph": "113", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_113_a&doctype=Standard", "URIDate": "2025-03-27" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2025-01-01", "Paragraph": "114", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_114&doctype=Standard", "URIDate": "2025-03-27" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2025-01-01", "Paragraph": "115", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_115&doctype=Standard", "URIDate": "2025-03-27" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2025-01-01", "Paragraph": "119", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_119&doctype=Standard", "URIDate": "2025-03-27" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2025-01-01", "Paragraph": "120", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_120_b_i&doctype=Standard", "URIDate": "2025-03-27" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "47", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_47_a&doctype=Standard", "URIDate": "2025-03-27" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2025-03-27" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "53", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53_a&doctype=Standard", "URIDate": "2025-03-27" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "53", "Subparagraph": "j", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53_j&doctype=Standard", "URIDate": "2025-03-27" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "53", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53&doctype=Standard", "URIDate": "2025-03-27" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "94", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_94&doctype=Standard", "URIDate": "2025-03-27" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "97", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_97&doctype=Standard", "URIDate": "2025-03-27" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "C12", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_C12_a&doctype=Appendix&subtype=C", "URIDate": "2025-03-27" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS16_g51-60_TI", "URIDate": "2025-03-27" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Section": "Presentation", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS16_g47-50_TI", "URIDate": "2025-03-27" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "109", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_109&doctype=Standard", "URIDate": "2025-03-27" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "109A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_109A&doctype=Standard", "URIDate": "2025-03-27" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "120", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_120&doctype=Standard", "URIDate": "2025-03-27" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "124", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_124&doctype=Standard", "URIDate": "2025-03-27" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "125", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_125&doctype=Standard", "URIDate": "2025-03-27" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "127", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_127&doctype=Standard", "URIDate": "2025-03-27" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "128", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_128_a_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "128", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_128_a&doctype=Standard", "URIDate": "2025-03-27" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "132", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_132_b&doctype=Standard", "URIDate": "2025-03-27" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "C32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_C32&doctype=Appendix&subtype=C", "URIDate": "2025-03-27" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_i&doctype=Standard", "URIDate": "2025-03-27" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_vi&doctype=Standard", "URIDate": "2025-03-27" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "45", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_d&doctype=Standard", "URIDate": "2025-03-27" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard", "URIDate": "2025-03-27" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2025-01-01", "Paragraph": "B64", "Subparagraph": "f", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_f_iv&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2025-01-01", "Paragraph": "B64", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2025-01-01", "Paragraph": "B67", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2025-01-01", "Paragraph": "B67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B67&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2025-01-01", "Paragraph": "33", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_a&doctype=Standard", "URIDate": "2025-03-27" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2025-01-01", "Paragraph": "33", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_b_i&doctype=Standard", "URIDate": "2025-03-27" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2025-01-01", "Paragraph": "33", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_b_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2025-01-01", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2025-03-27" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2025-01-01", "Paragraph": "33", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_c&doctype=Standard", "URIDate": "2025-03-27" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2025-01-01", "Paragraph": "33", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_d&doctype=Standard", "URIDate": "2025-03-27" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2025-01-01", "Paragraph": "38", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_38&doctype=Standard", "URIDate": "2025-03-27" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2025-01-01", "Section": "Presentation and disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS05_g30-42_TI", "URIDate": "2025-03-27" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "21C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_21C&doctype=Standard", "URIDate": "2025-03-27" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "22A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_22A&doctype=Standard", "URIDate": "2025-03-27" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "23B", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_23B_a&doctype=Standard", "URIDate": "2025-03-27" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_25&doctype=Standard", "URIDate": "2025-03-27" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "31", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_31&doctype=Standard", "URIDate": "2025-03-27" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_33&doctype=Standard", "URIDate": "2025-03-27" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_34&doctype=Standard", "URIDate": "2025-03-27" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "35H", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35H_b_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "35H", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35H&doctype=Standard", "URIDate": "2025-03-27" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "35I", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35I&doctype=Standard", "URIDate": "2025-03-27" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "35M", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35M_b_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "35M", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35M&doctype=Standard", "URIDate": "2025-03-27" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "39", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_39_a&doctype=Standard", "URIDate": "2025-03-27" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "42E", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_42E_e&doctype=Standard", "URIDate": "2025-03-27" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "42I", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_42I&doctype=Standard", "URIDate": "2025-03-27" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_6&doctype=Standard", "URIDate": "2025-03-27" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_7&doctype=Standard", "URIDate": "2025-03-27" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "B2", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B2_a&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "B8", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B8_c&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Section": "Defined terms", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&doctype=Appendix&subtype=A&dita_xref=IFRS07_APPA_TI", "URIDate": "2025-03-27" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "23", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_a&doctype=Standard", "URIDate": "2025-03-27" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "23", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_g&doctype=Standard", "URIDate": "2025-03-27" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "23", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_h&doctype=Standard", "URIDate": "2025-03-27" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23&doctype=Standard", "URIDate": "2025-03-27" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2025-03-27" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_a&doctype=Standard", "URIDate": "2025-03-27" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2025-03-27" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_c&doctype=Standard", "URIDate": "2025-03-27" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_d&doctype=Standard", "URIDate": "2025-03-27" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_e&doctype=Standard", "URIDate": "2025-03-27" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28&doctype=Standard", "URIDate": "2025-03-27" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_32&doctype=Standard", "URIDate": "2025-03-27" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "33", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_33_a&doctype=Standard", "URIDate": "2025-03-27" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_34&doctype=Standard", "URIDate": "2025-03-27" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI", "URIDate": "2025-03-27" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "9", "IssueDate": "2025-01-01", "Paragraph": "7.2.34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2025-en-r&anchor=para_7.2.34&doctype=Standard", "URIDate": "2025-03-27" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "9", "IssueDate": "2025-01-01", "Paragraph": "7.2.42", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2025-en-r&anchor=para_7.2.42&doctype=Standard", "URIDate": "2025-03-27" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2026-01-01", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "20B", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20B&doctype=Standard", "URIDate": "2025-03-27" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2026-01-01", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "30A", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_30A_b_i&doctype=Standard", "URIDate": "2025-03-27" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103&doctype=Standard", "URIDate": "2025-03-27" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "104", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_104&doctype=Standard", "URIDate": "2025-03-27" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "107", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_107&doctype=Standard", "URIDate": "2025-03-27" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "108", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_108_b_i&doctype=Standard", "URIDate": "2025-03-27" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "115", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115_a&doctype=Standard", "URIDate": "2025-03-27" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "115", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115_i&doctype=Standard", "URIDate": "2025-03-27" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "115", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115&doctype=Standard", "URIDate": "2025-03-27" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "122", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_122_a&doctype=Standard", "URIDate": "2025-03-27" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "124", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_124&doctype=Standard", "URIDate": "2025-03-27" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "128", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_128&doctype=Standard", "URIDate": "2025-03-27" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "138", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_138&doctype=Standard", "URIDate": "2025-03-27" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "160", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a_i&doctype=Standard", "URIDate": "2025-03-27" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "160", "Subparagraph": "a", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "160", "Subparagraph": "a", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a_iv&doctype=Standard", "URIDate": "2025-03-27" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "160", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a&doctype=Standard", "URIDate": "2025-03-27" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "160", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160&doctype=Standard", "URIDate": "2025-03-27" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "164", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_164_b&doctype=Standard", "URIDate": "2025-03-27" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "168", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_168_b_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "169", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_169&doctype=Standard", "URIDate": "2025-03-27" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "178", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_178&doctype=Standard", "URIDate": "2025-03-27" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "180", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_180_b&doctype=Standard", "URIDate": "2025-03-27" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "190", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_190&doctype=Standard", "URIDate": "2025-03-27" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "192", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_192&doctype=Standard", "URIDate": "2025-03-27" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "194", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_a&doctype=Standard", "URIDate": "2025-03-27" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "194", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_c_i&doctype=Standard", "URIDate": "2025-03-27" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "194", "Subparagraph": "c", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_c_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "194", "Subparagraph": "f", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_f_i&doctype=Standard", "URIDate": "2025-03-27" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "194", "Subparagraph": "f", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_f_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "200", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_d&doctype=Standard", "URIDate": "2025-03-27" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "200", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e_i&doctype=Standard", "URIDate": "2025-03-27" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "200", "Subparagraph": "e", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "200", "Subparagraph": "e", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e_vii&doctype=Standard", "URIDate": "2025-03-27" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "200", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e&doctype=Standard", "URIDate": "2025-03-27" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "200", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200&doctype=Standard", "URIDate": "2025-03-27" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "218", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_218_b&doctype=Standard", "URIDate": "2025-03-27" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "223", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_223_f&doctype=Standard", "URIDate": "2025-03-27" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "227", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_227&doctype=Standard", "URIDate": "2025-03-27" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "230", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_230_b&doctype=Standard", "URIDate": "2025-03-27" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "230", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_230&doctype=Standard", "URIDate": "2025-03-27" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "231", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_231_a&doctype=Standard", "URIDate": "2025-03-27" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "231", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_231_e&doctype=Standard", "URIDate": "2025-03-27" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "231", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_231_f&doctype=Standard", "URIDate": "2025-03-27" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "231", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_231_g&doctype=Standard", "URIDate": "2025-03-27" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "231", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_231&doctype=Standard", "URIDate": "2025-03-27" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2025-03-27" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "24", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2025-03-27" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "250", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_250&doctype=Standard", "URIDate": "2025-03-27" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "254", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_254_a&doctype=Standard", "URIDate": "2025-03-27" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "254", "Subparagraph": "e", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_254_e_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "255", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_255_a&doctype=Standard", "URIDate": "2025-03-27" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "263", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_c&doctype=Standard", "URIDate": "2025-03-27" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "263", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_e_i&doctype=Standard", "URIDate": "2025-03-27" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "263", "Subparagraph": "e", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_e_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "263", "Subparagraph": "e", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_e_vi&doctype=Standard", "URIDate": "2025-03-27" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "263", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_e&doctype=Standard", "URIDate": "2025-03-27" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "263", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263&doctype=Standard", "URIDate": "2025-03-27" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "266", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_266&doctype=Standard", "URIDate": "2025-03-27" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "269", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_269&doctype=Standard", "URIDate": "2025-03-27" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "271", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_271_c&doctype=Standard", "URIDate": "2025-03-27" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "271", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_271_d&doctype=Standard", "URIDate": "2025-03-27" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "273", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_273_a&doctype=Standard", "URIDate": "2025-03-27" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "273", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_273&doctype=Standard", "URIDate": "2025-03-27" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "274", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_274_e&doctype=Standard", "URIDate": "2025-03-27" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_28_a_i&doctype=Standard", "URIDate": "2025-03-27" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_28_a_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "31", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_i&doctype=Standard", "URIDate": "2025-03-27" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "31", "Subparagraph": "b", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_vi&doctype=Standard", "URIDate": "2025-03-27" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "31", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31&doctype=Standard", "URIDate": "2025-03-27" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35&doctype=Standard", "URIDate": "2025-03-27" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "37", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_37&doctype=Standard", "URIDate": "2025-03-27" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "43", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_43&doctype=Standard", "URIDate": "2025-03-27" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "56A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_56A&doctype=Standard", "URIDate": "2025-03-27" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "58", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_58&doctype=Standard", "URIDate": "2025-03-27" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "64A", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_64A_b_i&doctype=Standard", "URIDate": "2025-03-27" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "66", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_66_b_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_66&doctype=Standard", "URIDate": "2025-03-27" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "70", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_70&doctype=Standard", "URIDate": "2025-03-27" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "71", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_71_b_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "71", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_71&doctype=Standard", "URIDate": "2025-03-27" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "72", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_72_a&doctype=Standard", "URIDate": "2025-03-27" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "75", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_75_a&doctype=Standard", "URIDate": "2025-03-27" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "75", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_75_b&doctype=Standard", "URIDate": "2025-03-27" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "88", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_88_a&doctype=Standard", "URIDate": "2025-03-27" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "89", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_89&doctype=Standard", "URIDate": "2025-03-27" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "95", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95_a&doctype=Standard", "URIDate": "2025-03-27" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "95", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95_b&doctype=Standard", "URIDate": "2025-03-27" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "95", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95&doctype=Standard", "URIDate": "2025-03-27" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B10", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a_i&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B10", "Subparagraph": "a", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a_iii&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B10", "Subparagraph": "a", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a_iv&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B10", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B12", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B12&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B9", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_b&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B9", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_e&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B9", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_f&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expired 2023-01-01", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "22", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_22&doctype=Standard", "URIDate": "2025-03-27" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2026-01-01", "Name": "IFRS", "Number": "9", "IssueDate": "2025-01-01", "Paragraph": "7.2.49", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2025-en-r&anchor=para_7.2.49&doctype=Standard", "URIDate": "2025-03-27" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_103&doctype=Standard", "URIDate": "2025-03-27" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_a&doctype=Standard", "URIDate": "2025-03-27" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d_i&doctype=Standard", "URIDate": "2025-03-27" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d&doctype=Standard", "URIDate": "2025-03-27" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106&doctype=Standard", "URIDate": "2025-03-27" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "107", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_107&doctype=Standard", "URIDate": "2025-03-27" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "51", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_51&doctype=Standard", "URIDate": "2025-03-27" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_a&doctype=Standard", "URIDate": "2025-03-27" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_b&doctype=Standard", "URIDate": "2025-03-27" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_c&doctype=Standard", "URIDate": "2025-03-27" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_d&doctype=Standard", "URIDate": "2025-03-27" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_e&doctype=Standard", "URIDate": "2025-03-27" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_f&doctype=Standard", "URIDate": "2025-03-27" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_g&doctype=Standard", "URIDate": "2025-03-27" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_h&doctype=Standard", "URIDate": "2025-03-27" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_i&doctype=Standard", "URIDate": "2025-03-27" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "j", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_j&doctype=Standard", "URIDate": "2025-03-27" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "k", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_k&doctype=Standard", "URIDate": "2025-03-27" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "n", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_n&doctype=Standard", "URIDate": "2025-03-27" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "o", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_o&doctype=Standard", "URIDate": "2025-03-27" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "p", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_p&doctype=Standard", "URIDate": "2025-03-27" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "q", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_q&doctype=Standard", "URIDate": "2025-03-27" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "r", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_r&doctype=Standard", "URIDate": "2025-03-27" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard", "URIDate": "2025-03-27" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "56", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_56&doctype=Standard", "URIDate": "2025-03-27" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "61", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_61&doctype=Standard", "URIDate": "2025-03-27" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_66&doctype=Standard", "URIDate": "2025-03-27" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "69", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_69&doctype=Standard", "URIDate": "2025-03-27" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_b&doctype=Standard", "URIDate": "2025-03-27" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "78", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_d&doctype=Standard", "URIDate": "2025-03-27" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_e&doctype=Standard", "URIDate": "2025-03-27" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a_i&doctype=Standard", "URIDate": "2025-03-27" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a_iv&doctype=Standard", "URIDate": "2025-03-27" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a&doctype=Standard", "URIDate": "2025-03-27" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79&doctype=Standard", "URIDate": "2025-03-27" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "81A", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81A_a&doctype=Standard", "URIDate": "2025-03-27" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "81A", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81A_b&doctype=Standard", "URIDate": "2025-03-27" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "81A", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81A_c&doctype=Standard", "URIDate": "2025-03-27" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "82", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_a&doctype=Standard", "URIDate": "2025-03-27" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "82", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_b&doctype=Standard", "URIDate": "2025-03-27" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "82", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_c&doctype=Standard", "URIDate": "2025-03-27" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "82", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_d&doctype=Standard", "URIDate": "2025-03-27" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "82", "Subparagraph": "ea", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_ea&doctype=Standard", "URIDate": "2025-03-27" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "91", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_91_a&doctype=Standard", "URIDate": "2025-03-27" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "98", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_98_e&doctype=Standard", "URIDate": "2025-03-27" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "99", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_99&doctype=Standard", "URIDate": "2025-03-27" }, "r331": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "10", "IssueDate": "2025-01-01", "Paragraph": "22", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2025-en-r&anchor=para_22_c&doctype=Standard", "URIDate": "2025-03-27" }, "r332": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "80", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_80_a&doctype=Standard", "URIDate": "2025-03-27" }, "r333": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "37", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_37_b&doctype=Standard", "URIDate": "2025-03-27" }, "r334": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "37", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_37_c&doctype=Standard", "URIDate": "2025-03-27" }, "r335": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "37", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_37_g&doctype=Standard", "URIDate": "2025-03-27" }, "r336": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "37", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_37_h&doctype=Standard", "URIDate": "2025-03-27" }, "r337": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "138", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_138_d&doctype=Standard", "URIDate": "2025-03-27" }, "r338": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "147", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_147_c&doctype=Standard", "URIDate": "2025-03-27" }, "r339": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "32", "IssueDate": "2025-01-01", "Paragraph": "IE33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2025-en-r&anchor=para_IE33&doctype=Illustrative%20Examples", "URIDate": "2025-03-27" }, "r340": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "119", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_119_c&doctype=Standard", "URIDate": "2025-03-27" }, "r341": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "119", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_119_e&doctype=Standard", "URIDate": "2025-03-27" }, "r342": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "41", "IssueDate": "2025-01-01", "Paragraph": "43", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_43&doctype=Standard", "URIDate": "2025-03-27" }, "r343": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "41", "IssueDate": "2025-01-01", "Paragraph": "51", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_51&doctype=Standard", "URIDate": "2025-03-27" }, "r344": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "41", "IssueDate": "2025-01-01", "Section": "Example 1 XYZ Dairy Ltd", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&doctype=Illustrative%20Examples&dita_xref=IAS41_IE_ex1_TI", "URIDate": "2025-03-27" }, "r345": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "16", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_16_a&doctype=Standard", "URIDate": "2025-03-27" }, "r346": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2025-03-27" }, "r347": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2025-03-27" }, "r348": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "17", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_c&doctype=Standard", "URIDate": "2025-03-27" }, "r349": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "17", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_d&doctype=Standard", "URIDate": "2025-03-27" }, "r350": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2025-03-27" }, "r351": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "44C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_44C&doctype=Standard", "URIDate": "2025-03-27" }, "r352": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Section": "C Reconciliation of liabilities arising from financing activities", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_C_TI", "URIDate": "2025-03-27" }, "r353": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "IG63", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_IG63&doctype=Implementation%20Guidance", "URIDate": "2025-03-27" }, "r354": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B10", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r355": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B23", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B23_c&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r356": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "B6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_B6&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r357": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "IE63", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_IE63&doctype=Illustrative%20Examples", "URIDate": "2025-03-27" }, "r358": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "15", "IssueDate": "2025-01-01", "Paragraph": "B89", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r359": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "113", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_113_b&doctype=Standard", "URIDate": "2025-03-27" }, "r360": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "96", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_96_c&doctype=Standard", "URIDate": "2025-03-27" }, "r361": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "5", "IssueDate": "2025-01-01", "Paragraph": "33", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_d&doctype=Standard", "URIDate": "2025-03-27" }, "r362": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "5", "IssueDate": "2025-01-01", "Section": "Example 11", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&doctype=Implementation%20Guidance&dita_xref=IFRS05_ex11_TI", "URIDate": "2025-03-27" }, "r363": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_32&doctype=Standard", "URIDate": "2025-03-27" }, "r364": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "35N", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35N&doctype=Standard", "URIDate": "2025-03-27" }, "r365": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "B11", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B11_c&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r366": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "B11", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B11&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r367": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "B35", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B35_e&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r368": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "B35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B35&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r369": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "IG31A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance", "URIDate": "2025-03-27" }, "r370": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23&doctype=Standard", "URIDate": "2025-03-27" }, "r371": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2025-03-27" }, "r372": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "103", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103_a&doctype=Standard", "URIDate": "2025-03-27" }, "r373": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "191", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_191_c&doctype=Standard", "URIDate": "2025-03-27" }, "r374": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "193", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_193_a&doctype=Standard", "URIDate": "2025-03-27" }, "r375": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B9", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_b&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r376": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "102", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_102&doctype=Standard", "URIDate": "2025-03-27" }, "r377": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_103&doctype=Standard", "URIDate": "2025-03-27" }, "r378": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_108&doctype=Standard", "URIDate": "2025-03-27" }, "r379": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "68", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_68&doctype=Standard", "URIDate": "2025-03-27" }, "r380": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "70", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_70&doctype=Standard", "URIDate": "2025-03-27" }, "r381": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_b&doctype=Standard", "URIDate": "2025-03-27" }, "r382": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "82A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82A&doctype=Standard", "URIDate": "2025-03-27" }, "r383": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "IG6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_IG6&doctype=Implementation%20Guidance", "URIDate": "2025-03-27" }, "r384": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r385": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "81", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81&doctype=Standard", "URIDate": "2025-03-27" }, "r386": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "37", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_37&doctype=Standard", "URIDate": "2025-03-27" }, "r387": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_d&doctype=Standard", "URIDate": "2025-03-27" }, "r388": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2025-03-27" }, "r389": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "37", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2025-en-r&anchor=para_37&doctype=Standard", "URIDate": "2025-03-27" }, "r390": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "118", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_c&doctype=Standard", "URIDate": "2025-03-27" }, "r391": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "119", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_119&doctype=Standard", "URIDate": "2025-03-27" }, "r392": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "40", "IssueDate": "2025-01-01", "Paragraph": "79", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_79_c&doctype=Standard", "URIDate": "2025-03-27" }, "r393": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "41", "IssueDate": "2025-01-01", "Paragraph": "50", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_50&doctype=Standard", "URIDate": "2025-03-27" }, "r394": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "41", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_54_f&doctype=Standard", "URIDate": "2025-03-27" }, "r395": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "14", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_14&doctype=Standard", "URIDate": "2025-03-27" }, "r396": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "16", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_16&doctype=Standard", "URIDate": "2025-03-27" }, "r397": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17&doctype=Standard", "URIDate": "2025-03-27" }, "r398": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "20", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20_a&doctype=Standard", "URIDate": "2025-03-27" }, "r399": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "20", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20_b&doctype=Standard", "URIDate": "2025-03-27" }, "r400": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "20", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20_c&doctype=Standard", "URIDate": "2025-03-27" }, "r401": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20&doctype=Standard", "URIDate": "2025-03-27" }, "r402": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "31", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_31&doctype=Standard", "URIDate": "2025-03-27" }, "r403": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard", "URIDate": "2025-03-27" }, "r404": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "93", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_e_i&doctype=Standard", "URIDate": "2025-03-27" }, "r405": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "94", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_94&doctype=Standard", "URIDate": "2025-03-27" }, "r406": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "5", "IssueDate": "2025-01-01", "Paragraph": "33", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_c&doctype=Standard", "URIDate": "2025-03-27" }, "r407": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "5", "IssueDate": "2025-01-01", "Paragraph": "33", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_d&doctype=Standard", "URIDate": "2025-03-27" }, "r408": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "5", "IssueDate": "2025-01-01", "Paragraph": "38", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_38&doctype=Standard", "URIDate": "2025-03-27" }, "r409": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_7&doctype=Standard", "URIDate": "2025-03-27" }, "r410": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "10", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_10_e&doctype=Standard", "URIDate": "2025-03-27" }, "r411": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "104", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_104&doctype=Standard", "URIDate": "2025-03-27" }, "r412": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d&doctype=Standard", "URIDate": "2025-03-27" }, "r413": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_108&doctype=Standard", "URIDate": "2025-03-27" }, "r414": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "112", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_112_c&doctype=Standard", "URIDate": "2025-03-27" }, "r415": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "117", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_117&doctype=Standard", "URIDate": "2025-03-27" }, "r416": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard", "URIDate": "2025-03-27" }, "r417": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "78", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78&doctype=Standard", "URIDate": "2025-03-27" }, "r418": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a&doctype=Standard", "URIDate": "2025-03-27" }, "r419": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "85", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_85&doctype=Standard", "URIDate": "2025-03-27" } } }